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Tolerance to the effects of abused substances has long been implicated
as a causal factor in addiction. Such tolerance is not based entirely
on pharmacologic processes; recently the role played by nonpharmacol-
ogic factors has become an area of increasing research interest and
potential clinical importance. An understanding of the mechanisms of
tolerance is a key element in our eventually understanding the larger
question of human dependence upon such substances, and ultimately will
be useful for developing improved strategies for prevention and
treatment.
Aspects of tolerance are being investigated across a broad range of
drugs, in humans as well as a variety of animal species. At present,
no agreement exists on the mechanisms underlying behavioral tolerance,
but as data continue to be added to the base of empirical knowledge,
a theoretical synthesis may be approached.
The technical review at which the papers in this monograph were pre-
sented was held at the National Institute on Drug Abuse on June 23-24,
1977. At that meeting, past and present research findings on
behavioral tolerance in substance abuse were presented; theoretical
and experimental approaches to investigation in this field were com-
pared and contrasted; an attempt was made to develop a working defi-
nition of behavioral tolerance as it applies to substance abuse; and
possible new initiatives for investigating the concept within clinical
research and experimental treatment research settings were discussed,
The central purpose of this monograph is to share what was communicated
at the technical review, so as to stimulate further interest among the
scientific and medical communities in the part played by nonpharmacol-
ogic factors in drug tolerance and dependencies, and thus to further
the accumulation of new knowledge.
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viiiIntroduction
Norman A. Krasnegor, Ph.D.
Tolerance to a substance can be demonstrated by the observation
that repeated administrations of a fixed dose lead to a diminu-
tion of effect. Alternatively, one can demonstrate tolerance by
showing that a substance’s original effect, diminished in magni-
tude after sequential exposures to a fixed dose, can be reinstated
by an increase in that dose. An understanding of how tolerance
influences the dependence processes associated with chronic habit-
ual drug and alcohol use is essential for those who work in the
field of substance abuse research because of its reported necessary
role in the maintenance of drug addiction and alcoholism. Accord-
ing to this view, drug and alcohol addicts become physically
dependent, in part, because the initial effects of a substance
diminish with repeated use. In order to attain the original
effect that a substance produces in a user, therefore, larger or
more frequent doses are consumed. The problem is further com-
pounded for addicts because the diminished response to a fixed
dose of an abused substance may lead to the onset of withdrawal
symptoms. Thus, the development of tolerance to a substance can
contribute to the dependence process by escalating the need for
more of that substance to attain a desired effect or to postpone
or eliminate abstinence symptoms.
Pharmacologists generally divide the study of tolerance into two
broad categories: dispositional and functional. The former sub-
sumes all studies on a substance’s effect when changes occur which
limit the amount of a substance that bathes its target cells. Such
investigations encompass research on altered absorption, distribu-
tion, inactivation and/or excretion of a substance from the body.
Also included under this rubric is the study of physiological
tolerance, i.e., investigations of the altered responsivity of
the target cells themselves.
Studies of functional tolerance include all other investigations
of tolerance, which are excluded from the dispositional category
because the results obtained are not readily understood within
the framework of extant pharmacological and/or physiological
theories. Behavioral tolerance is an example par excellence of
functional tolerance. Study of this phenomenon is important
1because it represents a significant conceptual advance. The experi-
mental evidence available shows conclusively that nonpharmacological
factors can play a significant role in the development of tolerance.
The evidence presented in this monograph demonstrates the relevance
of behavioral and environmental variables for this area of research.
Even more important, the studies described in this monograph stress
the necessity to take the experimental history and the organism’s
interaction with its environment into account when designing research
protocols on tolerance.
Behavioral tolerance can be understood in three ways: empirically,
descriptively, and theoretically (Ferraro, this volume). As an
empirical term, it is defined relative to the procedures necessary
and sufficient to observe it. As a descriptive term, it is defined
relative to the aggregate of individual empirical relationships
which together constitute the basis for making generalizations and
predictions concerning it. As a theoretical term, it is defined
relative to underlying mechanisms of action which serve to provide
a meta- level explanation for the observed empirical relationships.
Behavioral tolerance is used in each of the three ways in this mono-
graph. In this respect, it accurately reflects the state-of-the-art
of such research.
At present, there is no acceptable empirical definition for the
concept of behavioral tolerance. The consensus of those present
at the meeting which led to the publication of this monograph was
that the necessary and sufficient conditions and procedures opera-
tionally to demonstrate behavioral tolerance are not known. There
is an emerging descriptive definition of the concept based upon the
continuing empirical work being generated; there is no clear consen-
sus, however, as to whether behavioral tolerance represents the
development of tolerance to the behavioral effects of a substance
or the effects of behavior on the development of tolerance to the
substance’s effects.
issue.
Further research may help to clarify this
There are several theoretical definitions of behavioral tolerance.
The elegant experiments of Siegel implicate the role of classical
conditioning processes. Carder discusses the possible importance
of stress in the development of tolerance. Others, such as Ferraro
and Woolverton and Schuster implicate operant principles in the
development of tolerance. While there is by no means a consensus,
it is apparent that those who have identified learning theory as a
mechanism, including Siegel and O’Brien, will actively pursue this
line of inquiry. (All of these investigators, this volume.)
It is unclear at present whether research in behavioral tolerance
is orthogonal to other types of research paradigms designed to
study tolerance in general. Suffice it to say that as the empirical
data accumulate, all those who study tolerance will have to inte-
grate such information into their approaches and experimental
designs. Future research designed to elucidate the concept of
behavioral tolerance could productively focus upon the environment
in which the substance abuse occurs. Thus, studies should be
2undertaken which investigate the abuser in the social setting and
physical surroundings where the habit was acquired and maintained.
In addition, the emerging field of human behavioral pharmacology of
substance abuse can serve as a framework within which the relation-
ship of self-administration of substance(s) to the development of
tolerance can be investigated. Of particular interest would be
studies undertaken to determine: why tolerance to a substance
develops in some individuals but not others; the relationship of
tolerance to the dependence process; and tolerance to the reinforcing
effects of substances. Data collected in the human behavioral
pharmacology laboratory could serve as a guide for designing studies
of substance abuse in the natural environment. For example, the
underlying relevant physiological parameters which define the sub-
jective phenomenon of “craving” could then be related to relevant
stimuli which occur in the natural environment and help clinicians
to treat more effectively those who are dependent.
The possibilities for future research in the field of behavioral
tolerance are rich and varied. If what already has been accomplished
is an accurate prologue to what will come, we can look forward to
much new knowledge which will contribute significantly to our under-
standing of the dependence processes associated with substance abuse.
I am pleased that the National Institute on Drug Abuse has helped
contribute to the emergence of this new and exciting field of inquiry
and am hopeful that the work presented in this monograph will help
to stimulate new and productive research.
3I. CONCEPTUALIZATION
Theoretical Basis of Behavioral
Tolerance:
Implications of the Phenomenon
for Problems of Drug Abuse
Charles R. Schuster, Ph.D.
Most studies in the area of behavioral pharmacology involve the de-
termination of the effects of a number of different doses of a drug
on a particular behavior. For accuracy in the determination of a
drug’s potency, such dose-response studies are designed to minimize
the interaction of previous drug experience with the effects of each
subsequent dose. These studies are essential to determine the pro-
file of behavioral actions of different classes of pharmacologic
agents. There are a number of reasons, however, for studying the
behavioral actions of drugs given repeatedly under conditions where
prior dose experience is likely to modify its subsequent actions.
The most compelling reason for conducting such studies is that this
is the usual manner in which drugs are taken both for therapeutic
reasons and when they are abused.
The most common change produced by prior experience with a drug is
a decrease in responsiveness to its effects. When an organism be-
comes less sensitive to the actions of a drug by virtue of past exper-
ience with the drug, we refer to this change as acquired tolerance.
If acquired tolerance to one drug confers tolerance to a second drug,
we refer to this phenomenon as cross-tolerance.
Investigations of the conditions leading to the development of drug
tolerance as well as the mechanisms underlying this change in sensi-
tivity are important areas of investigation for several reasons.
Tolerance development complicates the use of a drug in therapeutic
conditions demanding its repeated administration. Further, studies
of drug tolerance are extremely important in the area of drug abuse,
since this phenomenon may be responsible for many of the problems
associated with the repeated administration of a drug. The seemingly
unending increase in the amount of opiate drugs used by addicts is
but one obvious example of the relevance of the study of tolerance
to the problems of drug abuse. Of fundamental importance is deter-
mining the interrelationship between tolerance development and the
development of dependence upon a drug. This interrelationship will
be discussed in a later section of this paper.
On the basis of different experimental strategies, pharmacologists
have operationally defined tolerance in several ways. Tolerance may
be defined as a diminished effect with successive administration of
4the same dose of a drug. Tolerance may be further characterized by
experiments demonstrating that it is necessary to increase the dose
of a drug in order to produce the intensity and/or duration of action
originally observed. The most precise manner for defining and quan-
tifying tolerance is to determine dose-response relationships both
before and after repeated exposure to a drug. In such experiments a
parallel shift in the dose-response curve to the right is an indica-
tion that tolerance has developed. In addition, measuring the degree
of shift may provide an estimation of the degree of tolerance devel-
oped. (There are, however, same reservations regarding the precision
of such estimates in whole organism research which will be discussed
in a later section.)
Although tolerance is the most common change seen with repeated ad-
ministration of a drug, in some instances the reverse occurs.
Such increased responsiveness to a drug following its repeated admin-
istration is termed sensitization. Such sensitization has been re-
ported, for example, for certain of the actions of cocaine (Downs and
Eddy 1932; Post 1977; Stripling and Ellinwood 1977; Tatum and Seevers
1929). Although this paper will confine itself to studies of behav-
ioral tolerance, it should be pointed out that identical research
strategies are used to study sensitization to a drug.
Subsequent to the establishment of the fact that tolerance does de-
velop to a particular drug, a second stage of research involves the
investigation of the mechanisms underlying this change in sensitivity.
Many drugs have been investigated in this manner and certain general
classes of mechanisms producing tolerance have been established. Tol-
erance develops to any drug which can induce the synthesis of enzymes
responsible for its degradation. Certain barbiturates, for example,
are known to increase the concentration of liver microsomal enzymes
responsible for their degradation. Thus, when barbiturates are taken
repeatedly, we would expect a more rapid elimination of the drug from
the body, with a consequent decrease in the intensity and/or duration
of the actions of the drug. When amphetamines are administered re-
peatedly, food intake may be suppressed. Such altered food ingestion
causes a change in the pH of the urine, with a consequent effect upon
reabsorption of the drug in the kidney. In this case, the drug’s
disposition is being affected indirectly by a change produced in the
organism’s eating behavior. When the decreased sensitivity to a drug
is explicable on the basis of its altered absorption, distribution,
inactivation and/or excretion from the body, we refer to this change
as dispositional tolerance. This mechanism, however, cannot account
for the tolerance to drugs observed when drug concentrations are
equal at the target organs of tolerant and non-tolerant organisms.
Under these circumstances, the term functional tolerance is used to
suggest some adaptation of the organism to the drug-induced physio-
logic perturbation. Thus, the term “functional” is used in instances
where tolerance cannot be explained on the basis of the drug’s altered
disposition.
The term “tolerance” is used in relation to a variety of effects. For
example in the pharmacologic literature we may read that “cardiovascu-
lar tolerance” develops to a drug. Such a term is used purely descrip-
tively to imply that: 1) the drug had some cardiovascular effect, and
52) this effect diminished with repeated administration of the drug.
It is in this descriptive sense that I intend to use the term "behav-
ioral tolerance.” As this term is being used in this paper it has no
mechanistic implications but rather simply means that a drug has some
behavioral action which diminishes with its repeated administration.
This change in sensitivity to the behavioral actions of a drug may
be because of its altered disposition or any functional mechanism.
An excellent review by Kalant et al. (1971) has covered the variables
affecting the development of dispositional tolerance to different
classes of drugs. In the present chapter, I will concentrate on func-
tional tolerance to behaviorally active drugs, since it is in this
area that environmental variables may have influence. Before con-
sidering these environmental variables affecting functional behav-
ioral tolerance, we will consider: 1) the strategies for studying
behavioral tolerance; 2) strategies for discriminating between func-
tional and dispositional tolerance, and 3) pertinent pharmacologic
variables affecting functional tolerance to the behavioral actions
of drugs.
I. STRATEGIES FOR STUDYING BEHAVIORAL TOLERANCE
Potentially any behavior which is affected by a drug could be used in
studies of tolerance development. For investigations of the rate and
extent of tolerance development, however, the behavior must be quan-
tifiable. Further, there are advantages to using within-subject ever-
imental designs for investigating the effects o repeated administra-
tion of a drug. With such designs it is essential that the behavior
be stable over long periods of time approximating the duration of the
repeated drug regimen. The methods of operant conditioning have been
shown to generate behavioral baselines which are ideal for the study
of both the acute and chronic effects of drugs (Seiden and Dykstra
1977; Thompson and Schuster 1968). These methods emphasize the main-
tenance of behavior over periods of days, weeks, and months. Further,
a wide range of behaviors can be brought under experimental control
and precisely measured using these procedures. These attributes make
this methodology extremely valuable for the study of drug tolerance.
A study from my own laboratory illustrates how such procedures may be
used (Fischman and Schuster 1974). In this study, effects of chronic
intravenous administration of d-methamphetamine were determined
in rhesus monkeys trained to lever press on a Fixed-Ratio 10 schedule
of food reinforcement for two hours each day. These animals received
an intravenous infusion of drug every three hours beginning at a dose
of .0625 mg/kg/infusion. After tolerance developed to the behavioral
suppressant effects of the drug, the dose was systematically increased
over a six to ten month period to dosage levels as high as 6.5 mg/kg/
. . It should be obvious that in order to interpret the effects .
of drugs given repeatedly over an eight to ten month period we must
have a procedure which would have generated a stable behavioral base-
line if drug had not been given. The methods of operant conditioning
are particularly well suited for this purpose, since they have been
shown to produce behavioral baselines which remain stable over years
(Ferster and Skinner 1957).
6In most studies of the effects of repeated administration of a drug
on operant behavior, the animals are brought under the discriminative
control of lights or tones, and performance is maintained by food
or water presentation or the cessation of an aversive stimulus. It
is possible, however, to use drugs as discriminative or reinforcing
stimuli (Schuster and Balster 1977; Schuster and Johanson 1974;
Schuster and Thompson 1969). These studies have obvious implications
for the problem of drug abuse. It is of great importance to investi-
gate the development of tolerance to these stimulus functions of
drugs. Unfortunately, relatively little systematic work has been
done in this area. Recent evidence (Shannon and Holtzman 1976) sug-
gests that tolerance does develop to the discriminative stimulus
effects of morphine. However, no systematic studies of tolerance
development to the reinforcing actions of morphine have been carried
out. Balster and Schuster (1973) presented data showing that there
was little change in the reinforcing actions of cocaine over a period
of several months. If tolerance developed to the reinforcing actions
of the drug, the number of injections taken daily would be expected to
increase, and this was not found to be the case. On the other hand,
tolerance to the reinforcing actions of cocaine was suggested by the
fact that one of the animals in this experiment had a longer past
history of self-administering cocaine, and this animal showed a much
higher level of intake than the other animals in the study. Clearly,
more systematic work must be done to determine whether tolerance de-
velops to the reinforcing actions of cocaine. Such work is now in
progress in my laboratory and the data strongly suggests that toler-
ance to the reinforcing actions of cocaine does not develop.
Observations from my own laboratory also indicate that tolerance does not
develop to the reinforcing actions of d-methamphetamine (Fischman
and Schuster 1973). This study used two rhesus monkeys previously
treated with gradually increasing doses of d-methamphetamine admin-
istered intravenously every 3 hours for a period of eight months.
During and after the chronic d-methamphetamine regimen it was estab-
lished that these animals were tolerant to the disruptive effects
of the drug on DRL performance maintained by food (Fischman and
Schuster 1977). Subsequently, we determined the rate of lever pres-
sing for intravenous infusions of d-methamphetamine delivered under
an FR-10 schedule during a Z-hour daily experimental session. Ani-
mals were tested with three doses of d-methamphetamine (0.025, 0 .05
and 0.1 mg/kg/infusion) . Figure 1 shows the mean number of drug
infusions delivered at each dose of d-methamphetamine. As has pre-
viously been shown (Bolster and Schuster 1973), there is an inverse
relationship between dose and the number of infusions earned. For
comparison purposes the mean number of infusions earned by a group
of 5 monkeys never exposed to the chronic drug regimen is also shown
in Figure 1 for the dose of 0.05 mg/kg. As can be seen there is no
difference in the amount of d-methamphetamine self-administered by
the two groups of animals. clearly these observations need confir-
mation in a more systematic manner. Nonetheless, they strongly sug-
gest that exposure to very high doses of d-methamphetamine does not
alter the animal’s subsequent responsiveness to the reinforcing
actions of the drug. It is important to note that these same animals
7FIGURE 1
Dose of d-methamphetam ine
(mg /kg / infusion)
were tolerant to the disruptive effects of d-methamphetamine on their
food-maintained DRL performance. The important point in the present
context is that through the use of operant conditioning procedures,
tolerance to the discriminative and reinforcing effects of drugs can
be studied. More research in this area is needed and should be a
high priority item because of its implications for the problems of
drug abuse.
To summarize, it is the position of this paper that the methods of
schedule-controlled operant conditioning are uniquely suited for the
study of the changes in responsiveness to the repeated administration
of drugs.
II. METHODS FOR DISCRIMINATING BETWEEN DISPOSITIONAL AND
FUNCTIONAL TOLERANCE
Following the observation that tolerance develops to the behavioral
actions of a drug, it is important to determine whether this change
in responsiveness is due to changes in the disposition of the drug
or to functional adaptations to the drug. Ideally, to make this dis-
8crimination we would determine whether the concentrations of the
drug are the same in the brains of tolerant and nontolerant animals.
If the concentrations of the drug are the same in the brains of tol-
erant and nontolerant animals, we infer that the lowered sensitivity
to the drug must be due to some functional change in the organism.
If there is a lower drug concentration in the brains of tolerant
animals, this suggests that at least in part, the decreased drug
responsiveness is caused by dispositional changes. To rule out the
involvement of functional changes as well requires giving tolerant
animals an increased amount of the drug sufficient to equalize brain
concentrations. Only if both groups are then equally responsive
may we conclude that the tolerance is completely attributable to
dispositional factors.
These ideal strategies, however, are rarely obtainable in practice.
With many drugs we are not certain whether metabolites may be pharma-
cologically active. If they are, then their concentration in the
brain as well as the parent compound must be assayed. There is also
a question of whether whole brain levels of these substances are the
appropriate level of analysis or whether regional distribution of
the drug and its metabolites should be measured. In any case, these
“ideal” procedures are beyond the capability of most laboratories
studying behavioral tolerance. Fortunately there is an alternative
strategy which can be utilized to determine whether tolerance to a
drug is functional or dispositional. This strategy is based upon
the fact that changes in a drug’s disposition in the body should
result in comparable changes in responsiveness to all of the behav-
ioral actions of a drug. Conversely, it is unlikely that functional
tolerance would develop at the same rate or to the same extent to
all of a drug’s behavioral actions. Thus, if one can demonstrate
differential tolerance development to the various behavioral effects
of a drug, this strongly suggests that the mechanism is functional.
A particularly powerful strategy for showing differential tolerance
development is the use of a multiple schedule of reinforcement.
This strategy is illustrated in a study by Schuster et al. (1966).
In this study rats were trained to lever press on a multiple fixed-
interval (FI)-DRL schedule of reinforcement. When these animals were
given repeated administration of d-amphetamine, tolerance developed
to the rate-increasing effects in the DRL component but not in the
FI component. Clearly, changes in the disposition of d-amphetamine
cannot account for the selective tolerance development to the ac-
tions of the drug in only one component of the multiple schedule.
This strategy for determining whether behavioral tolerance is func-
tional or dispositional does depend upon the selection of the right
behavioral measures. In instances where functional tolerance de-
velops to all the behavioral measures taken, it is impossible to dif-
ferentiate between functional and dispositional tolerance. This
outcome appears unlikely, however, if a broad sample of behavior is
obtained.
9III. PHARMACOLOGIC VARIABLES AFFECTING TOLERANCE TO THE
BEHAVIORAL ACTIONS OF DRUGS
A. Dosage Regimens
As mentioned in the introduction there are a variety of experi-
mental strategies for demonstrating tolerance development to a drug.
In most behavioral experiments investigating the effects of repeated
administration of a drug, only one dose of the drug is used. If the
effects of this dose diminish with repeated administration, we con-
clude that tolerance has developed to the drug. In most instances
this approach is adequate for this conclusion. It is conceivable,
however, that changes in response to the repeated administration of
the drug might result from its accumulation rather than tolerance.
It is impossible to determine this unless full dose-response rela-
tionships are known. For example, an early study of dl-amphetamine
tolerance used rats trained on a DRL 17.5 sec. schedule of reinforce-
ment (Schuster and Zimmerman 1961). The acute effect of dl-amphcta-
mine was to increase the animal’s response rate. With daily adminis-
tration of dl-amphetamine, response rates showed progressively
smaller increments. This was interpreted as demonstrating tolerance
development to the actions of dl-amphetamine on the animal’s DRL per-
formance . An alternative explanation of this decrease could be that
with repeated daily administration the dl-amphetamine accumulated;
therefore, functionally the daily dose was increasing. Since the
actions of dl-amphetamine on DRL are biphasic (low doses increase
rate and high doses decrease rate), the decreased responding observed
could simply represent the effects of a gradually increasing daily
dosage level.
One simple manipulation to rule out this alternative interpretation
is to determine whether the original effect of the drug can be obtained
in tolerant animals by increasing the drug dose administered. This
manipulation is a truncated version of the ideal strategy which involves
determining a full dose-response curve before, during, and after the
chronic drug regimen. Whenever possible this strategy should be util-
ized. There are, however, some limitations to the use of this ideal
strategy in attempting to quantify the degree of tolerance development.
These limitations are based upon the fact that when we obtain a dose-
response relationship using a behavioral measure, it is highly un-
likely that we are dealing with a single effect which varies only
quantitatively. This is particularly true when dealing with drug
effects which cause a decrease in the rate of an operant response,
since many unrelated factors may produce this common outcome. It is
argued that a parallel shift in the dose-response curve indicates
that we are dealing with the same drug effect. This presumes, how-
ever, that the variability in the dose-response relationships is
small enough meaningfully to discriminate differences in slopes of
the dose-response curves. Unfortunately, behavioral measures often
show large variations in response to drugs, thus limiting the use-
fulness of looking for parallel shifts in dose-response relationships.
Clearly this indicates that for quantitative work we must make every
effort to improve our behavioral control procedures. It seems quite
plausible to speculate that the mechanisms responsible for disruption
10of operant performances will vary as a function of the dose of a drug.
For example, a low dose of amphetamine might disrupt a food-reinforced
lever pressing operant simply because of drug-induced interoceptive
changes which function as novel stimuli. As dose is increased the
drug may disrupt the ongoing operant by virtue of its interaction with
the food deprivation state of the organism. At still higher doses,
the drug may elicit stereotypical behaviors, which are greater in
strength and incompatible with the operant response. Tolerance may
develop to any or all of these actions of the drug. Clearly, the
development of tolerance to the novel stimulus effects of the drug
could cause a shift in the dose-response curve to the right. However,
it is questionable whether in the redetermination we are estimating
the degree of tolerance to the novel stimulus effects of the drug or
obtaining an unchanged dose response curve for an effect with a higher
threshold. This strongly suggests that to investigate fully the de-
velopment of tolerance to a drug, several dosage levels should be used
as the dose given repeatedly.
B. The Selection of Dose for the Chronic Drug Regimen
In the previous section, I have suggested that more than one
dose should be studied when investigating whether and to what extent
tolerance develops to the behavioral actions of a drug. With drugs
which induce enzymes responsible for their degradation, maximal tol-
erance develops to doses producing maximum enzyme levels. Therefore,
studies of this type of tolerance may use relatively high doses of
the drug. With functional tolerance, however, the selection of doses
is more complicated. If the functional tolerance represents some
form of homeostatic adaptation, this adaptation may only be possible
across a limited dose range. For behavioral studies, doses somewhere
between the ED-25 and ED-75 determined when the drug is given acutely
are most appropriate for repeated administration. Higher doses may
be tested, but only after tolerance develops to lower doses. If the
dose selected for repeated administration causes a complete suppres-
sion of the behavior being studied, this may prevent or at least de-
lay the development of compensatory mechanisms which result in toler-
ante. This is particularly true if the compensatory mechanisms are
behavioral in nature and require reinforcement for their strengthening
and maintenance. More will be said about this in a later section.
C. Frequency of Drug Administration
Recent work in my laboratory has suggested that more than one
type of tolerance can develop to the behavioral actions of the same
drug when given with different frequencies. Amphetamines given once
daily immediately prior to a session in which rats or monkeys per-
form on a DRL schedule of reinforcement show the development of tol-
erance to the drug (Campbell and Seiden 1973; Schuster et al. 1966;
Schuster and Zimmerman 1961). Such tolerance development has been
shown to be critically dependent upon whether the drug is given be-
fore the session or after the session (Campbell and Seiden 1973).
When the drug is given chronically after the session, no tolerance
develops to its behavioral actions.
11This suggests that there is an interaction between the drug and the
performance contingencies. On the other hand, we have recently found
a marked degree of tolerance to the behavioral actions of d-metham-
phetamine in rhesus monkeys who did not perform in their behavioral
task during the repeated drug regimen. In this case, the repeated
drug regimen consisted of twice daily intramuscular injections of
d-methamphetamine in gradually escalating dosages from 0.5-16 mg/kg/
injection. Following this regimen, the animals showed a 2-4 fold
decrease in sensitivity to the disruptive actions of the drug. Neuro-
chemical analysis of the brains of similarly treated monkeys have
shown an irreversible depletion in brain monoamines (Seiden et al.
1976). Since the actions of amphetamines in the brain are mediated
through monoamines, it seems entirely probable that the tolerance
observed in these animals is attributable to the decreased availabil-
ity of monoamines. Such depletions of monoamines are not seen when
low doses of the drug are given to animals daily and hence this can-
not be the explanation for tolerance developed when injections are
given only once daily. Thus, the mechanism responsible for behavioral
tolerance may critically depend on the frequency of administration of
the drug during the chronic regimen.
Clearly, systematic investigations of drug tolerance should include
the investigation of various doses given at various frequencies.
Only in this manner is it possible to define the various conditions
under which tolerance may develop. Although such research projects
are ambitious, there is no way of shortcutting the task.
IV. ENVIRONMENTAL VARIABLES AFFECTING TOLERANCE DEVELOPMENT TO THE
BEHAVIORAL EFFECTS OF DRUGS
In the past few years, studies have begun to appear in the pharmaco-
logic literature demonstrating that environmental variables are of
considerable importance in the development of functional tolerance to
behaviorally active drugs. In this section I would like to review
some of my own work which has convinced me of the central importance
of the reinforcement contingencies as a variable affecting behavioral
tolerance to a drug. In 1961, I co-authored a paper with Dr. Joseph
Zimmerman on the effects of repeated administration of dl-amphetamine
to rats trained to lever press on a DRL 17.5 second schedule of milk
reinforcement. In this study we observed that the initial effects of.
dl-amphetamine were to increase the animals’ lever press rate and, as a
&sequence, decrease the number of reinforcements received. With
repeated administration, however, the animals showed a gradual de-
cline in response rate, a shift in the Inter Response Time (IRT) dis-
tribution toward control patterns, and an increase in the number of
reinforcements received. Since the effect of the drug declined with
repeated administration, we concluded that partial tolerance had de-
veloped. In a second study we repeated the original experiment with
the addition of obtaining a measure of the animals’ general activity
every other day. Thus animals were tested on alternate days in the
activity apparatus and the operant chamber under the DRl schedule of
milk reinforcement. The initial effects of dl-amphetamine were to
increase general activity and increase 1ever responding in the DRL
sessions. With daily administration of the drug we again observed a
gradual shift in the animals’ DRL performance towards that observed
12under nondrug conditions. In contrast, drug-induced general activ-
ity increments were sustained throughout the course of the chronic
drug regimen. This development of selective tolerance to one of the
behavioral actions of dl-amphetamine and not to another strongly
suggested to us that this tolerance was functional and not disposi-
tional. Further, we speculated that the decline in reinforcement
frequency in the DRL sessions might have contributed to the develop-
ment of functional tolerance to the drug. Since there were no rein-
forcement contingencies associated with the general activity session,
the drug-induced behavioral change did not “cost” the animal anything
and therefore no tolerance developed.
A later experiment (Schuster et al. 1966) was designed specifically
to investigate the role of reinforcement contingencies in the devel-
opent of functional tolerance to the amphetamines. In this study
three rats were trained to lever press on a multiple DRL 30 sec-FI 30
sec schedule of food reinforcement. Following training and the deter-
mination of a dose-response curve for single administrations of d-
amphetamine, the animals were given 1.0 mg/kg of d-amphetamine daily
for 30 consecutive days. Initially for all three-animals d-ampheta-
mine produced a decrement in reinforcement frequency in the DRL com-
ponent of the multiple schedule. With repeated administration of the
drug, however, rate increases and/or temporal patterning of lever
pressing gradually returned toward control values with a consequent
increase in reinforcement frequency. For two of these animals d-
amphetamine caused a rate increase in the FI component but no change
in reinforcement frequency. These increased rates in the FI compon-
ent were maintained over the entire 30 days of the chronic drug regi-
men. In the third animal, d-amphetamine initially produced a rate
decrease and a fall in frequency of reinforcement in the FI component.
With repeated administration of the drug, rate and reinforcement
frequency returned to control values. These data strongly suggest
that tolerance to changes in response rate developed only when these
changes produced a decrease in reinforcement frequency. The toler-
ance developed whether the drug induced increases in responding (DRL)
or decreases (FI) provided that the rate change decreased the frequency
of reinforcement. In a second experiment in this series rats were
trained to lever press in order to avoid an electric shock delivered
every 30 seconds. Four of the animals trained under these contingen-
cies continued to receive a number of electric shocks in each daily
session. When given 1.0 mg/kg of d-amphetamine for 35 consecutive
days their lever press response rate remained consistently elevated.
That is, tolerance did not develop to the rate increasing effects of
d-amphetamine. It is to be noted that because of the increased re-
sponse rate the number of shocks received was markedly reduced during
the chronic drug regimen.
The data from all of these experiments prompted us to put forth a for-
mal hypothesis stating that: “Behavioral tolerance will develop in
those aspects of the organism’sbehavioral repertoire where the action
of the drug is such that it disrupts the organisms behavior in meet-
ing the environmental requirement for reinforcements. Conversely,
where the actions of the drug enhance, or do not affect, the organism's
behavior in meeting reinforcement requirements, we do not expect the
development of behavioral tolerance.” It was not our intention to
13put forth this reinforcement-loss hypothesis as an alternative to
other physiological theories of drug tolerance. Rather, we intended
to stress that the interaction of the contingencies of reinforcement
with the drug-induced behavioral change is an extremely important
variable affecting the development of functional tolerance to a drug.
It is beyond the scope of this paper to review those studies which
have derived data which support or refute our hypothesis. I am cer-
tain it will get a few bruises in the other papers presented
in this monograph. It seems clear to me that any such simple hypo-
thesis regarding the interaction of drug effects with contingencies
of reinforcement would need great elaboration in order to take into
consideration all of the other pharmacologic and environmental vari-
ables affecting functional tolerance. To do this at the present
time, however, would be largely speculative, since relatively few
systematic studies of behavioral tolerance have been done. We need
more data before we can further refine our hypothesis. I am in hopes
that this symposium may suggest those variables which should be system-
atically studied in relationship to the reinforcement-loss hypothesis.
V. IMPLICATIONS OF BEHAVIORAL TOLERANCE FOR PROBLEMS  OF DRUG ABUSE
We have all been asked by the sponsors of this monograph to speculate
about the implications of behavioral tolerance for the problems of
drug abuse. Before beginning such speculation, I would like to state
that in my opinion we need more systematic experimentation before we
can begin properly to appreciate the interrelations between toler-
ance and the abuse of a drug. Clearly, tolerance develops to most, if
not all, drugs commonly abused in our society. An understanding of
the pharmacology of these drugs, including the mechanisms underlying
the development of tolerance to their behavioral actions, is essential
if we are to make any real progress in comprehending the problems of
drug abuse.
Now let me indulge in some speculations regarding the importance
of studies of behavioral tolerance to the problems of drug abuse.
As stated previously, the chronic administration of a drug for non-
therapeutic reasons is complicated by the development of tolerance.
The seemingly inexorable escalation of daily dosage which character-
izes the abuse of most drugs clearly involves one of the consequences
of the development of tolerance. It is not at all clear, however,
when such dosage escalation is due to the development of tolerance
to the reinforcing effects of a drug or to some other effects which
may have initially limited the intake of the drug. For example, when
rhesus monkeys are allowed unlimited access to intravenous morphine
delivered on an FR-1 schedule of reinforcement they show a gradual
increase in responding for the first 40-50 days (Deneau et al. 1969).
Thereafter, the number of injections received daily remains stable.
It is tempting to attribute the original increase in drug intake to
the development of tolerance to the reinforcing effects of the drug.
Equally possible, however, is that originally the animals’ intake was
suppressed by the direct effects of morphine on lever-pressing behav-
ior. As the animals become tolerant to the response-suppressing
effects of the drug, the number of injections could increase. Clearly,
14this matter needs additional research to clarify the relative impor-
tance of these two alternative explanations. This points to a general
need for research to clarify under what pharmacologic and environ-
mental conditions tolerance develops to the reinforcing effects of
drugs. It seems obvious that if conditions could be arranged so that
drug dosage was not continually escalated, many of the social and med-
ical problems associated with drug abuse could be avoided. Stated
another way, by studying the variables that give rise to the dosage
escalation characterizing drug abuse, it may be possible to develop
procedures for aiding drug users to maintain their drug use at lower
levels. Such a therapeutic goal is perhaps admissible at this time
since it is obvious that the goal of total drug abstinence is probably
not obtainable for the vast majority of drug abusers.
I have stated elsewhere that I believe that drug abuse involves not
only the self-administration of a drug, but also the demonstration
that such drug taking has deleterious consequences (Schuster and Jo-
hanson 1974). This means that drugs must be evaluated not only for
their reinforcing effects but for their physiological and behavioral
toxicity as well. It is clear that tolerance does develop to many
of the toxic effects of abused drugs. For example, what might be a
behaviorally incapacitating dose of marihuana to the nontolerant
individual might actually enhance certain performances of the highly
tolerant individual. One must be very careful therefore in defining
the drug history of experimental subjects when assessing a drug’s pos-
sible toxicity. Further, this complicates legal and social policies
regarding acceptable levels of drug use. Ultimately it would seem
appropriate to base legal decisions as to acceptable levels of drug
use on the basis of functional tests rather than on arbitrary blood
levels.
A final issue concerns the relationship of tolerance to drug depend-
ence . The WHO (WHO Tech. Report 1964) has stated that drug dependence
includes three distinct components: tolerance, physical dependence,
and compulsive abuse (psychic craving). Different classes of abused
drugs show these three components in differing proportions. Opiates,
for example, produce all three components whereas with drugs such as
the psychomotor stimulants, the physical dependence component is mini-
mal if not completely absent. It is unclear whether there are common
mechanisms underlying both tolerance and physical dependence. On the
other hand, it is clear that both tolerance and physical dependence
can be separated from a drug’s ability to generate compulsive abuse.
Thus, tolerance may occur with all drugs of abuse, but not all drugs
producing tolerance are subject to abuse. Clearly, more research is
needed to determine the importance of tolerance in the development of
drug dependence and the consequent abuse of drugs. I believe we have
only begun to do the systematic work necessary to define the pharma-
cologic, organismic, and environmental variables which affect the de-
velopment of functional tolerance to the behavioral actions of drugs.
As the papers presented in this monograph emphasize, studies of
the repeated administration of drugs must take into consideration the
complex interaction between drug-induced behavioral change and the
consequences of such behavioral change in the organism’s adaptation
to his environment. I believe that behavioral pharmacologists have a
15great deal to contribute to the understanding of the mechanisms under-
lying functional tolerance to behaviorally active drugs. Ultimately,
such understanding is essential for the evolvement of rational preven-
tive and therapeutic approaches to the problems of drug abuse.
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17I. CONCEPTUALIZATION
Behavioral Tolerance
P. B. Dews, M.D., Ph.D.
Many different mechanisms for the development of tolerance to drugs
have been demonstrated, yet for some well-established examples of
tolerance, no mechanism has been shown. No doubt, additional mech-
anisms remain to be discovered. It is, therefore, impossible
to infer by exclusion a mechanism in any particular example of tol-
erance. We are here to discuss a particular mechanism of tolerance:
behavioral tolerance. Behavioral tolerance must be identified by
positive criteria, not by exclusion. Further, as the various mecha-
nisms of development of tolerance are not usually exclusive, we must ex-
pect that more than one mechanism will be involved in the development
of tolerance to a drug, even in a single individual at a particular
time. A mechanism that has been shown to operate may make only a
trivial contribution to the total tolerance in a particular instance.
It is, therefore, necessary to measure the contribution of a particu-
lar mechanism; for, if the quantitative contribution is not assessed,
the major contributors to tolerance may be overlooked. Behavioral
tolerance has been discussed only in recent years and relatively few
workers have studied it quantitatively. It is the purpose of this
essay to contribute to the search for criteria for behavioral toler-
ance that can be applied in the laboratory and clinic and that lead
to quantitative assessments. The presentation will be largely theo-
retical and forward looking, and will rely heavily on analogies.
Quantitative criteria will be sought that will be hard to achieve,
and, indeed, comparable precision rarely has been achieved in physio-
logical and biochemical studies. That most physiological and biochem-
ical studies on tolerance do not fulfill precise quantitative criteria
is no reason why studies on behavioral tolerance should not seek to
do better. The establishment of strict criteria may be useful in sug-
gesting the area of doubt remaining to be resolved in a particular line
of investigation; for example, the strict criteria articulated by Paton
(1958) for identification of neurohumora1 transmitters may have helped
to reduce premature claims for transmitter roles for substances found
in the CNS.
18Tolerance has been defined as a reduction in the intensity of the ef-
fect of a dose of a drug, or the requirement of a larger dose for the
original intensity, when the drug has been previously present in a sub-
ject. It is preferable, however, to define tolerance as a shift to the
right of the dose-effect curve of a drug following appropriate exposure
to the drug. This definition emphasizes the importance of exploring
dose-effect relations and leads naturally to measurement of the degree
of tolerance as the shift in the curve. Pharmacologists have long
realized that it is more useful to measure changes in dose-effect
curve and not just changes in effect. The shift-to-the-right defini-
tion of tolerance also leads to analogies to drug antagonisms that
may be useful heuristically. Tolerance is antagonism to the effects
of a drug as a result of exposure to the drug itself or to a relative,
in which case the effect is called cross-tolerance. Tolerance may
be considered as reflexive (in the sense of a reflexive verb) self-
antagonism.
We are led to ask whether there are varieties of tolerance correspond-
ing to the varieties of antagonisms. Is there surmountable tolerance
in which the full range of effects of the drug can still be achieved,
but at consistently higher doses Tolerance to many of the effects ?
of morphine appears to be of this type. Is there unsurmountable tol-
erance, in which the full effect of the drug in the nontolerant sub-
ject can no longer be achieved at any dose, no matter how large? Tol-
erance to indirect effects of drugs, the drug liberating pharmacolog-
ically active substances from pre-existing body stores, must become
unsurmountable if the stores can be depleted. Is there irreversible
tolerance in which the effects of a drug in a subject are permanently
changed? The tolerance to some behavioral effects of drugs may be
of this type: in initial exposures the effects of the drug are en-
hanced by novelty that is permanently lost in the drug-experienced
subject (Dews 1962, p. 438). Negative tolerance clearly occurs in
the form of sensitization to the effects of a drug by prior exposure,
corresponding to potentiation in the realm of antagonism.
DEFINITIONS
Tolerance may be defined as the reduction in the effect of a con-
straint on a biological system as a result of exposure to the con-
straint. Tolerance develops to a variety of physical circumstances
such as heat, cold, and delivery of electric shocks. Tolerance de-
velops to exercise and the effects of many brain lesions. Tolerance
is a very common biological phenomenon. The changed effect of a
drug is called pharmacological tolerance. Three types of pharma-
cological tolerance can be recognized by the processes they involve:
dispositional, physiological, and behavioral. Dispositional toler-
ance is conceptually the easiest to understand: as a result of
exposure to a drug, the physicochemical processes handling the drug
in the body are so modified that reduced concentrations of the drug
reach the receptive cells, whose modification produces the pharma-
cological effects of the drug.
19The most familiar mechanism of dispositional tolerance is increased
rate of metabolism of the drug following repeated administration, as
by the induction of higher activity of metabolizing enzymes, typical-
ly in cells other than those responsible for the pharmacological ef-
fects of the drug. It follows that tolerance to all the effects of
the drug will occur, evidenced by a reduction in effect corresponding
to a movement left along the dose-effect curve by an amount determined
by the reduction in concentration of the drug. Because of the dif-
fering slopes and positions of dose-effect curves for different ef-
fects of even the same drug, the proportional reduction in the various
effects of the drug will not generally be the same even with pure
dispositional tolerance. Dispositional tolerance rarely produces a
more than 2- or 3-fold decrease in sensitivity, i.e., an 0.5 log unit
shift of the dose-effect curve to the right.
Physiological tolerance is a change in the receptive cells, or in
cells functionally related to them, such that the effects of a dose
of the drug are reduced, even though the receptive cells are subject-
ed to the same concentration of the drug. The changes must be in the
specific cells related to the pharmacological effects of the drug.
Physiological tolerance may lead to a shift in the dose-effect by
one log (10) unit or more to the right. Rarely is much more known
about the mechanism.
Behavioral tolerance to a drug is a change in the effect of the drug
due to alteration of environmental constraints. In common parlance,
subjects learn to cope with the effects of the drug, but “learn” is
an undesirable word as it seems to point to a specific process, a
gratuitous and meaningless extension.
The distinction between the three types of tolerance is based on the
kind of mechanism involved, but the type of tolerance may be recog-
nized without knowing the specific mechanism. Dispositional tolerance
may be diagnosed by knowledge of drug levels, without any information
on how the levels came to be changed in the tolerant subject. Phys-
iological tolerance may be identified by the reduced responsiveness
of isolated tissue from a tolerant subject, also without any infor-
mation on how the cells have changed their susceptibility. Recogni-
tion of type is generally much easier than elucidating mechanism and
is usually a prerequisite for the latter.
As with all relatively simple definitions, our definitions of types
of pharmacological tolerance should not be considered exhaustive.
New types may well be discovered. Indeed, it is easy to think of
possible mechanisms of tolerance that would not fit easily into any
of the three types. Suppose the reduction in the peripheral blood
flow caused by a vasoconstrictor is progressively attenuated because
the heart, unaffected directly by the drug, hypertrophies and gen-
erates higher arterial pressures. Such a mechanism of tolerance is
hardly covered by the definitions. Conversely, the definitions cover
some trivial cases of “tolerance.” Schuster points out that for a
drug with an inverted U-shaped dose-effect curve, in the absence of
any change in sensitivity, cumulation can move the effect to the
20upper descending limb of the dose-effect curve, simulating tolerance.
Rather than elaborating the definitions in a futile attempt to make
them perfectly apposite to preconceptions, let us stay with brief,
simple definitions and add the limiting and aberrant cases as co-
dicils. Such a course is surely better heuristically than defining
behavioral tolerance as tolerance to the behavioral effects of a
drug, which merely specifies the obvious dependent variable and pro-
vokes no further thought or experiment.
BEHAVIORAL TOLERANCE
Behavioral tolerance, then, is tolerance due to behavioral mechanisms.
Generally, behavioral tolerance is thought of only when the behavioral
effects of a drug change, but behavioral tolerance may develop to non-
behavioral effects of a drug. For example, a pigeon may continue to
work under FR 50 following a dose of pentobarbital that puts a non-
working pigeon to sleep and abolishes its righting reflexes. Be-
havioral tolerance to the nonbehavioral effects of pentobarbital in
producing sleep and abolishing righting reflexes may be developed,
therefore, by bringing a subject under the control of a behavioral
schedule. (If it be objected that sleep and righting reflexes may
be classified as behavior, we may predict confidently that the car-
diovascular and respiratory effects of pentobarbital under the above
circumstances will be greatly influenced by the behavioral tolerance.)
Most of the tolerance to physiological and biochemical effects by
behavioral mechanisms is probably indirect, however, as in the example.
Obviously, tolerance to the behavioral effects of a drug may be dis-
positional and physiological as well as behavioral. The different
types are not exclusive and usually all occur simultaneously, so it
is important to measure the contributions. The rest of the discussion
will be devoted to behavioral tolerance to behavioral effects of
drugs.
Study of tolerance necessitates repeated measurements on the same
subject . If the behavior measured is of a kind that changes with
repeated measurements even in the absence of a drug, the assessment
of the development of tolerance to the effect of a drug would be so
hampered as to be usually unfeasible. In practice, we must seek be-
havioral activities that are quantitatively repeatable many times,
whenever consistent conditions are reimposed. The behavioral ac-
tivities in relation to their environmental controls during sessions
must be in a steady state that persists predictably through successive
experimental sessions. For example, subjects under many schedules
of reinforcement emit similar patterns of responding and numbers of
responses in similar sessions repeated over long periods of time;
rhesus monkeys under mult FR FI yielded similar patterns and rates
over hundreds of sessions over a period of years (Dews 1977)) and
there are many other examples in the literature. Also, the effects
of doses of most drugs, judiciously spaced to avoid tolerance, on
schedule-controlled responding are qualitatively and quantitatively
similar on repeated administration. Unless it has been shown that
21under some circumstances the effects of a dose of a drug are re-
plicable in a subject, it is difficult to see how tolerance can be
identified and distinguished from metastability of the behavior it-
self, leading to irreversible change following a single exposure to
a variety of more or less nonspecific influences.
Repeatable patterns of behavior and repeatable effects of drugs on
the patterns indicate that the drug effect is a modulation of the
governing relations between schedule and consequent pattern of re-
sponding. With doses of drug insufficient to abolish behavior, the
patterns of responding continue to have a recognizable relation to
the controlling schedule; for example, under a variety of drugs,
clear differences in responding under FR and under FI of a multiple
schedule persist, though both patterns may be drastically changed
from control patterns. It is as though the schedule continued to
exert functional control under the drug, but that the drug had, in
effect, changed the parameter values of the functional relationship.
When the drug disappears, the parameters return to their prevailing
values. The development of behavioral tolerance would be a lessening
in the change of parameter with repeated doses of the drug.
One of the difficulties in studying tolerance to a drug is that, as
indicated before, the several types are usually operating simul-
taneously and jointly in the development of tolerance: mechanisms
of physiological, dispositional, and behavioral types, and often
more than one mechanism within each type. It may be useful in iden-
tifying specifically behavioral mechanisms in behavioral tolerance
to examine behavioral tolerance to agencies other than drugs. Con-
sider a subject responding consistently in repeated sessions under
a particular schedule. If an additional salient, but irrelevant,
stimulus is added, the patterns of responding can be modified, as
with a drug. Repeated sessions with the new stimulus will lead to
a progressive return to the patterns of responding occurring before
the introduction of that stimulus. The progressive reduction in the
effect of the stimulus may be considered as behavioral tolerance to
the stimulus. The progressive reestablishment of original patterns
of responding in discrimination-reversal situations, for example,
when stimuli of a multiple schedule are interchanged, is behavioral
tolerance, although, of course, it has not been discussed in these
terms. The advantage of studying such situations to illuminate some
of the features of behavioral tolerance to drugs is that the direct
effects of the stimuli do not change with the development of tolerance.
If we use visual stimuli, the effects of the stimuli on the retina and
the resultant discharges in the optic nerves do not change as a stim-
ulus comes to control, e.g., FR rather than FI patterns of behavior.
The same is true with auditory stimuli. The evidence for the preced-
ing statements is that with the exception of a few very special cir-
cumstances such as visual deprivation in early life, neurophysiolo-
gists obtain consistent discharge patterns from eye and ear to spe-
cific stimuli from subject to subject without regard to the behavioral
history of the subject. Behavioral tolerance to a stimulus can be
studied with assurance that the direct impact of the stimulus is
22constant. The situation is therefore clearer than for study of
behavioral tolerance to a drug, where the development of behavioral
tolerance is accompanied by the development of dispositional and
physiological tolerances.
Accepting that the behavioral mechanisms involved in behavioral tol-
erance to a stimulus are the same as those involved in behavioral
tolerance to a drug, study of tolerance to a stimulus can provide
valuable quantitative information on the rate of development of
behavioral tolerance. If the effects of a drug can be even very
roughly mimicked by manipulation of salient stimuli, then the amount
and rate of development of behavioral tolerance to the stimulus can
be used as an estimate of the contribution of behavioral tolerance
to the development of tolerance to the drug. There are three pos-
sibilities. First, the develoment of tolerance to the drug may be
greater than the development of behavioral tolerance to the stim-
ulus. We would conclude that there was a significant contribution
from other mechanisms of tolerance developing along with the be-
havioral tolerance, the extent of the last being estimated from the
development of behavioral tolerance to the stimulus. Second, the
development of tolerance to the drug may be the same as the develop-
ment of behavioral tolerance to the stimulus. We would conclude
that the develolpment of tolerance to the drug was primarily due to
behavioral mechanisms. Third, the development of tolerance to the
drug may be less than the developent of behavioral tolerance to the
stimulus . We would conclude that some aspects of the effects of the
drug were impairing the development of behavioral tolerance more than
dispositional and physiological mechanisms were enhancing tolerance.
For example, a drug interfering with motor coordination as well as
schedule-controlled responding may show little development of behav-
ioral tolerance, because the drug impairs motor execution of the per-
formance and so prevents the normalizing effect of the schedule on
the patterns of responding.
As is usual in pharmacology, indeed, in biology, the arguments of the
previous paragraph are by no means definitive and conclusive. For
example, impairment of the development of behavioral tolerance to
some effects of a drug by other effects of the drug may occur even
when the development of tolerance to the drug exceeds behavioral
tolerance, so that the contribution of dispositional and physiolog-
ical mechanisms would be underestimated. Such refinements of estimates,
however, must surely await until an initial attack has measured the
contributions of the various mechanisms to a first order of approxi-
mation.
Let us consider another scheme for the measurement of behavioral
tolerance to drugs. It is characteristic of schedule-controlled
patterns of responding, at steady-state, that the control does not
diminish appreciably with the mere passage of time out of the situa-
tion. A subject showing stable patterns of responding under, say,
mult FR FI may be left without exposure to the schedule for days,
23weeks, or even months, and then when re-exposed will give, from the
first, patterns of responding indistinguishable from those before
the recess. A subject with stable patterns under mult FR FI may be
subjected to sessions only once per week or once per two weeks and
will continue to respond during the sessions as it does when sessions
are daily, or, as is most common, on five days per week. It is
possible to have a subject work in daily sessions on an entirely
different schedule and still not interfere with responding in inter-
polated sessions under mult FR FI, provided, of course, that care
is taken not to confound stimuli. The property of durability is not
peculiar to mult FR FI; it is seen with most schedules that have
been studied; mult FR FI is chosen as an example because it is one
of the most widely studied schedules in behavioral pharmacology. In
the development of dispositional and physiological tolerance, however,
the frequency of exhibition of the drug is a crucial variable; it
is generally supposed that the more frequent the administration, the
greater and faster the development of tolerance. Indeed, the
optimum procedure for dispositional and physiological tolerance may
be to keep the subject continuously under the influence of the drug,
the target cells continuously bathed. If a subject undergoes a daily
session of schedule-controlled responding, and if repeated aclminis-
trations of a dose of a drug at one-or two-week intervals yield con-
sistent effects, it is reasonable to assume that the development of
dispositional and physiological tolerance is minimal at that frequen-
cy of administration. The subject could then be exposed to the sched-
ule only once per week, or once per two weeks, but always under the
influence of the drug, the drug not being given otherwise. If toler-
ance to the effects of the drug develops under this regimen, a clear
case would exist for identifying all of the tolerance as behavioral.
Interesting variants of the scheme are apparent.
Since the beginning of behavioral pharmacology, there have been two
general experimental designs. Some workers have exposed subjects
to daily sessions, giving drugs on some days and leaving other days
as control days. Other workers have exposed subjects to double ses-
sions daily, the first session being always a control session and the
second session being sometimes preceded by administration of a drug.
In light of experience, it is unlikely that either design has a de-
cisive general advantage over the other, and they are used inter-
changeably. With respect to study of tolerance, the difference in
the design may make an important difference. Take a drug with a
moderate duration of action, say 1/2 time of about 4 hours? to whose
behavioral effects tolerance develops when the drug is given daily
before a session. If the double session design is used, the control
session will start about 20 hours after the previous day’s admin-
istration of the drug, so that only about 6% of the drug will remain,
and performance in the control session would presumably be normal.
Sessions under the drug would alternate with normal sessions. Under
the single session design, all responding would take place under
the influence of the drug. The development of behavioral tolerance
would be expected to be more pronounced under the latter regimen.
Further, when administration of the drug is discontinued, performance
in the first session without drugs would be expected to be abnormal
24under the single session design, where all of the previous several
sessions had been performed under drug; under the double session
regimen, however, there is no reason to expect disturbance even in
the first postdrug session, since normal sessions have continued
to occur. The general approach offers the advantage that the con-
tribution of behavioral mechanisms to tolerance is assessed during
continuing sessions rather than only during occasional probes or once
in the course of the experiment. As before, responding in the first
session after drug cessation should be abnormal under the single
session design, even if enough time is allowed to permit complete
dissipation of the physiological and biochemical aftermath of re-
peated drug administrations.
SUMMARY
Behavioral tolerance is defined as tolerance due to behavioral mech-
anisms. The study of behavioral tolerance to behavioral effects of
drugs requires, in the present state of knowledge, objective and
quantitative means of recording behavior. Behavioral activities that
do not lend themselves to such recording should probably be left
aside in the study of tolerance until the more general quantitative
features of tolerance have been measured in quantifiable systems.
The behavior selected should occur reproducibly in many successive
daily sessions. Many varieties of schedule-controlled patterns of
responding fulfill the preceding criteria! and it is likely that
study of schedule-controlled responding will play a central role
in elucidation of behavioral tolerance in the foreseeable future.
Drug and behavior should also be chosen that yield reproducible
effects of the drug when dosing is suitably spaced.
In a suitable system, the contribution of behavioral tolerance to
a drug tolerance may be estimated by:
1. measuring behavioral tolerance to changes in the environment
that grossly mimic the effect of the drug,
2. measuring tolerance development under conditions that permit
behavioral tolerance, but minimize other forms of tolerance.
These two criteria are insufficient. Our confidence in our estimate
of a contribution of behavioral tolerance depends on the number of
independent ways in which the estimate can be made and the closeness
in agreement of values arrived at in the different ways. Additional
criteria are needed. Understanding of behavioral tolerance may come
slowly, but interesting quantitative behavioral pharmacology will
be accumulating along the way.
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26II. NARCOTICS
A Pavlovian Conditioning Analysis
of Morphine Tolerance
1
Shepard Siegel, Ph.D.
INTRODUCTION
Many of the effects of a variety of drugs, including morphine, decrease
in magnitude over the course of successive administrations, the pheno-
menon being termed tolerance. Most theories of tolerance stress the
physiological consequences of repeated pharmacological stimulation.
There is considerable evidence, however, that the display of tolerance
is highly dependent upon the organisms' experience with the drug
administration environment as well as the drug. The role of such
environmental signals of the drug in the development of tolerance has
been emphasized in an account of morphine tolerance which stresses
Pavlovian conditioning principles (Siegel 1975b; 1976, 1977b). This
paper describes this conditioning theory of tolerance and summarizes
data which support the theory.
DRUG ADMINISTRATION PAVLOVIAN CONDITIONING, AND DRUG TOLERANCE
A prototypical learning design is that developed by Pavlov (1927) who,
in fact, suggested that the usual drug administration procedure was
operationally similar to his conditioning situation (Pavlov 1927).
The basic conditioning preparation used by Pavlov involves
the use of TV cues. The first of these, the "conditional stimulus"
is said to be "neutral"; it elicits little relevant activity prior to
its pairing with the second stimulus, the unconditional stimulus. As
the name implies, the unconditional stimulus is selected because it
elicits relevant activities from the outset--unconditionally--prior to
any pairings. In Pavlov's well-known conditioning work, the condition-
al Stimulus was some conveniently manipulated exteroceptive stimulus
(bell, light, etc.), and the unconditional stimulus was either food or
orally injected dilute acid, both of which elicited a conveniently
monitored salivary response. In the case of drug administration, the
conditional stimili. are those procedures, cues, or rituals reliably
predicting the systemic stimulation induced by the drug, with the
actual central effects of the drug constituting the uoconditional
stimulus. The development of the association between these stimuli
may be revealed if the subject, following a history of administration
of the drug, is presented with the usual drug administration procedure
27not followed by the usual pharmacological. consequences--rather, for
such a conditional response test session, a placebo is administered.
The Compensatory Pharmacological Conditional Response
Following Pavlov's demonstration that responses to drugs can be condi-
tioned, there has been a considerable amount of research concerning
such pharmacological learning (see review by Siegel, 1977a). Although
many forms of conditional drug responses can be conceptualized, and
have been reported, an especially common type of pharmacological con-
ditional response is opposite in direction to many of the effects of
the pharmacological unconditional stimilus. Table 1 (next page) sum-
marizes a number of investigations which have reported such condition-
al responses opposite to the unconditional effects of the drug.
The Compensatory Pharmcological ConditionalResponse and Drug Toler-
ance
As suggested by Bykov (1959), conditional drug responses'
evidenced in anticipation of the actual pharmacological assault should
be expected to interact with the drug-induced unconditional response.
and thus pharmacological learning may be evidenced by the modulation
of the unconditional effects of the drug as it is repeatedly presented
in the context of the same situational cues. Since the drug condition-
al response is often opposite in direction to the drug unconditional.
response, the effect of the drug would be expected to became reduced
by this compensatory conditional response evidenced in anticipation of
the drug's central effects. Because the association between the drug
administration procedure and the systemic effects of the drug is
strengthened by repeated pairings, the drug's effect would be expected
to become increasingly cancelled as the drug-compensatory conditional
response grows stronger. Such a decreased effect of a drug, as a
function of successive experiences with the drug, defines tolerance.
The Morphine Compensatory Conditional Response and Morphine Tolerance
Of special relevance to the conditioning analysis of morphine tolerance
are several. demonstrations that the conditional response following
training with morphine consists of a variety of morphine-compensatory
responses. As indicated in Table 1, animals with a history of morphine
administration (with its analgesic, hyperthemic, and bradycardic
effects), when administered a placebo, display hyperalgesia (Siegel
1975b), hypothermia (Siegel, submitted), and tachyardia (Rush, Pearson,
& Lang 1970). Since organisms evidence such  responses opposite to
those induced by morphine confronted with the usual predrug cues,
but without actual administration of the drug, it would be expected that
when morphine is presented in conjunction with the usual predrug cues,
these compensatory conditional responses would attenuate the
unconditional responses, thereby decreasing the observed response to
the drug over the can-se of successive administrations.
COMPARISON OF THE CONDITIONING THEORY WITH OTHER INTERPRETATIONS OF
TOLERANCE
The conditioning interpretation of tolerance may be contrasted with
formulations of the phenomenon which do not acknowledge a role for
28TABLE 1
COMPENSATORY CONDITIONAL PHARMACOLOGICAL RESPONSES
Unconditional
Stimulus
epinephrine
epinephrine
epinephrine
glucose
insulin
nicotine
atropine
chlorpromazine
amphetamine
dinitrophenol
histamine
methyl dopa
lithium
chloride
nalorphine
morphine
morphine
morphine
Unconditional
Response
tachycardia
gastric secretion
hyperglycemia
hypoglycemia
hypoglycemia
hypoglycemia
antisialosis
activity
 02 consumption
to consumption,
hyperthemia
hypothermia
blood pressure
Conditional
Response
bradycardia
gastric secretion
hypoglycemia
hyperglycmia
hyperglycemia
hyperglycemia
hypersalivation
activity
O2 consumption
O2 consumption
hypothermia
hyperthermia
blood pressure
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
drinking
tachycardia
bradycardia
hyperthermia
analgesia
drinking
bradycardia
tachycardia
hypothermia
hyperalgesia
(l3)
(14)
(15)
(16)
(17)
a
(1) Russek & Pina (1962); Subkov & Zilov (1937). (2) Guha, et al.
(1974). (3) Russek & Pina (1962). (4) Mityushov (1954); Deutsch
(1974); LeMagnen (1975). (5) Siegel (1972a, 1975a). (6) Lundberg &
Thyselius-Lundberg (1931). (7) Korol, et al. (1966); Lang, et al.
(1966, 1969); Mulinos & Lieb (1929); Wikler (1948). (8) Pihl & Alt-
man (1971). (9) Obal (1966). (10) Obal (1966). (11) Obal, et al.
(1965). (12) korol & McLaughlin (1976). (13) Domjan & Gillan (in
press). (14) Goldberg & Schuster (1967, 1970). (15) Rush, et al.
(1970). (16) Siegel (submitted). (17) Siegel (197%).
Reference
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29associative processes. These alternative theories usually postulate
physiological changes, induced by early drug administrations, which
functionally reduce the effects of later drug administrations. Such
systemic alterations may involve opiate receptors in the brain (e.g.,
Collier 1965; Snyder & Matthysse 1975), or peripheral changes which
hinder the drug from gaining access to central receptors (e.g., Cochin
1971; Mule & Woods 1969). These physiological theories have been
extensively reviewed elsewhere (see Hug 1972, Kuschinsky 1977, Take-
mori 1975).
Some nonassociative interpretations of tolerance! like the conditioning
theory, stress the role of homeostatic counter adjustments to the phar-
macological stimulation: As the drug is repeatedly administered, these
"autonomic hyperreactions" (Himmelsbach 1943) or "opponent processes"
(Solomon & Corbit 1974) elicited by the drug become stronger as they are
repeatedly exercised, acting increasingly to attenuate the effects of
the drug (for a review of many such theories, see Collier 1972).
These counteradjustment models, like those models which more particu-
larly specify the nature of the systemic drug-induced alterations, do
not incorporate a learning process in the acquisition of tolerance.
In summary, all these traditional interpretations of tolerance are non-
associative. That is, they assert that tolerance results simply from
repeated pharmacological stimulation, and specify no role for drug-
associated environmental stimuli in the display of tolerance. In
contrast, the conditioning interpretation of tolerance indicates that
the development of tolerance depends on repeated pairings of environ-
mental cues signalling the drug with the systemic effect of the drug,
and not merely the frequency of pharmacological stimulation -
A Note on Associative vs. Nonassociative Theories of Tolerance
For purposes of exposition, a conditioning theory of tolerance is
distinguished from the more traditional, nonassociative theories. In
fact, both associative mechanisms and systemic processes unrelated to
associative mechanisms are undoubtedly involved in tolerance. Clearly,
processes unrelated to learning are relevant to interpreting tolerance
observed when the drug is not repeatedly presented (e.g., pellet im-
plantation studies, Way, Loh, & Shen 1969), or when tolerance is
observed in the offspring of rats prenatally treated with opiates
(O'Callaghan & Holtzman 1976, 1977), or when tolerance is observed in
isolated tissue (e.g., Paton 1957; Takemori 1962). However, it is
equally as clear that many tolerance phenomena appear inexplicable
without incorporating a learning mechanism in interpretations of toler-
ance and that until recently the contribution of learning to tolerance
has been largely ignored by investigators in the area. The research
reported in this paper was designed to clarify the role of conditioning
in tolerance, but not to suggest that pharmacological phenomena
can best be understood merely with an appreciation of Pavlov-
ian principles.
EVIDENCE FOR THE CONDITIONING THEORY OF TOLERANCE
We have completed a substantial amount of research which provides evi-
dence that association between the drug administration ritual and
the systemic effects of the drug plays an important role in the
30acquisition of tolerance. The complete reports of most of these experi-
ments have been published, and only the major findings will be briefly
summarized here.
General Methods
Certain procedures were common to all the experiments summarized
in this section. The subjects were experimentally naive, male, albino
rats. All injections were made subcutaneously in the dorsal surface of
the neck. The drug dose was 5mg/kg (of a 5 mg/ml solution) of morphine
sulfate. All placebo injections consisted of an equivalent volume of
physiological saline (i.e., 1 ml/kg).
In some investigations, the analgesic effect of the drug was assessed
with the hot plate technique (Fennessy & Lee 1975) which involves the
determination of the rat's latency to lick a paw following placement
on a warm (54.2" C) surface (with analgesic responses indicated by
relatively long paw-lick latencies). In other investigations, anal-
gesia level was assessed with a cammercially available version of the
Ramdall-Selitto paw-pressure analgesiometer (Randall & Selitto 1957).
To use the analgesiometer, the rat is positioned so that it is free
to withdraw its paw from a source of gradually and constantly increas-
ing pressure, with the amount of pressure applied before the paw-
withdrawal response occurs providing a measure of pain sensitivity
(with analgesic responses indicated by relatively high paw-withdrawal
thresholds).
The dose of morphine used in these experiments elevates, body temperature
in the rat, the magnitude of this hyperthermic response successively
decreasing with successive drug administrations (Gunme 1960, Hermann
1942; Winter 6 Flataker 1953). In same experiments, the role of
conditioning in such pyretic tolerance was investigated. 21 these
studies, colonic temperature was assessed with an electronic thermo-
meter 30 sec after the probe was inserted 4 cm into the rat's rectum.
In these experiments, unless otherwise indicated, the usual drug
administration procedure involved transporting the rat, in its home
cage, from the colony room to a different room which, in different
experiments, contained either the hot plate, analgesiometer, or temper-
ature assessment apparatus. A constant background of white noise waS
maintained in this room. The rat was injected in this distinctive
environment, and, in sane experiments, the drug's effect was determined
on a single occasion, usually one-half hr after the injection. In
other experiments, the time course of the drug's effect was determined
by sequential assesments on many occasions after administration. The
interval between injections differed in different experiments, but was
never less than 24 hr.
The Situation Specificity of Tolerance
Although there are many nonassociative interpretations of tolerance,
they are all similar in stipulating that tolerance results from system-
ic changes induced by repeated pharmacological stimulation However,
there are many demonstrations that tolerance does not result simply
from the organism suffering repeated pharmacological stimulation. It
does result from repeated administration of the drug in the context of
31environmental. cues which reliably signal the impending chemical stimu-
lation. A remarkable series of experiments by Mitchell and his col-
leagues have demonstrated that rats (Adams, Yeh, Woods, & Mitchell
1969, Ferguson, Adams, &Mitchell 1969, Gebhart &Mitchell 1971, 1972;
Gebhart, Sherman, & Mitchell 1971, 1972, Kayan, Ferguson, & Mitchell
1973; Kayan &Mitchell 1969, 1972; Kayan, Woods, &Mitchell 1969,
1971) and humans (Ferguson &Mitchell 1969) respond in the expected
tolerant manner to the analgesic effect of the last of a series of
morphine injections only if this final injection is presented in the
same environment as the prior injections in the series. These find-
ings, although not readily interpretable by theories of tolerance which
do not acknowledge a role for drug-associated environmental cues in the
acquisition of tolerance, are expected on the basis of the conditioning
theory of tolerance. According to this conditioning theory, cues that
reliably predict the systemic effect of the drug should be crucial to
the development of tolerance because they enable the subject to make
timely compensatory responses in anticipation of the central responses
elicited by the drug.
We have completed a number of studies (Siegel 197fb, 1976, submitted,
in preparation) which confirm and extend these previous reports indi-
cating that the display of morphine tolerance is greater in the envi-
ronment in which the drug has been previously administered than in an
alternative environment. The details of the designs of these investi-
gations from our laboratory differ somewhat from experiment to experi-
ment, but they all incorporated two groups, both of which received
morphine a sufficient number of times for tolerance to develop, with
the effect of the drug being assessed following the Last administration.
For one group, this final administration and evaluation of the drug's
effect took place in the same environment as that in which the previous
injections occurred. For the second group, this tolerance test took
place in a different environment than that in which the previous injec-
tions occurred. The results of a number of such experiments are sum-
marized in Figure (next page). These experiments have consistently
demonstrated that animals tested following drug administration in the
same environment in which they had previously experienced the drug
respond less (i.e., are more tolerant) than animals tested following
drug administration in a different environment from that which they
had an opportunity to associate with the drug. The difference between
these two conditions, labeled SAME and DIFFERENT in Figure 1, were, in
each experiment, statistically significant.2
Figure IA indicates the results of one of these experiments (Siegel
1975b, Experiment IA) in which independent groups of rats were tested
for the analgesic properties of morphine either in the same environment
in which they had previously received the drug, or in a different environ-
ment. Rats in the group labeled SAME were injected with morphine on
four occasions in the distinctive room, with hot-plate responsivity
determined for the first time 30 min following the fourth administra-
tion of the drug. The latency to respond to the heat stimulation in
this group, which was tested for the effects of the fourth drug admini-
stration in the context of the same environmental cues as those present
at the time of the three prior administrations, was contrasted with
that displayed by rats in the group labeled DIFFERENT, which received
the three pretest drug administrations in a different environment, the
colony room. As can be seen in Figure lA, Group SAME was more sensitive
32FIGURE 1
Summary of results of experiments demonstrating that rats
display greates morphine tolerance to the final injection of a series
if this final injection is administered in the same environment  as the
prior injections (SAME) than if the final injection is administered in
a different environment (DIFFERENT ). Figure IA illustrates hot-plate
response latencies reported by Siegel (1975b, Experiment IA), with
groups designated SAME and DIFFERENT corresponding to Groups M-CP and
M-CAGE, respectively, in the original experiment. Figure IB illust-
rates hot-plate response latencies reported by Siegel (1976), with
groups designated SAME and DIFFERENT corresponding to groups trained
with a nonfunctional hot plate and nonfunctional paw-pressure analgesio-
meter, respectively. Figure 1C illustrates analgesiometer paw-withdraw-
al thresholds reported by Siegel (1976), with groups designated SAME
and DIFFERENT corresponding to groups trained with a nonfunctional
analgesiomter and nonfunctional hot plate, respectively. Figure ID
illustrates hot-plate response latency time-effect curves, constructed
with independent groups at each temporal interval (Siegel, in prepara-
tion), Figure 1E illustrates thermal modifications reported by Siegel
(submitted), with groups designated SAME and DIFFERENT corresponding
to Groups Mor-ROOM/Sal-CAGE and Mar-CAGE/Sal-EWM, respectively, in
the original experiment.
33to the heat stimulation (i.e., more tolerant to the analgesic effect
of the drug) than Group DIFFERENT.
Figure 1B displays the results of another experiment (Siegel, 1976)
which similarly demonstrated that, following eight morphine injections,
rats responded on the hot plate following a subsequent injection of the
drug more rapidly if this test injection was administered in the same
environment as the previous injections, rather than in a different
environment.
Figure 1C presents the results obtained from additional groups included
in Siegel's (1976) study, for which pain sensitivity was assessed with
the paw pressure analgesiometer. Once again, rats with a similar his-
tory of morphine stimulation do not respond in a similar manner to the
final test injection Group SAME subjects were more sensitive to the
pressure stimulation (i.e., n-ore tolerant) than Group DIFFERENT subjects.
In a further experiment, the time course of the analgesic response to
morphine was assessed (Siegel, in preparation). Independent groups of
rats (6 rats per group) were tested on the hot plate at various inter-
vals of time following their sixth morphine injection. That is, time-
effect curves were constructed using independent groups at each assess-
ment interval (rather than testing each subject repeatedly). The
results are displayed in Figure lD. As may be seen in Figure ID, rats
displayed much more tolerance to the analgesic effect of morphine the
sixth time it was administered if such administration occurred in the
same environment as that in which they were injected on the five prior
occasions than if this sixth injectionoccurred in a different environ-
ment.
The results of the expertits summarized in Figures IA-D demonstrated
that environmental cues are crucial for the display of tolerance to
the analgesic effect of morphine. This pain-sensitivity measure of
opiate action (althogh the most common in investigations of tolerance)
uses an indirect behavioral criterion of pharmacological activity, and
it has been suggested that it may be an uncertain manifestation of the
drug's effect (Goldstein, Arnow, & Kalman, 1974). Thus, an
additional experiment was conducted to determine if environmental cues
are also important in the display of hyperthermic tolerance (Siegel,
submitted, Experiment IA), The design of this experiment was somewhat
different from that of the analgesia experiments. During the pretest
phase of the experiment, tolerance waS induced in two groups of rats
by injecting them with morphine on 10 occasions, one injection every
On those alternate days when morphine was not administered,
both groups of rats were injected with physiological saline. Morphine
and physiological saline were systematically administered in either of
two different environments, with the two groups differing only with
respect to the environmental cues associated with each injected sub-
stance. One group received its morphine injections in the distinctive
room and its saline injections in the colony room. The second group
received its morphine injections in the colony room and its saline
injections in the distinctive roan For both groups, following each
injection in the distinctive room, the rat remained in this room for
two hr, with colonic temperature assessed immediately after the injec-
tion and thereafter at 10-min intervals. Following this tolerance
development phase of the experiment, rats in both groups were
34administered morphine in the distinctive roan, followed by colonic
temperature assessment. It should be emphasized that prior to this
final session, both groups had equalexposuretothetestenvironment
and temperature assessment procedure For one group, however, this
final test session consisted of the usual pre-morphine environmental
cues signalling the usual pharmacological consequences (Group SAME).
In contrast, for the second group, morphine was administered in the
context of cues which, in the past, signalled physiological saline
rather than the opiate (Group DIFFERENT). The time course of the mean
temperature alteration following this final injection in the distinc-
tive room for each group is shown in Figure I.E. As is obvious in
Figure IE, the pyretic effect of the drug was much more pronounced in
Group DIFFERENT than in Group SAME. In fact, Group DIFFERENT showed
no evidence of pyretic tolerance, the hyperthermic response following
this eleventh injection of morphine for Group DIFFERENT did not differ
significantly from that which would be expected the first time rats
receive the drug.
In all the experiments summarized in this section, prior to the final
tolerance test session, both Groups SAME and DIFFERENT suffered the
same morphine-induced systemic effects, equally as often, and at the
same intervals. The rats in these groups should have been subject to
the same metabolic, cellular, or immunifacient modifications that,
according to the various nonassociative theories, mediate tolerance.
Thus, it would be expected, according to any of these traditional
theories of tolerance, that the two groups should not differ in the
acquisition of tolerance. In every experiment, it was found that the
group which received the drug in a distinctly different environment
for the pre-test sessions evidenced little if any indication of toler-
ance on the test session, suggesting that reliable environmental sig-
nals of the drug are important in the development of tolerance. These
results are expected on the basis of the conditioning analysis of
tolerance, but not of the alternative formulations.
Extinction of Morphine Tolerance
A unique prediction of the conditioning account of morphine tolerance
is that tolerance should be subject to the decremental effects of ex-
tinction. That is, if morphine tolerance occurs because environmental
cues signalling the central effect of the drug elicit a compensatory
conditional response, acting to cancel the effect of the opiate, pre-
senting the administration cues without the drug to the tolerant organ-
isn should extinguish these learned responses, and thus cause some
recovery of the response to morphine. In other words, according to
the conditioning theory of tolerance, repeated placebo sessions should
be an effective procedure for attenuating established tolerance.
The results of a number of experiments have, in fact, demonstrated that
morphine tolerance is subject to extinction (Siegel 1975b, Experiment
3; Siegel 1977b-, Experiments 1 and 2, Siegel, submitted, Experiment
2). Although there were numerous procedural differences between the
experiments, all incorporated two groups, both of which initially
received a series of daily morphine injections sufficient to induce
tolerance. This constituted the tolerance acquisition phase of each
experiment. Some days later, subjects received at least one further
injection of morphine. This final experience with the drug constituted
the tolerance test phase of each experiment. The two groups differed
35only with respect to their treatment during the interval between the
tolerance acquisition phase and the tolerance test phase. One group
received daily placebo sessions, i.e., they were treated in the same
manner as on morphine sessions, except the substance injected was
physiological saline rather than the opiate (hereinafter referred to
as Group EXT, i.e., extinction). The response of Group EXT to the drug
during the tolerance test indicated the effects of repeated presenta-
tions of the morphine administration procedure, in the absence of the
drug, on tolerance acquired during the tolerance acquisition phase
Rats in the second group were simply left undisturbed in their home
cages during the period between tolerance acquisition and tolerance
testing (hereinafter referred to as Group REST). The response of sub-
jects in Group RED to the drug during the tolerance test provided a
measure of any alteration in tolerance attributable simply to the in-
terval that intervened between the tolerance acquisition phase and the
tolerance test phase.
According to the conditioning interpretation of tolerance, presenting
drug-associated environmental conditional stimuli without the drug is
an extinctionprocedure, and thus the group receiving such treatment
subsequent to tolerance acquisition (Group EXT) would be expected to
display less tolerance on the tolerance test than would the group with
no such extinction experience (Group REST). Results of four experi-
ments demonstrating that such extinction does, in fact, occur, are
summarized in Figure 2 (next page). In all experiments, it was found
that extinction attenuated tolerance established during the tolerance
acquisition phase of the experiment.
Figure 2A illustrates results reported by Siegel (1975b, Experiment 3).
In this experiment, rats in Groups REST and EXT were each initially
given three, daily, morphine-hot plate analgesia assessment sessions
in the distinctive room, which was sufficient for a substantial amount
of tolerance to the analgesic effect of the drug to develop (there
being no difference between the two groups in the acquisition of anal-
gesic tolerance). Group EXT rats were then given nine daily placebo
sessions, and Group REST rats Were left undisturbed for nine days. On
the tolerance test session, which occurred on the day after the ninth
placebo session (Group EXT) or the ninth rest day (Group REST), all
subjects me again injected with morphine. As is obvious in Figure
2A, on this test session, morphine had a me pronounced analgesic
effect in Group ExT than in Group REST. (The difference between Groups
EXT and REST was statistically significant in this and other experi-
ments summarized in Figure 2.)
Prior to the morphine test session, both groups suffered the systemic
effects of morphine equally as often, at the same intervals, and with
the same analgesic effect. According to the nonassociative interpre-
tations of tolerance, both groups should display equal tolerance when
presenting the morphine administration ritual unacconpanied by the
again injected with the drug on the test session. However 
central effects of the opiate to Group EXT, tolerance subsequently ob-
served in this group was substantially attenuated Such attenuation
of tolerance was not due simply  the nine-day delay between the end
of tolerance acquisition and the tolerance test, since this delay did
not affect the tolerance of Group REST (in agreement with other reports
that morphine analgesic tolerance dissipates little simply with the
36FIGURE 2
Summary of results of experiments demonstrating that morphine
tolerance can be extinguished. In each experiment, all subjects
were first made tolerant to morphine, and then given a series of either
placebo sessions (EXT) or a rest interval (REST) prior to a morphine
tolerance test session, with only the results obtained on this toler-
ance test session illustrated for each experiment. Figure 2A illust-
rates hot-plate response latencies reported by Siegel (1975b, Experi-
ment 3). Figures 2B and 2C illustrate analgesiometer paw-withdrawal
thresholds reported by Siegel (1977b, Experiments 1 and 2, respective-
ly) . Figure 2D illustrates thermal modifications reported by Siegel
(submitted, Experiment '2).
37passage of time [e.g., Cochin & Kornetsky 1964, Kayan & Mitchell
19721).
Inasmch as no nonassociative interpretation of tolerance would predict
that tolerance should be subject to extinction, it was thought desir-
able to assess the reliability of this confirmation of a unique predic-
tion of the conditioning theory of tolerance with a different analgesia
assesment situation. The design of this subsequent experiment (Siege1
1977b, Experiment 1) was similar to that of the earlier hot-plate ex-
periment by Siegel (1975b, Experiment 3), with the following exceptions:
Analgesia level was assessed with the paw-pressure analgesiomter; the
tolerance acquisition phase of the experiment consisted of six sessions;
and subjects received either 12 placebo sessions (Group EXT) or a 12-
day rest interval (Group REST) between tolerance acquisition and toler-
ance testing. The results obtained on the tolerance test session are
shown in Figure 2B. It required significantly more pressure to elicit
a paw-Withdrawal response in Group EXT rats than in Group REST rats.
Once again, Group EXT responded to morphine with a higher level of
analgesia (i.e., more tolerance) than Group REST, despite the fact that
the two groups did not differ in any manner with respect to their ex-
perience with the opiate prior to the test session.
The results of the two experiments described above indicated that pre-
sentations of the morphine administration procedure to morphine toler-
ant rats deleteriously affected the display of tolerance. In both
experiments, an attempt was made to make the placebo-initiated extinc-
tion sessions as similar as possible to the drug administration ses-
sions, including the application of nociceptive stimulation. Thus,
only the group subjected to extinction (Group EXT) had any experience
in making the analgesia-indicant response--either paw licking (Figure
2A) or paw withdrawal (Figure 2B)--whilenot drugged. A further
experiment was conducted (Siegel, 1977b, Experiment 2) to determine
whether extinction is an effective procedure for attenuating established
tolerance even if subjects do not practice the analgesia-indicant re-
sponse during the extinction sessions. In addition, this experiment
differed from the previous tolerance-extinction experiments in two
other major respects: (a) the time course of the opiate-induced anal-
gesia was assessed (in the previous experiments, the analgesic effect
of each administration was assessed on only a single occasion, .5 hr
after injection), and (b) the effect of extinction on single dose toler-
ance was evaluated (previous work has demonstrated that only a single
experience with morphine is sufficient to subsequently reduce the anal-
gesic effect of a second administration [Ferguson, et al. 1969; Kor-
netsky & Bain 19681). During the tolerance acquisition phase of this
further extinction experiment, subjects in Groups EXT and REST were
injected with morphine on only a single occasion, and evidenced similar
analgesic tin-e-effect curves. Group REST subjects were then left un-
disturbed for four days, while Group EXT subjects received four daily
placebo sessions, but without analgesia assessment. On these placebo
sessions, Group EXT rats were positioned in the analgesiometer after
each of the post-injection assessment intervals, but the apparatus was
nonfunctional and no pressure was applied to the paw. Five days follow-
ing their tolerance acquisition injection of morphine, all subjects
received their tolerance test session. Thus, prior to this second
morphine session, both groups had but a single experience with opiate
stimulation and analgesia assessment.
38The time course of the analgesic effect of the drug on the tolerance
test session for both groups is shown in Figure 2C. Examination of the
time-effect curves reveals that Croup EXT was less sensitive to the
pressure stimulation than Group REST, and evidenced peak responsivity
to the drug closer to the tin-e of administration than Croup REST--both
indicative of less analgesic tolerance (see Siegel, 1977b, Experiment
2). The results of this experiment, in agreement with the previously
described experiments, demonstrated that morphine tolerance is subject
to extinction, supporting the conditioning analysis of tolerance.
Additionally, the results of this experiment indicated that such ex-
tinction of morphine tolerance can be observed after only a single
administration of the drug, and is not attributable to any additional
practice that extinguished subjects have in responding to the aversive
stimulation used to evaluate the effect of the drug.
The results of experiments summarized in Figures 2A-C demonstrated that
tolerance to the analgesic effect of morphine can be extinguished. A
final experiment in this series was designed to determine whether toler-
ance to the py-retic effect of morphine similarly could be extinguished
(Siegel, submitted, Experiment 2). During the tolerance acquisition
phase of this experiment, subjects in Groups REST and EXT were each
administered morphine for 12 daily sessions, with the colonic tempera-
ture of each subject being determined at 15-min intervals following
each injection. Both groups evidenced a similar course of tolerance
acquisition. Croup EXT subjects then received 12 daily placebo ses-
sions (which were conducted in the same manner as morphine sessions,
except that the substance injected was physiological saline) As WAS the
case in the previously described experiments, Group REST was left un-
disturbed during this period. Finally, all rats received a tolerance
test session, which was initiated with an injection of morphine.
To evaluate the extent to which extinction can attenuate tolerance, the
design of this hyperthermic tolerance experiment included a group which
received morphine for the first time during tolerance testing (Group
CONTROL).
3 To the extent that extinction is an effective procedure
for attenuating established pyretic tolerance, Croup EXT should, on
the tolerance test, evidence a drug-induced hyperthermia resembling
that seen in Group CONTROL. The thermic effects of the drug on the
tolerance test session, for each group, are shown  in Figure 2D. By
comparing Croups REST and EXT, it is clear that extinction decreased
hyperthermic tolerance. Indeed, the hyperthermic tolerance of Croup
EXT was so reduced that the pyretic effect of morphine was similar to
that obtained in Group CONTROL, which received the drug for the very
first time during the tolerance test. Thus, in this experiment, ex-
tinction not only was an effective procedure for attenuating tolerance--
in fact, the procedure eliminated tolerance.
It would appear to be well-established that tolerance can be extinguish-
ed. Indeed, under sane circumstances, repeated presentations of the
drug administration environment in the absence of the drug to the
tolerant subject can completely abolish tolerance. Evidence for the ex-
tinction of tolerance is robust, having been demonstrated in four experi-
ments encompassing a range of procedural differences and parametric
manipulations. These findings that tolerance is subject to extinction
(like the previously presented findings on the situation-specificity of
tolerance) appear inexplicable by traditional interpretations of
39tolerance which stress only the effects of repeated pharmacological
stimulation, and ignore the importance of cues present at the time of
such stimulation. However, the finding that tolerance can be extin-
guished is readily interpretable by the conditioning model of tolerance.
Partial Reinforcement of Morphine Tolerance
Results discussed previously demonstrated that extinction, a procedure
which decrementally affects established conditional responses, similarly
affects established analgesic and pyretic tolerance, thus supporting the
conditioning analysis of tolerance. If tolerance is a manifestation of
a conditioning process, it would be further expected that manipulations
of the putative conditional stimulus (i.e., environmental. cues present
at the time of drug administration) known to be effective in retarding
acquisition of conditional responses would similarly retard the acqui-
sition of morphine tolerance. One such procedure that is effective in
retarding conditional response acquisition is partial reinforcement.
if the unconditional stimulus is paired with the conditional stimulus
on less than 100% of the trials, conditional response acquisition is
generally poor, relative to a situation in which every conditional
stimulus is paired with the unconditional stimulus (see Beecroft 1966).
Although most studies of partial reinforcement effects
in classical conditioning have compared 100% to 50% reinforcement
schedules, there is evidence that acquisition rate declines as the per-
centage of reinforced conditional stimuli decreases, even when the
number of reinforced trials is equated in the various reinforcement
schedule conditions (i.e., both partially and continuously reinforced
groups receive the same number of paired presentations of conditional
and unconditional stimuli, with the partially reinforced group receiv-
ing additional conditional stimlus-alone trials interspersed between
these paired trials).
The implication of the partial reinforcement literature for the condi-
tioning theory of tolerance is clear: A group in which only a portion
of the presentations of the drug administration cues are actually
followed by morphine (i.e., a partial reinforcement group) should be
slower to acquire tolerance than a group which never has exposure to
environmental cues signalling the drug without actually receiving the
drug (i.e., a continuous reinforcement group), even when the two groups
are equated with respect to all pharmacological parameters.
We have completed experiments concerned with the effects of partial
reinforcement on both analgesic (Siegel 1977b_, Experiment 4) and
pyretic (Siegel, submitted, Experiment 3) tolerance In both experi-
ments, rats were administered morphine a sufficient number of times
for tolerance to be evidenced, with the interval between morphine ses-
sions irregularly varied between two and five days. In each experiment,
one group was continuously reinforced (Group CRF). For Group CRF all
presentations of the drug administration procedure were accompanied by
the drug, subjects in this group simply being left undisturbed in their
home cages on the days between morphine sessions. A second group in
each experiment was partially reinforced (Group PRF). For Group PRF,
only a portion (25%) of the presentations of the drug administration
procedures were accompanied by the drug. Subjects in this group re-
ceived the drug on the same days as subjects in Group CRY, but on each
of the days between drug sessions they received placebo sessions (that
40is, they were treated in the same manner as on morphine sessions, except
the substance injected was physiological saline rather than the opiate).
Thus, in each experiment, rats in Group CRF and PRF received the same
dose of the drug, equally as often, and at the same intervals. The two
groups differed only with respect to the reliability of environmental
cues as signals for the drug. Group CRF subjects always experienced
these cues in conjunction with the drug, and never without the drug.
In contrast, Group PRF subjects had extensive experience with these
cues, without the drug, between drug sessions.
The results of the two partial reinforcement experiments are summarized
in Figure 3 (next page). Figure 3A displays the mean response latency
on the hot plate, 30 min following each morphine injection, for both
goups in the analgesic tolerance experiment (Siegel, 1977b_, Experiment
. As indicated in Figure 3A, both groups displayed analgesic toler-
ance, that is, decreasing response latency to the thermal stimulation
as a function of repeated morphine sessions. However, as may be seen
in Figure 3A, tolerance was acquired more rapidly by subjects in Group
CKF than by subjects in Group PRF. This difference, which is statisti-
cally significant (mixed design analysis of variance, p's <.Ol), demon-
strates that partial reinforcement retards the development of morphine
analgesic tolerance, much  as it has been demonstrated to retard learning
in more traditional conditioning preparations.
The deleterious effect of partial reinforcement on tolerance was also
demonstrated in the investigation of pyretic tolerance (Siegel, sub-
mitted, Experiment 3). The results obtained in that experiment are
summarized in Figure 3B, which displays the mean colonic temperature
two hr following each morphine injection for groups which either did
or did not have placebo sessions interspersed between these morphine
sessions (Groups PRF and CRF, respectively).
4 Again, both groups evi-
denced tolerance to the hyperthermic effects of morphine, but this
tolerance developed significantly more rapidly in Group CRF than in
Group PRF.
It should be emphasized that in both partial reinforcement experiments,
Groups CRF and PRF do not differ with respect to pharmacological his-
tory, yet they do differ in speed of tolerance acquisition. These
experiments clearly demonstrate that the development of tolerance can
be affected simply by manipulation of the reliability of environmental
cues as signals for morphine. The findings, although not explicable
by any interpretation of tolerance which ignores these cues, are to be
expected on the basis of the conditioning model of tolerance.
Latent Inhibition of Morphine Tolerance
The results of the experiments described in the previous section indi-
cated that one procedure that is effective in retarding the acquisition
of conditional responses, partial reinforcement, is also effective in
retarding the development of morphine tolerance, thus supporting the
conditioning analysis of tolerance. Another procedure which is known
to have a deleterious effect on conditional response formation is pre-
conditioning exposure to the conditional stimulus. It has been report-
ed that in many conditioning preparations, with both human and a
variety of infrahuman subjects, presentations of the conditional
stimulus prior to the start of acquisition serve to decrease the
41FIGURE 3
Summary of results of experiments demonstrating that the
acquisition of morphine tolerance is retarded in a group in which only
25% of the presentations of the drug administration procedure are accom-
panied by morphine (PRF), compared to a group in which all presentations
of the drug administration procedure are accompanied by morphine (CRF).
Figure 3A illustrates hot-plate response latencies reported by Siegel
(1977b, Experiment 4). Figure 3B illustrates therma1 effects reported
by Siege1 (submitted, Experiment 3).
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42effectiveness of that stimulus when it is subsequently paired with an
unconditional stimulus during conditioning. The deleterious effect of
conditional stimulus preexposure has been termed "latent inhibition"
(Lubow & Moore 1959). Although there is some controversy concerning
the mechanism of latent inhibition (see reviews by Lubow, 1973, Siegel
1972b), the theoretical interpretation of the phenomenon is irrelevant
for its exploitation as a technique to assess the conditioning theory
of morphine tolerance. According to this theory, inasmch as tolerance
results from an association between the predrug environmental condition-
al. stimulus and the pharmacological unconditional stimulus, the course
of tolerance acquisition should be affected by the relative novelty of
environmental cues present at the time of drug administration. Thus,
on the basis of the conditioning theory of tolerance, animals with ex-
tensive experience with the administration procedure prior to its actual
pairing with morphine should be relatively retarded in the acquisition
of tolerance, compared with animals with mininmal prior experience with
these environmental cues, despite the fact that both groups suffer the
systemic effects of the same dose of the opiate, given the same number
of times, at the same intervals.
We have reported the results of an experiment designed to assess whether
the latent inhibition procedure does, in fact, retard the acquisition
of analgesic tolerance (Siegel 1977b, Experiment 3). In this experi-
ment, one group of rats was extensively preexposed to the drug adminis-
tration cues, in the absence of the drug, before these cues were actu-
ally followed by morphine. Rats in this group (Group 18P) received 18
daily placebo sessions prior to seven daily morphine sessions. Rats in
a second group received only a single preexposure to the administration
procedure prior to this procedure actually signalling the drug (Group
1P). Rats in Group 1P received a placebo session the day before the
start of the seven daily morphine sessions.
The mean response latencies of Groups 18P and IP on the hot plate fol-
lowing each morphine injectionare shown in Figure 4 (next page). As
can be seen in Figure 4, both groups evidenced similar, highresponse
latencies following the first morphine administration, which is a
manifestation of the initial analgesic effect of the drug. Response
latencies of both groups rapidly decreased on subsequent drug sessions
(i.e., analgesic tolerance developed), but this decrease was signifi-
cantly more rapid [F(1,20)=6.25,p=.02] for Group IP than for Group 18P.
On the basis of any of the systemic, nonassociative theories of toler-
ance, it would be expected that Groups IP and l8P should become equally
tolerant to the analgesic effect of morphine. The two groups displayed
equivalent levels of analgesia the first time they received the drug,
and both groups had equivalent experience with the systemic effects of
the drug. However, contrary to this expectation of nonassociative
interpretations of tolerance, tolerance was more marked in Group 1P
than in Group 18P. This finding that predrug experience with the
administration procedure retards the acquisition of tolerance (i.e.,
that tolerance is subject to latent inhibition) supports yet another
unique prediction of the conditioning model of tolerance, and is not
explicable by alternative theories of tolerance which do not enphasize
the role of drug-associated environmental cues in the development of
tolerance.
43FIGURE 4
Mean response latency on the hot plate following each of
seven morphine injections for groups receiving either 18 preexposures
(18p) or 1 preexposure (1P) to the drug administration procedure prior
to morphine administration (from Siegel 1977b, Experiment 3).
1 2 3 4 5 6 7
MORPHINE SESSIONS
44LEARNING AND TOLERANCE : RESEARCH FROM OTHER LABORATORIES
The results of a number of experiments conducted in my laboratory have
been summarized, all supporting the Pavlovian conditioning analysis of
morphine tolerance. These investigations have all demonstrated that
tolerance (at least in part) is a manifestation of an association
between the drug administration ritual and the systemic effects of the
drug. Drug preparatory conditional responses, evidenced in anticipation
of the actual pharmacological assault, attenuate the pharmcological
insult. It should be noted that other investigators, while not commit-
ting themselves to a specific associative model of tolerance, have also
presented evidence implicating learning or memory processes in the
development of morphine tolerance.
Retention of Tolerance
Evidence suggesting that associative processes may be involved in
tolerance is provided by experiments indicating that tolerance dissi-
pates little with the passage of time (see Cochin & Kornetsky 1964;
Kayan &Mitchell 1972). Indeed, it has been reported that four
opiate addicts display profound tolerance to the analgesic effect of
morphine as long as eight years after their last experience with the
drug (Andrews 1943). Gochin (1970) has suggested that such persist-
ence of tolerance in the absence of any experience with the opiate is
not interpretable by many systemic theories of tolerance. However,
this great retention of tolerance would be expected on the basis of a
learning analysis of tolerance, since learned responses are highly re-
sistant to decrement merely as a result of the passage of time (see
Kimble 1961, p. 281). Indeed, Cochin (1972) suggested that since
tolerance occurs with very long intervals between drug administrations,
"a reaction analogous to memory" (p. 265) may be important in the
phenomenon.
Metabolic Intervention and Tolerance
There is evidence that a variety of suppressors of protein synthesis,
such as puromycin and cycloheximide, retard the acquisition of certain
learned responses (see review by Nakajima, 1976). These drugs also
retard the development of morphine tolerance (see review by Ginsburg
& cox, 1972). Cohen, Keats, Krivoy, and Ungar (1965) suggested that
there may be a parallel between learning and tolerance since metabolic
inhibitors have similar effects on both processes.
It has been reported that the ability of metabolic inhibitors to retard
learning is antagonized by the pituitary peptide, desglycinamide
9-
lysine vasopressin (e.g., Lande, Flexner, & Flexner 1972). Further-
more, this vasopressin facilitates sane types of learning (e.g., lande,
Witter, & DeWied 1971).
demonstrated that desglycinamide
9-1ysine vasopressin facilitated the
Recently, Krivoy, Zimmerman, and Lande (1974)
acquisition of morphine analgesic tolerance, again demonstrating a
similarity in the effect of metabolic agents on learning and tolerance.
Consolidation and Tolerance
Learning can be retarded by a variety of cerebrally insulting events
presented shortly after the learning experience, such as electrocnvul-
45sive shock (ECS) or electrical stimulation of certain brain regions,
such as the frontal cortex (see Jarvik 1970; McGaugh & Herz 1972).
Recently reported results from two laboratories, obtained in experi-
ments specifically designed to examine the analogy between tolerance
and learning, both indicate that ECS retards the development of toler-
ance to the analgesic effect of morphine (Stolerman, Bunker, Johnson
Jarvik, Krivoy, Zimmermann 1976; Kesner, Priano, & Dewitt 1976).
5
Similarly, Kesner, et al. (1976) further demonstrated that stimulation
of the frontal cortex following each morphine administration disrupts
the acquisition of tolerance, and they concluded:
.the data from both the ES and discrete brain stimulation
experiments provide additional support for a possible paral-
lel between conventional learning and tolerance to drugs
(Kesner, et al. 1976, p. 1081).
In summary, investigations from a number of laboratories have demon-
strated that the acquisition of tolerance shares many similarities
with more conventional learning preparations: Both tolerance and
learning are retained over long periods of time, and both are similarly
disrupted by ECS, frontal cortical stimulation, and metabolic inhibi-
tors (and both are facilitated by antagonists of metabolic inhibitors).
These findings generally support the view that learning plays a role
in tolerance and are fully consistent with the conditioning theory of
tolerance.
SUMMARY
It has been demonstrated that many conditional responses to a variety
of drugs are opposite in direction to the unconditional effects of the
drug, and the conditioning analysis of morphine tolerance emphasizes
the fact that subjects with a history of morphine administration dis-
play morphine-campensatory conditional responses when confronted with
the usual administration procedure but without the drug. Thus, when
the drug is presented in the context of the usual administration cues,
these conditional morphine-compensatory responses would be expected to
attenuate the drug-induced unconditional responses, thereby decreasing
the observed response to the drug. Research has been summarized which
supports this compensatory conditioning model of tolerance by demonstra-
ting that the display of tolerance is specific to the environment in
which the drug has been previously administered. Further evidence
supporting this theory of tolerance has been provided by studies estab-
lishing that extinction, partial reinforcement, and latent inhibition--
non-pharmacological manipulations known to be effective in generally
affecting the display of conditional responses--similarly affect the
display of morphine tolerance. Additional research has suggested many
parallels between learning and morphine tolerance. Both processes
exhibit great retention, both are disrupted by electroconvulsive shock
and frontal cortical stimulation, both are retarded by inhibitors of
protein synthesis, and both are facilitated by antagonists of these
metabolic inhibitors.
46FOOTNOTES
 
1This paper was prepared for a National Institute on Drug Abuse Sympo-
siun on Behavioral Tolerance, June 23-24, 1977. Research by the
author smmarized in this paper was supported by NIDA Grant DA-01200.
2In addition to groups labeled SAME and DIFFERENT _ in Figure 1, each of
the summarized experiments included additional treatment conditions
which, for simplicity, are omitted from the figure. The two groups
that are displayed for each of the analgesia experiments (Figures IA-
ID) were similarly treated in that, in each case, no subject had any
practice in performing the analgesia-indicant response until the final
assessment of the drug's effect. The design of the hyperthermic tol-
erance experiment (Figure lE) was somewhat different, and is described
in the text.
3The data labeled CONTROL in Figure 2D represent the man of readings
for two groups, both of which received morphine for the first time
during the tolerance test, and both of which responded to the drug
similarly. One of these groups received the same schedule of pretest
injections as Group BEST, and the other group received the same sched-
ule of pretest injections as Group EXT; but, in each case, all pre-
test injections consisted of physiological saline.
4In the hyperthermic tolerance experiment, the time course of the tem-
perature alteration on all sessions was determined. For simplicity,
Figure 3B displays the temperature measured 120 min following each of
the 10 morphine injections. The more complete time-effect data may
be found in the original report of the experiment (Siegel, submitted).
5It should be noted that the authors of one experiment suggested that
their results indicated that post-administration ECS did not affect
the development of analgesic tolerance (Ferguson, Adams, & Mitchell
1969). However, examination of their tolerance acquisition data
indicates that they, too, obtained an ECS-induced tolerance retarda-
tion effect, but the statistical significance of the trend cannot be
evaluated from the data presented in the published paper.
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53II. NARCOTICS
Narcotic Tolerance and
Operant Behavior
James H. Woods, Ph.D., and John Carney, Ph.D.
This paper describes the production and measurement of narcotic
tolerance as It is reflected in operant behavior. The long-term
goals of the project are to describe the variables that control
the development and extent of narcotic tolerance; to describe
how narcotic tolerance affects different types of operant behavior
and vice versa; and, further, to document the types of narcotic
tolerance that may exist, as defined by different inducing agents.
Additionally, we are interested In particular behavioral conse-
quences of tolerance development, e.g., changes in rate and pat-
tern of narcotic-reinforced responding. Although It is commonly
assumed that changes in narcotic self-injection reflect increased
tolerance development, to our knowledge no direct evidence
bearing on this issue has been offered.
We have devoted most of our attention toward simple characteri-
zation of narcotic tolerance. Nevortheless, we have been influ-
enced by evidence that suggests that tolerance to narcotic-
induced behavioral changes may be of both a metabolic and non-
metabolic nature (e.g., Goldstein et al. 1973). Moreover, we
share the suppositions proposed by a number of participants that
dose-effect expressions of tolerance are good measurement tools,
and that operant behavior iS a good starting point for the analy-
sis of behavioral tolerance. Because of the variety of behavior-
al circumstances under which we make observations of nar-
cotic tolerance, operant behavior is the only cohesive descrip-
tive system available to us. We will draw particular attention
to aspects of our findings on narcotic tolerance where it appears
to reflect behavioral mechanisms above and beyond the types of
narcotic tolerance noted above.
Narcotics affect a variety of operant behaviors, including beha-
viors not closely related to painful events (e.g., Dews 1973).
Dose-effect relations and relative potency measures of agonists
and narcotic antagonism may be obtained with operant behavior
in a variety of species (e.g., McMillan 1973), suggesting the
suitability of measuring tolerance using this endpoint. There
is the suggestion that examples of narcotic tolerance observed
54may be characterized as a shift to the right in dose-effect curve
of the narcotic (McMillan and Morse 1967). In the following ex-
periments, the generality and degree of narcotic tolerance were
assessed in a variety of ways.
NARCOTIC TOLERANCE AND FOOD-REINFORCED PERFORMANCE
Pigeons
In an experiment with pigeons in which key-peck responses were
maintained by occasional food presentations, we gave weekly
administrations of morphine to obtain dose-effect relations that
would serve as a referent for subsequent tolerance development.
Individual cumulative records of performance are shown in
Figure 1 for one of the birds from the experiment. Each bird’s
key peck performance was maintained by 4 sec periods of food
access following the first response after five minutes (fixed
interval 5 [FI 5]) in the presence of a red key light, or follow-
ing 30 responses (fixed ratio 30 [FR 30]) in the presence of a
blue key light. These schedule conditions alternated following
either reinforcement, after 1 min periods of nonresponding under
FR 30, or 1 min periods of nonresponding after 5 minutes had
elapsed in the FI. Responding was maintained at a lower rate
in the FI, and responding gradually increased in rate during the
interval (Figure la). Following food delivery, fixed-ratio
responding ocurred at a rapid rate until food was delivered
again. Morphine at 5.6 mg/kg reduced responding in both com-
ponents of the schedule (Figure lb) and almost completely elimi-
nated the behavior at 32 mg/kg (Figure lc) . We then delivered
the drug daily in gradually increasing doses over the course of
six months. At this point, occasional substitutions of larger
and smaller doses of morphine were administered; the effects of
32.0, 56.0, and 320 mg/kg are shown in the d-f segments of
Figure 1. Clearly, there is loss of sensitivity to morphine in
this individual case that suggests a lo-fold change. There do
not appear to be other qualitative changes in performance that
accompany tolerance development.
The grouped performances following maintenance for over 50 days
at 32.0 mg/kg/day showed an approximately 6- to 10-fold shift
to the right of dose-effect curves on response rates for mor-
phine in FI and FR components (Figure 2). Before chronic mor-
phine, a 3.2 mg/kg dose decreased response rates to approximate-
ly 45% of control; after daily maintenance at 32.0 mg/kg/day,
however, doses of 17.8 and 32.1) mg/kg were required to produce
about the same decrease in response rates. Similarly, before
daily morphine maintenance, a 32.0 mg/kg dose almost completely
suppressed responding. After daily maintenance at 32.0 mg/kg/
day, however, a test dose of 320 mg/kg was required to cause
about the same degree of response suppression.
55NONTOLERANT
FIGURE 1
TOLERANT (320 mg/kg /day)
30 MINUTES
Cumulative records of a pigeon’s performance on a multiple fixed-interval 5 min,
fixed-ratio 30 schedule of food presentation. Individual responses step the recorder pen up;
diagonal deflections indicate food delivery. The fixed-interval and fixed-ratio components
alternate and the recorder pen resets automatically after the completion of the fixed-ratio
component . Records a, b, and c are examples of the effects of the pretreatments of saline or
morphine in the doses shown when the morphine was delivered at weekly intervals. Records d, e,
and f are from a later stage of the experiment in which 32 mg/kg morphine was delivered daily
prior to the session and still larger doses were given as probes. This bird developed slightly
more tolerance than is presented in subsequent grouped data (from Carney et al. 1977; in press).FIGURE 2
MORPHINE DOSE (MG/KG)
Effects of morphine test doses and saline (S) on FI
and FR response rates and FT quarter-life before chronic morphine
(open symbols) and after daily maintenance at 32.0 mg/kg/day
(closed symbols). Control values were calculated from 5 non-
injection sessions before morphine testing. Each point repre-
sents the mean (f S.E.) of nine observations in the nontolerant
conditions and 18 observations in the tolerant condition. Mor-
phine and saline were administered intramuscularly immediately
before the session (from Carney et al. 1977).
57In both nontolerant and tolerant pigeons, morphine test doses
caused dose-related decreases in FI quarter-life. However, in
contrast to FI and FR response rates, the dose-effect curve
for FI quarter-life was shifted to the right by about 30-fold
after daily administration of 32 mg/kg for 50 days. Decreases
in FI quarter-life usually represented a tendency for responding
to become relatively evenly distributed within FI components, even/
though the actual number of responses emitted may have been
reduced substantially.
Thus, the amount of tolerance that develops to the rate-decreas-
ing effects of morphine is substantial and is even greater for
the measure of temporal pattern of responding in the interval.
This differential tolerance suggests a behavioral mechanism,
and it would be interesting to examine temporal patterns of
responding on other multiple schedules involving temporal vari-
ables in order to generalize this result.
We then examined, in these tolerant birds, the sensitivity to
narcotics in which stereoisomers are available. With the mor-
phinans, levorphanol and dextrorphan, only the levorotatory form
has a full range of narcotic activity, while dextrorphan lacks
many of the actions of narcotics and is thought not to bind to
narcotic receptors (e.g., Goldstein et al. 1971). Levorphanol
(Figure 3) and dextrorphan (Figure 4) reduce food-maintained
key-pecking, with levorphanol being more potent in the case of
nontolerant birds. Chronic morphine administration conferred a
marked loss of sensitivity to levorphanol but considerably less,
if any, tolerance to dextrorphan. Thus, stereospecific toler-
ance may be conferred by morphine even in situations in which
the nonnarcotic has a comparable behavioral activity.
Rhesus Monkeys
We have carried out similar experiments with rhesus monkeys in
behavioral situations in which FR 30 responding was maintained
by the delivery of 300-mg banana-flavored food pellets. The
same paradigm of tolerance assessment was used in that dose-
effect relations were obtained before and during chronic admini-
stration of morphine. Cross tolerance was assessed by examin-
ing changes in sensitivity to levomethorphan and dextromethor-
phan. Figure 5 shows the extent of tolerance observed under
conditions in which 3.2 mg/kg morphine was administered at 8-
hour intervals. There was a large shift to the right in the
morphine and levomethorphan dose-rate functions without any
change in dextromethorphan’s effects on FR responding.
Operant behavior has served us well in describing changes in
sensitivity to narcotics and assessing the pharmacological spec-
ificity of this effect. A variety of drugs may affect food-
reinforced operant behavior, and this fact was taken advantage
of in these situations to obtain comparable effects of the
stereoisomers. Another important advantage of operant behavior
during chronic drug administration is that of being able
58FIGURE  3
MG/KG
The effects of Ievorphanol on rates of FI responding,
quarter-life values and rates of FR responding in nontolerant
(open symbols) and morphine tolerant (closed symbols) pigeons.
Each point represents the mean (* S.E.)of at least five obser-
vations at each dose (from Carney et al. 1977).
59FIGURE 4
The effects of dextrorphan on rates of FI responding,
quarter-life values and rates of FR responding In nontolerant
(open circles) and morphine tolerant (closed circles) pigeons.
Each point represents the mean (± S.E.) of at least 5 observations
of each dose (from Carney et al. 1977).
60FIGURE 5
DOSE (mg/kg)
Effects of morphine, levomethorphan and dextromethorphan on fixed-ratio food-reinforced
responding in rhesus monkeys before (open symbols) and durin, g (closed symbols) the chronic
administration of 3.2 mg/kg morphine every 8 hours. Each data point represents 3-12 observations.
Brackets indicate 1 standard error (from Carney and Woods 1977).to assess control performance in the absence of drug. In our
case, at some times absence of drug yielded behavior that did
not differ in rate in any important way from predrug rates.
Thus, rates of responding in the presence and absence of toler-
ance can be comparable, and dose-effect relations may be
expressed as shifts from a common starting point.
The extent of narcotic tolerance in the monkey and pigeon was
roughly comparable in that there was a 6- to lo-fold increase
in the dose-effect relations. These experiments thus provided
a good test of the empirical significance of the definition of
tolerance in the two species.
NARCOTIC DEPRIVATION: PIGEON AND RHESUS MONKEY
One way of examining other consequences of tolerance development
is to deprive the organism of the narcotic. When the pigeons
were deprived of morphine, they had been maintained on morphine
for about 18 weeks. Saline was substituted for the morphine for
ten days. During this time, there was a transient fall in body
weight; maximum weight loss occurred 2 days after the last mor-
phine InJection (Figure 6). Thus weight loss required an In-
crease in daily postsession feeding in an attempt to maintain
the 80% deprivation weights. Body weight and amount of grain
fed returned to nontolerant control values by the end of the
ten-day withdrawal period. Rates of food-reinforced responding
generally increased over the ten-day period. After ten days,
fixed-interval response rates returned to slightly less than
the nontolerant control level. Fixed-ratio response rates not
only returned to the nontolerant control level, but increased
to 153% of control rate by the end of 10 days.
Thus, morphine deprivation in the pigeon did not result in chang-
es in schedule-controlled responding consistent with the ex-
pression of an abstinence syndrome. Similar lack of response
disruption by withdrawal in narcotic-tolerant pigeons was re-
ported by Heifetz and McMillan (1971) following 26 days of 5.6
mg/kg/day of methadone or morphine. Morphine deprivation
produced a transient weight loss which is consistent with
other species and has been taken as an abstinence sign.
The rhesus monkey does not withstand morphine deprivation as
readily. If the monkey is deprived of two of the three daily
3.2 mg/kg injections of morphine, the food-reinforced perfor-
mances are completely suppressed and may be reinstated with a
morphine injection Carney and Woods 1977).
These findings taken together with the tolerance definition
(a shift in dose-effect relationship) suggest that factors
other than a simple equivalent shift of a dose-effect relation
are necessary to predict correlates of tolerance development.
Any number of factors need to be tracked down in order to
supplement the definition in an appropriate way.
62FIGURE 6
Days of Morphine Deprivation
Effects of morphine deprivation on FI and FR response
rates and FI quarter-life (left) and on body weight and amount
of grain fed to maintain 80% food-deprivation weights (right).
Data for the nontolerant (B) and morphine tolerant (M: 3210 mg/kg/
day) conditions are provided for comparison. Prior to morphine
deprivation, birds were maintained at 32.0 mg/kg/day. Each point
represents the mean (±1 S.E.) of nine observations (from Carney
et al. 1977).
63TYPES OF NARCOTIC TOLERANCE
Martin and his colleagues (1976) have postulated multiple types
of narcotic receptors on the basis of the effects of particular
prototype agents that, while antagonized by naloxone, have
marked differences in their effects upon various behavioral
measures in the chronic spinal dog. Mark Llewellyn, at the
University of Michigan, has explored the possibility of develop-
ing tolerance to ketocyclazocine in the rhesus monkey. Both
morphine and ketocyclazocinc reduce multiple FI 5 FR 30 sche-
dule performances maintained by food presentations. Chronic
administration of morphine and ketocyclazocine produced com-
parable 3-fold shifts to the right in their dose-effect rela-
tions. When tested for cross tolerance, however, there was no
decrease in sensitivity to morphine of monkeys receiving
ketocyclazocine and vice versa. If any change occurred, a
slight supersensitivity developed to ketocyclazocine in the
monkeys receiving chronic morphine. In this experiment,
when we have produced comparable degrees of tolerance to both
morphine and ketocyclazocine, drug deprivation leads to marked
disruption of food-reinforced responding in the case of mor-
phine, but not with ketocyclazocine.
These data lend support via species and behavioral generality
to Martin’s conjectures concerning a different type of recep-
tor for compounds of the ketocyclazocine type. They also
suggest that cross tolerance tests with narcotics and operant
behavior may be an important investigational tool for dis-
tinguishing different types of narcotics.
NARCOTIC TOLERANCE AND NARCOTIC-REINFORCED RESPONDING
We have recently adapted the behavioral situations described
above to encompass narcotic-reinforced responding (Carney
1976). The situation is a multiple FR 30 schedule of food
and codeine delivery. Before the monkey is given access to
intravenous codeine for self-injection, a set of dose-effect
curves is obtained with FR responding maintained by food pre-
sentation. Subsequently, codeine self-injection is added
under different cue-light conditions but under the same FR
schedule. Drug-reinforced responding is continued for over
a month until stable, and then dose-effect relations are ob-
tained again. Decreased drug sensitivity on food-reinforced re-
sponding with narcotics would indicate tolerance development;
however, we have been able to maintain codeine-reinforced re-
sponding at high rates for over a month without obtaining a
shift in sensitivity upon food-reinforced responding. Thus,
it is possible to sustain narcotic-reinforced responding with-
out inducing significant tolerance development. If the dose of
codeine is increased markedly, we can induce tolerance. Under
these conditions of tolerance induction, we have not found a
64corresponding change in pattern of codeine-reinforced respond-
ing. We are confident of the dissociation of tolerance and
sustained rates and patterns of narcotic-reinforced responding.
We have no direct evidence that tolerance influences narcotic
drug self-Injection
SUMMARY
Narcotic tolerance was measured as a shift to the right in
dose-effect relations on operant behavior following repeated
administration of drug. Tolerance has been observed with
operant responding in both pigeons and rhesus monkeys. The
amount of tolerance observed with food-reinforced responding
is related both to the amount of morphine administered and to
the nature of the drug-induced change In operant responding.
Pharmacological specificity of the narcotic tolerance has been
confirmed by equivalent loss of sensitivity to other narcotics
without concomitant changes in sensitivity to nonnarcotic
stereoisomers. Tolerant birds do not show disturbed operant
behavior when narcotic administration is terminated abruptly.
Tolerance has been induced by narcotic self-injection and
Its effects measured on rates and patterns of food- and
narcotic-reinforced responding. Tolerance does not necessar-
ily confer changes in narcotic-reinforced responding. More-
over, narcotic-reinforced responding may be initiated and
maintained for periods of over one month without conferring
tolerance.
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Conditioning Effects of Narcotics
in Humans
Charles P. O’Brien, M.D., Ph.D., Thomas Testa, Ph.D.,
Joseph Ternes, Ph.D., and Robert Greenstein, M.D.
Observations from classical conditioning studies in human narcotic
addicts suggest ways in which behavioral tolerance may be involved
in human addiction. Narcotic addicts experience sequential drug-
related states usually called “highs”
drawal, craving) , . Such changes are iden-
tifiable by self-reports and by measurable physiological changes.
These states are obviously influenced by pharmacological factors
(dose, time since last dose, route of administration, etc.), but
there is also increasing evidence that they are influenced by learn-
ing factors. When environmental stimuli are consistently paired
with drug-related states, the stimuli alone may acquire the ability
to produce these states or to modify them. The subject’s adapta-
tional responses to these states may also be learned. Modification
of drug-related states by learning is, of course, related to the
phenomenon of tolerance.
CONDITIONED WITHDRAWAL
We have been studying behavioral and autonomic changes in drug-
related states and the effects of learning on these changes. The
first state we examined experimentally was that of withdrawal.
Animal studies [Goldberg 1970) and clinical evidence (Wikler 1973a)
indicated that withdrawal can be conditioned. We obtained system-
atic self-report data from the clinic (O’Brien 197%) and then pro-
duced withdrawal as a conditioned response in the laboratory
(O’Brien et al. 1975a; O’Brien et al. 1977). SubJects were volun-
teers, maintained on a steady dose of methadone. Use of confound-
ine drugs was excluded by daily urine tests. The unconditioned
response (UR) was naloxone-precipitated withdrawal. This consisted
of brief, dose-related behavioral, subjective, and autonomic signs
of narcotic abstinence. It was paired with a complex conditioning
stimulus (tone/odor CS) . After 7-10 conditioning trials, a condi-
tioned response (CR) was evident which generalized to the test room
and frequently had its onset before the discrete CS. The CR was simi-
lar to the UR and in the same direction. The withdrawal consisted
67of subjective components (craving, nausea, cramps), behavioral com-
ponents (yawning, blinking, restlessness, touching of eyes, rubbing
of abdomen) , and autonomic components (decreased skin temperature,
tearing of the eyes, increased heart rate and respiration, changes
in skin resistance and electrogastrogram). Thus a state similar to
drug withdrawal was produced by a CS in human subjects under labor-
atory-controlled conditions.
Concerning conditioning in the natural environment, there is anec-
dotal evidence that addicts may begin yawning and tearing while
discussing drugs during group therapy. We have also reported with-
drawal behavior in addicts shown video tapes of drug-administration
rituals (O’Brien et al. 1974). Teasdale reported changes in mood
scales when addicts were exposed to drug-related slides (Teasdale
1973). The most consistent physiological evidence that we have
found to date for a naturally conditioned withdrawal response is a
study in which the “cook up” ritual serves as a CS (O’Brien et al.
1977b). Drug-free (detoxified) addicts who perform this ritual
develop withdrawal responses (pupillary dilatation, decreased skin
temperature) prior to receiving any drug. The CS seems to be a
complex of the sight of a bag of heroin, the odor of the “cooker ,"
and the anticipation of a self-injection. Nonaddicts exposed to
the same stimuli showed a novelty response which did not persist
the way the addict response did. Thus we have evidence that in some
circumstances the withdrawal or drug-negative state can occur as a
conditioned phenomenon.
CONDITIONED AGONIST EFFECTS
We have also examined the drug-positive state in detoxified human
addicts. When the subject is permitted to go through pre-injection
rituals in the laboratory and then inject a narcotic, a sequence of
subjective, behavioral, and autonomic changes occurs. bring
the pre-injection phase, withdrawal or drug-negative responses
usually occur. During the post-injection phase, the withdrawal re-
sponses are reversed, and the drug-positive responses occur. The
subject reports relief of craving and withdrawal and the presence
of pleasant or euphoric feelings. Autonomic responses include
pupillary constriction, increased skin temperature, and slowing of
respirations and gut contractions. Of course, the intensity and
duration of the drug-positive effects depend on the dose and pre-
vious drug experience of the subject. We have also found that in-
tensity and duration are influenced by pre-injection rituals and
expectation of the subject.
The subjective effects of a narcotic are most influenced by these
nonpharmacological factors, but in some subjects even the autonomic
changes respond to expectation. A test dose of narcotic tends to
produce greater drug-positive effects when self-injected along with
rituals than when given over the same time interval through an intra-
venous infusion with no drug expectation signals to the subject.
The conditioning of drug-positive responses is further exemplified
by the effects of placebo injections. if a detoxified addict is
68permitted to self-inject with rituals either narcotic (4 mg hydro-
morphone) or saline under double-blind conditions, the saline in-
jection will be followed by a small drug-positive effect. This
will extinguish in most subjects after one or two trials, especially
if the subject has the opportunity to compare the effects of saline
and narcotic (cognitive influence).
Addicts who are placed on a narcotic antagonist (cyclazocine or
naltrexone) and then allowed to self-inject show an interesting
series of responses. Most of those receiving saline extinguish
drug-positive responses (high) within 1-3 trials and then show only
drug-negative responses (withdrawal) after subsequent injections.
Those who self-inject a narcotic show drug-positive responses for a
greater number of trials, in spite of the antagonist, but in most
cases extinction is complete within 8-10 trials. (There were some
notable exceptions, with a few subjects showing euphoric responses
for 20-25 trials even with saline injections. It is not clear
whether this relates to prior conditioning history or individual
variation.) After extinction of drug-positive responses, only drug-
negative (withdrawal) responses remain, and these may be persistent
and intense. The drug-positive responses probably persist longer
when narcotic is injected in the presence of antagonist than when
saline is injected, because some of the pharmacological effects of
the narcotic are not completely blocked. The cyclazocine or nal-
trexone acts as a competitive antagonist of narcotic effects, but
some narcotic enteroceptive cues apparently still occur. This
explanation is supported by the fact that drug-positive effects
persist longer when patients self-inject a narcotic while receiving
cyclazocine than while receiving naltrexone. Naltrexone, since it
has few side effects, can be used in a higher dose and thus can
provide an agonist/antagonist ratio more favorable to the antagonist.
Our work with humans, therefore, suggests that both drug-positive
and drug-negative effects can be learned. We have interpreted
these findings within the framework of Solomon’s opponent-process
theory (Solomon and Corbit 1974). The findings are also compatible
with Wikler’s description of conditioned counteradaptive effects
(Wikler 1973b) and Siegel’s discussion of tolerance as a conditioned
phenomenon (Siegel 1975). While Wikler and Siegel deal mainly with
conditioning which reduces drug effects (drug-negative phenomena),
we also have evidence of conditioned drug-positive effects. The
opponent process framework provides a convenient means of describing
the interaction between conditioned drug-positive and conditioned
drug-negative effects. Briefly stated, it is postulated that a
consistent set of rituals reliably signals the appearance of opiates
in the body. The adaptive responses provoked by the impact of the
drug on homeostatic mechanisms act to oppose the drug effects.
These drug-negative responses, after repeated pairings with the
antecedent rituals, can be elicited by the rituals alone. This
learning of drug-negative responses is facilitated by the fact that
the addict frequently is already in a pharmacological state of with-
drawal as a result of metabolism of the previous dose by the time
he performs the rituals. Thus there are two pathways for the rein-
forcement of drug-negative responses.
69The learned drug-positive effects tend to be briefer and less reli-
able than drug-negative effects and more easily extinguished.
These can be manifested in self-reports of “high” or euphoria and
in such autonomic changes as pupillary constriction, decrease in
respiratory rate, or increase in skin temperature. These learned
responses are similar to what has been called the placebo effect
and the “needle freak” phenomenon. Their onset follows self-
injection, and they tend to augment rather than reduce the effects
of the drug. These effects appear to be more influenced by expec-
tation or cognitive factors than are conditioned drug-negative
effects. This may help to explain why addicts continue to report
pleasure from street “heroin” which contains minimal, if any,
narcotic (O’Brien 1975b).
Our work with conditioned drug states in humans, though still
preliminary, suggests that learning does play a role. It is too
soon to state how important that role may be or whether the findings
will have a direct application to the clinical management of drug
dependent people.
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Tolerance as a Behavioral
Phenomenon:
Evidence from Two Experimental
Paradigms
A. E. Le Blanc, Ph.D., C. X. Poulos, Ph.D., and
H. D. Cappell, Ph.D.
INTRODUCTION
The purpose of this conference is to define and assess the impor-
tance of the phenomenon that has come to be known as “behavioral
tolerance.” Our contribution to this task will be based on two
lines of research that have been continuing in the laboratories of
the Addiction Research Foundation over the course of many years.
During the development of this research, it has become evident to
us, as to others, that no comprehensive account of tolerance can
ignore behavioral concepts. This is so whether the object of study
is drug-induced motor impairment or aversive conditioning by psycho-
active drugs.
What Are the Descriptive Requirements of Tolerance?
Before an alteration in drug response can be characterized as toler-
ance, two requirements must be met:
(a) A drug effect will diminish in magnitude with repeated exposure
to a fixed dose.
(b) A drug effect diminished in magnitude by repeated exposure to
a fixed dose can be reinstated by an increase in dose.
These requirements imply nothing in particular about mechanisms
of tolerance. They merely establish criteria to be applied in
order to characterize a reduction in a drug effect as tolerance.
It is often the case that investigators invoke the concept of tole-
rance even when only the first of the above requirements has been
met. Usually, this is not a problem because enough is known about
the pharmacology of drugs of interest that other characterizations
of reduced response can be eliminated. However, reduction of res-
ponse may be a reflection of tachyphylaxis resulting from depletion
of a response mechanism, rather than genuine adaptation (cf. Kalant
et al. 1971a). Where tachyphylaxis is involved, the second require-
ment for the existence of tolerance could not be met.
72In the ideal case the production of tolerance should result in a
parallel shift in the dose-response curve for the effect under
investigation (Kalant et al. 1971a). This would be indicative
of a shift in threshold of the dose required to produce the effect.
It is not often the case that this ideal is achieved in actual
research. In any event, this criterion is only applicable in the
relatively simple case of linearity of dose-response function. A
parallel shift of a nonmonotonic relationship may be more diffi-
cult to demonstrate. The notion of parallel shift is important
for reasons of interpretation, since the nature of the alteration
of the dose-response curve may be an important clue as to the
mechanism of adaptation involved (Kalant et al. 1971a).
Behavioral Tolerance versus Other Kinds: A Preliminary View
The ideation and experimentation that led to the formulating of
the concept of behavioral tolerance developed in part as a reac-
tion to more physiologically or pharmacologically based conceptions.
(Although “metabolic” tolerance is included as a physiological
notion, we are not concerned with it here, especially since it
seems not to be important in the studies we are discussing. Our
meaning of physiological tolerance refers to changes in sensitiv-
ity of receptors at which a drug is presumed to act centrally.)
This distinction has been considered in detail by a research group
(Kalant et aL 1971a) with no inflexible allegiance to either con-
ception. “Physiological” tolerance was defined as “a compensatory
or homeostatic change in the neurons affected by the drug, which
renders them less sensitive to it.” The implication of such a
definition is that tolerance is a necessary consequence of contin-
ued contact between a drug and the receptors upon which it acts,
unmodulated by conditions other than pharmacological ones such as
dose and duration of exposure. What is obviously wrong with such
a conception is that it fails to account for numerous examples
of adaptation to a drug that are modulated by nonpharmacological
variables; perhaps more importantly, it fails to account for the
comparative absence of adaptation in instances in which the
pharmacological exposure per se was not adequate to evoke an adap-
tive response (e.g., Carlton & Wolgin 1971; Schuster et al. 1966).
The final conclusion of Kalant’s review was that there is in fact no
qualitative difference between “physiological” and “learned” (the
word used in the review) or ‘behavioral” (the word adopted for
this conference) tolerance. Rather, Kalant et al.argued, behavi-
oral variables contribute to the rate of development of tolerance
by modulating the rate of a physiological process common to all
manifestations of tolerance. To quote:
. . . . it appears that the “learned tolerance” is essen-
tially the same as “physiological tolerance’ except that
it is acquired somewhat more rapidly. (p.158)
This was not meant to trivialize behavioral factors in tolerance,
but only to emphasize the hypothesis that, fundamentally, some
common mechanism is at work in various manifestations of the adap-
tation to the behavioral disruptions produced by drugs. As an
73expression of this conclusion Kalant et al.coined the phrase
“behaviorally augmented tolerance” in order to emphasize a funda-
mental similarity rather than a fundamental difference in varieties
of tolerance. It may well be the case that a distinction between
behavioral and physiological tolerance is unnecessary in consider-
ing an ultimate mechanism of tolerance. Yet it seems also to be
the case that any such mechanism is not fully engaged merely by
the presence of a drug at a receptor site, independently of other
events. The purpose of this paper is to ruminate about what
some of these “other events” might be, and to arrive at a concep-
tion of tolerance that does no violence to pharmacology, psychology,
or fact.
EVIDENCE FROM STUDIES OF MOTOR IMPAIRMENT OF RELATIONSHIPS BETWEEN
TOLERANCE AND OTHER FORMS OF ADAPTATION
A reliable consequence of the administration of alcohol and other
CNS depressants is motor Impairment. Such impairment can be effec-
tively quantified in rats by means of a test requiring an animal
to walk a moving treadmill (Gibbins et al. 1968). Alcohol and
barbiturates impair the ability to perform this response, and the
method is highly sensitive to small variations in dose. In this
test, tolerance is evident as reduced impairment of performance
as a result of chronic exposure to a drug. Much of the work reported
in this section employed the treadmill test, although occasionally
other behavioral tests of impairment have been used. To anticipate
somewhat, the thrust of this section is an attempt to draw parallels
between tolerance and other forms of adaptation, such as learning.
Interestingly, another participant in this conference (Siegel 1975)
has viewed the existence of such parallels as an alternative to
a purely physiological conception of tolerance to the analgesic
effect of morphine. The search for alternatives should not be seen
as a dismissal of the relevance of physiology and pharmacology;
rather it represents the addition of a novel dimension that is
clearly needed to account for certain features of tolerance. We
will describe the findings with a minimum of detail since most are
available in the published literature and have been reviewed else-
where recently (Le Blanc &, Cappell 1977).
Cortical Ablations and Tolerance
One strategy for demonstrating a parallel between tolerance and
general adaptive processes is to compare the impact of an experi-
mental manipulation designed to interfere with them. The parallels
here come from work on ablations of the frontal cortex. An intact
frontal cortex appears to be essential in several species for the
acquisition of behavior requiring a delay of response or a sensory
discrimination in order to receive reward (cf. Grossman 1967).
Thus, frontal cortical ablations may interfere with learning. More-
over, lesions of the frontal cortex have been shown to impair the
physiological adaptation to thermally elicited tachycardia that
is evident in normal animals (Glaser 1966). If tolerance has
something in common with these other adaptive phenomena, It should
74be possible to interfere with its acquisition by means of compar-
able ablations. Le Blanc et a1.(1976) tested this hypothesis using
alcohol. Using the treadmill test, rats were first made tolerant
to the motor impairment produced by alcohol. The animals were allowed
to recover from tolerance for a month before being assigned to
groups selected for bilateral frontal polar lesions, sham operations,
or no operation. Following recovery from surgery, the reacquisi-
tion of tolerance was studied under conditions identical to those
of initial acquisition. Although all groups were shown to be
capable of acquiring tolerance before surgery, only the controls
did afterward; the lesioned animals displayed virtually no reac-
quisition of tolerance. A smaller pilot study yielded similar
results with lesions to the occipital cortex.
These results in themselves offer only modest support for our basic
thesis. However, they do indicate that alcohol tolerance shares
a property in common with complex learning and a physiological
adaptation. Moreover, research on amphetamine (Glick 1973) suggests
that the involvement of the frontal cortex in tolerance develop-
ment is not peculiar either to alcohol or to motor impairment.
Protein Synthesis and Tolerance
The evidence on the effects of frontal cortical ablations provided
some support for a commonality of process in tolerance development
and the acquisition of new responses. To the extent that protein
synthesis is involved in learning, another opportunity for pursu-
ing the analogy presents itself. Evidence of a role for protein
synthesis in learning is provided in a study by Segal et a1.(1971),
who showed that cycloheximide, an inhibitor of central protein
synthesis, interfered with the retention of discrimination learning
in mice. The effect of cycloheximide on alcohol tolerance was
pursued by Le Blanc et a1.(1976) using a design and procedures very
similar to those adopted in the ablation study; the major difference
was that the effects on reacquisition of tolerance of treatment .
with cycloheximide were at issue. During exposure to the initial
tolerance-inducing regime, cycloheximide treatment was combined
with alcohol in the critical experimental group. On tests of the
reacquisition of tolerance to the impairing effects of ethanol the
performance of controls improved over time by more than 50%, where-
as rats treated with cycloheximide acquired virtually no tolerance
whatsoever. Hence, the evidence for our general hypothesis increases,
although it is conceded that this experiment does not rule out
mechanisms of interference with tolerance acquisition not involving
the inhibition of central protein synthesis (e.g., subclinical
convulsions) . The effect of cycloheximide on tolerance is not unique
to alcohol, since cycloheximide has been found to inhibit the
development of tolerance to the analgesic property of morphine in
mice (Loh et al. 1969).
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A third source of evidence for the tolerance/adaptation parallel
derives from recent data on the role of serotonin in the develop-
ment of tolerance to ethanol. That depletion of serotonin retards
habituation to non-drug stimuli has been amply demonstrated in
studies of acoustic startle responding (Carlton & Advokat 1973;
Connor et al. 1970; Swonger et al. 1970). In all of these studies,
serotonin level was manipulated by prior treatment with p-chloro-
phenylalanine (PCPA), an established depletor of serotonin in the
CM. The drug studies (Frankel et al. 1975) employed the moving-
belt test to measure tolerance. Both alcohol and pentobarbital
were investigated, but since the results were quite similar,
only the ethanol work will be presented in any detail.
The essential strategy of the study was to expose animals depleted
of serotonin to a schedule of alcohol administration that would
be expected to promote tolerance to the impairing effects of a test
dose. Treatment with pCPA was given daily for 10 days before
chronic exposure to alcohol, and continued for 25 further days
during which experimental animals were also exposed daily to large
doses of alcohol by gavage. Tests of impairment on the treadmill
apparatus were interspersed at intervals during the chronic regime
of treatment. Control animals exposed to ethanol but not pCPA
clearly developed tolerance to the test dose; rats exposed to pCPA
also displayed some tolerance, but the rate of acquisition was
significantly impaired, and the level did not approach that of
controls during the course of the experiment. Much the same
assertion can be made where pentobarbital was concerned.
As with the other data presented in support of our general hypo-
thesis, these findings are by no means free of alternative inter-
pretation. Yet they do seem to enhance the credibility of the
hypothesis by providing supporting data from another general domain
of investigation. Moreover, there is evidence that comparable
manipulations retard the development of tolerance to morphine as
well way et al. 1968; Shen et al. 1970).
Topographical Similarity between Tolerance and Learning
A fourth source of parallels between tolerance and adaptation de-
rives from a topographical similarity in one aspect of tolerance
and learning. One property of learning that is demonstrable by
appealing to both personal experience and the scientific literature
(Kimble 1961) is that responses are reacquired after a period
of disuse with much greater facility than they are initially
mastered. A similar process can be demonstrated in studies of
adaptations of a more fundamental physiological nature; for example,
physiological adaptation to thermal stimuli proceeds more rapidly
to the extent that an organism has a history of adaptation to those
stimuli (Glaser 1966). The parallel was illustrated in a study
by Kalant et al. (1971b), in which repeated cycles of acquisition
of tolerance to alcohol were studied using the treadmill test.
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day drug-free intervals between cycles to permit recovery to base-
line levels of impairment. The basic finding was that the same
Level of tolerance was achieved during each cycle, but that this
level was attained in fewer and fewer trials over successive cycles
of acquisition. Whereas 13 to 16 days of chronic exposure were
required for maximal tolerance to be attained during an initial
cycle, maximal tolerance was evident with 4 days of treatment during
a fourth cycle.
Effects of Behavioral Manipulations on Tolerance
Although they do not, strictly speaking, provide an example of a
parallel between tolerance and learning, studies in which the acqui-
sition of tolerance has been manipulated by behavioral interventions
are quite pertinent to our approach. Some studies have explicitly
attempted to provide an empirical distinction between ‘behavioral”
and “physiological” tolerance. Physiological tolerance implies a
change in the sensitivity of the neurons directly affected by a
drug, and should be a consequence of mere exposure; this is to be
distinguished from the functional adaptation (i.e., adaptation to
some ultimate behavioral effect of a drug) implied by behavioral
tolerance. Experiments that provided evidence of this distinction
where amphetamine is concerned have been reported by Carlton and
Wolgin (1971) and Schuster et al. (1966). Briefly, these studies
showed that tolerance to effects of amphetamine developed to the
extent that adaptation was of some “benefit” to the drugged animal;
given equivalent pharmacological exposure, tolerance was not observed
when there was no “benefit” to be gained thereby. Our discussion
focuses on a related phenomenon involving alcohol.
In the study that inspired our own research, Chen (1968) compared
groups of rats that first received injections of alcohol either
before or after performance was tested on a maze task in which ap-
proach behavior was maintained by food reward. On the critical
test, all rats received their injection before testing. The finding
from this test was that tolerance was evident in the group that
had consistently received alcohol before the test, but not in the
group that was given alcohol prior to the test for the first time.
This outcome seems to indicate clearly that mere exposure to alcohol
was not in itself sufficient to provoke tolerance. Chen concluded
that this was evidence of a qualitative distinction between physio-
logical and behavioral tolerance. However, Le Blanc et al. (1973)
argued that Chen’s manipulation may simply have affected the rate
of tolerance development, and that his results may have depended
on the limited number of exposures to alcohol (4 in all} that he
employed. Clearly, one would draw different conclusions about the
existence of a fundamental difference between behavioral and phy-
siological tolerance if the rate and not the asymptote of a process
were the major difference. Le Blanc et al. (1973) tested their
hypothesis using a design similar to Chen’s, but one which incorporated
many more exposures to alcohol prior to the critical test of toler-
ance . Consistent with the hypothesis, tolerance was acquired more
77rapidly if alcohol treatment consistently preceded the behavioral
test, but the same final level of tolerance was achieved if during
acquisition a sufficient number of exposures to the same dose
was given following the behavioral measurement. Le Blanc et al.
(1973) concluded from these data that one need not entertain the
possibility of a separate cellular mechanism for behavioral and
physiological tolerance if behavioral manipulations primarily affect
only the rate of tolerance development. For this reason, they pro-
posed the phrase “behaviorally augmented tolerance” to describe
the interaction between behavioral demand and the rate of tolerance
development, while rejecting the suggestion of fundamentally dif-
ferent mechanisms. Other studies involving opiates (Kayan et al.
1969)) barbiturates (Waslstrom 1968)) and chlorpromazine (Irwin
1963) are consistent with this hypothesis.
In an important extension of this work, it has been found that
behaviorally augmented tolerance is not task-specific (Le Blanc et
al. 1975). First it was shown that behavioral augmentation of
tolerance could be demonstrated on the treadmill test; although
this result was not novel, it extends the generality of the pheno-
menon. More importantly, it was found that the behavioral augmen-
tation of tolerance was transferred to a maze task on which perfor-
mance was shown to be entirely independent of treadmill performance
(i.e., there was no transfer of training in no-drug control condi-
tions) . This outcome is of particular Importance because it demon-
strates that behaviorally augmented tolerance results in more than
an enhancement of learned compensation for the impairment produced
in a specific behavioral test. Rather, it appears that behavioral
augmentation facilitates\ the development of a fundamental adaptation
at neuronal level that is generalizable to an entirely novel be-
havioral circumstance. Moreover, it is worth noting that behavioral
augmentation of physical dependence was also shown in this work.
In summary, it appears that it may not be necessary to think of
behavioral and physiological tolerance as independent phenomena
that challenge the possibility of a single neural mechanism of toler-
ance , This resolution ispossible to the extent that we entertain
a unitary mechanistic theory of adaptation that allows for the
influence of behavioral manipulations on the rate of adaptation.
The fact that behavioral manipulations do have a clear influence
on the rate of adaptation seems to strengthen rather than weaken a
unitary theory, although it does require some revision of any thought
that mere exposure of the CNS to the drug is the only adaptive
stimulus of importance in tolerance development.
SUMMARY
Although our case rests to a large extent on analogy, it is diffi-
cult to avoid being impressed by the convergence of all of the fore-
going data. It may be possible to dispute the persuasiveness of
any or even all of the experimental illustrations taken individually,
but the mass of evidence taken together is remarkably consistent with
our basic supposition that tolerance and adaptation are quite similar
78processes. The parallels hold across a diversity of experimental
manipulations and they are not peculiar to any single pharmacolo-
gical agent. Yet admittedly the argument is still speculative
and must remain so until there is some better understanding of the
unitary neural mechanism of adaptation that we have suggested.
With our basic thesis established, we can now turn to an area of
research that has proceeded somewhat independently from that already
described. On the face of it, it would have been difficult to see
that these lines of research would ever converge, but they have.
EVIDENCE FROM STUDIES OF GUSTATORY AVOIDANCE CONDITIONING
Our first encounters with gustatory avoidance conditioning some
years ago were characterized by a combination of intrigue and
puzzlement. Using doses that were known to be positively reinforce-
ing to rats, we were able to condition avoidance behavior with amphe-
tamine (e.g., Cappell & Le Blanc 1973). When the response of
drinking saccharin was paired with doses of amphetamine that were
not obviously toxic, a phenomenon that looked much like punishment
occurred. At first, this behavioral model was intriguing, in large
part because it generated an outcome that was nonobvious and appa-
rently paradoxical. Of the possible research avenues to follow,
we opted to consider conditioned gustatory avoidance as a model of
control of behavior by a pharmacological stimulus, just as intra-
venous self-administration is. The study of tolerance to the effects
that exert such control is obviously important, but intravenous
self-administration methods had not been ideally suited for the
purpose. For one thing, it is quite difficult to use the intravenous
model to generate baselines of drug-maintained behavior that obviate
the development of tolerance prior to the acquisition of a stable
baseline. Another problem, although not an insuperable one, is
that the presentation of the reinforcer might affect the behavior
on which it is contingent in such a way as to obscure the measure-
ment of tolerance. Although it has problems of its own, the gus-
tatory conditioning method averts these two.
Since much of this work is already published and the earlier work
is reviewed elsewhere (Cappell & Le Blanc 1975a; in press) we will
deal briefly with the history and later concentrate more fully on
our newer findings. Our first effort in this area (Le Blanc &
Cappell 1974) began with an essentially traditional (i.e., “phy-
siological”) conception of tolerance. Animals were chronically
exposed to regimes of treatment with high and low doses of morphine
or amphetamine. Next, their acquisition of avoidance of saccharin
conditioned by these drugs was studied. Attenuation of the acqui-
sition of avoidance in this procedure could reflect tolerance to
the drug effects that are responsible for avoidance. Pretreatment
with amphetamine at both a high (20 mg/kg) and low dose (4 mg/kg)
greatly attenuated the degree of gustatory avoidance that could be
subsequently conditioned with a dose of 1 mg/kg. These results
were corroborated in an analogous experiment with morphine. Although
there were several alternative explanations for the results, the
best one seemed to be that the pretreatment regimes had produced
79tolerance to the effects of the drugs that were responsible for
avoidance conditioning (whatever these effects might be).
The next logical series of experiments was also dictated by a tra-
ditional contention of tolerance. It was here that the trouble
with such a notion first began to emerge. The reasoning (Cappell
et al. 1975) was that if pretreatments were effective because they
produced pharmacological tolerance, pretreatment with a drug from
one pharmacological class should not affect gustatory conditioning
by a drug from another class. This prediction was found to be
generally true: pretreatments by morphine, amphetamine, or
chlordiazepoxide were effective in attenuating conditioned
avoidance by themselves, but not by each other. The one strange
exception to this was that amphetamine did attenuate conditioning
by morphine, although the reverse was not true. We could find only
scant evidence to account for this on pharmacological grounds, but
the flaw in the tolerance hypothesis still seemed to be outweighed
by its merits. Recently, similar anomalies have been reported by
other laboratories (Braveman 1975; Vogel & Nathan 1976).
Other experiments were designed specifically to further the inter-
pretation of these pretreatment effects as evidence of tolerance
to the unconditioned effects of the drugs. Two parametric studies
(Cappell & Le Blanc 1975b) showed that the rate of acquisition
and loss of the effectiveness of amphetamine pretreatment corres-
ponded to what might be expected if pharmacological tolerance was
at work (Kalant et al. 19719). The effectiveness of pretreatment
increased linearly with the number of pretreatments and was lost
in linear relationship to the duration of withdrawal following a
fixed duration of pretreatment. We also found that the persistence
of the effect of pretreatment with morphine outlasted that of amphe-
tamine (Cappell & Le Blanc 1977). This result seemed very persu-
asive in view of the evidence, admittedly meagre and controversial,
that tolerance to morphine is uniquely persistent (Cochin & Kometsky
1964).
In the same paper, however(Cappel1 & Le Blanc 1977), another finding
not entirely consistent with a purely physiological conception of
tolerance emerged. We compared the effectiveness of 1.5 “massed”
and “spaced” pretreatments with morphine and amphetamine in attenu-
ating the acquisition of aversive conditioning by themselves. As
far as possible, comparability across the two drugs was attempted
by selecting approximately equipotent doses of the two drugs during
pretreatment ( morphine, 40 mg/kg; amphetamine, 4 mg&kg) and
conditioning (morphine, 10 mg/kg; amphetamine, 1 mg/kg). Despite
the fact that animals in the “spaced” conditions were injected at
intervals of 120 hr compared to 24 hr for the “massed” conditions,
the two schedules of pretreatment were highly and equally effective
regardless of the drug used. Why is this inconsistent with a purely
pharmacological construction of tolerance? According to some empir-
ical evidence and a mathematical model of the kinetics of toler-
ance acquisition developed in our laboratories (Kalant et al. 197la;
Le Blanc & Cappell 1975), a drug treatment schedule should be more
effective in producing tolerance to the extent that the adaptive
80response to the pharmacological stimulus can accumulate with mini-
mal opportunity for dissipation over time. From this postulate
we predicted the greater effectiveness of the massed schedule -
incorrectly.
Our prediction was based upon the assumption that there is a
decay of the tolerance produced by a single injection of a drug to
the point that injections spaced at 120 hr will not provoke much
cumulation of tolerance. The loss of the adaptation was assumed
to represent a recovery to normalcy, in this case to nontolerant
status, in the prolonged absence of a continued pharmacological
stimulus to adapt. If this model is not applicable, what kind of
interpretation could predict such “savings” of the effectiveness
of drug administrations spaced at wide intervals? One possibility
that we had considered and rejected earlier (Le Blanc & Cappell
1974) and that has been specifically proposed by Braveman (1975)
to account for pretreatment effects is the operation of an asso-
ciative process. Although Braveman did propose two versions of the
operation of an associative mechanism, he was necessarily specu-
lative about how they might work. However, even in the absence of
a specific proposal of how such a mechanism might work, in principle
it would seem less vulnerable to decay with the mere passage of
time than a physiological one such as we had been entertaining.
The reason for this is that an active intervention rather than the
mere passage of time seems to be required to offset the effective-
ness of an associative mechanism,
Further exploration of an associative basis for these pretreatment
effects involved an excursion into some principles of conditioning
theory. Specifically, pretreatment phenomena were analysed in the
context of Rescorla and Wagner’s (1972) associative-blocking model
of conditioning. First, the operations involved in our typical
experimental paradigm were subjected to scrutiny as a conditioning
procedure per se. Consider first the operations involved in a pre-
treatment procedure. The animal is repeatedly exposed to a rela-
tively consistent set of cues (i.e., the cues of handling and in-
jection) followed reliably by the pharmacological effects of the
administered drug. Formally, this can be considered as the repeated
Pavlovian pairing of a CS and a KS. During gustatory conditioning,
the animal is exposed to an intended CS (the flavor of saccharin)
followed in 5 minutes by handling, injection, and pharmacological
effects. That is, during conditioning there is an attempt to esta-
blish a new associative link between a flavor (CS2) and a pharma-
cological effect, although such a link between the cues of handling
and injection (CS1) has already been established. According to
an associative-blocking analysis, the prior association of CSl and
the UCS should ‘block” an association between CS2 and the same UCS
because CS1 has in effect preempted the associablllty of the UCS
to other CSs. In an empirical test of this analysis, we specifi-
cally attempted to neutralize the association between handling and
injection cues and a drug effect by an explicit nonreinforcement
procedure, and thus to “unblock” the association between flavor and
drug effect. In the interest of brevity, only the results of one
experiment that supported this analysis will be presented, although
81it should be added that we have successfully replicated and extended
the results recently.
On the basis of our analysis, it is evident that the cues requiring
neutralization are those that most reliably and immediately precede
the drug effect; thus an effective procedure must neutralize the
associative value of handling and injection cues. An obvious way
to do this is by nonreinforcement- that is, by presenting these
cues not followed by a drug effect. In our first experiment designed
to test this conceptualization, we examined the effect of a nonre-
inforcement procedure on the effectiveness of pretreatment by
amphetamine (7.5 mg/kg for 12 days). The nonreinforcement proce-
dure simply consisted of administering injections of saline 4 times
per day for 4 days prior to the beginning of conditioning trials
and on the 2 days intervening between each conditioning trial.
The conditioning dose was 1.0 mg/kg of amphetamine. The nonrein-
forcement procedure had the predicted effect. In the group exposed
to the procedure, the usual effect of pretreatment was completely
reversed.
This finding can be approached in at least two ways. First, an
unelaborated interpretation based on the concept of associative
blocking and its reversal suffices on its own. In such an approach,
tolerance need not be mentioned, and the information value of the
nonreinforcement procedure can be emphasized. Thus it may be that
the application of the nonreinforcement procedure tells the rat
that the important association in gustatory conditioning is between
the flavor and the drug effect, rather than between the handling
and injection procedure and the drug effect. Consequently, it
learns to avoid the flavor. However, one cannot help but be im-
pressed by the comparability of our nonreinforcement procedure to
the associative manipulations that Siegel (reported elsewhere in
this monograph) has applied to interfere with analgesic tolerance
to morphine. Both involve nonreinforced presentations of a CS
intended to interfere with a drug effect that is also associated
with the same CS at another point in an experimental procedure.
But Siegel (1975) has suggested, and provided direct evidence for,
a particular mechanism that mediates the effectiveness of his asso-
ciative manipulations. Specifically, he has argued that his asso-
ciative procedures bring under stimulus control the occurrence of
a conditioned compensatory response to morphine without which anal-
gesic tolerance will not occur. Could something similar apply to
our own procedures?
In theory, it is possible to specify how such a mechanism might
work. During pretreatment, a compensatory response might be con-
ditioned to the cues of drug administration by the repeated pairing
of these cues with the systemic effects of amphetamine. If this
conditioning were allowed to remain intact, these cues would elicit
a compensatory response when an injection of amphetamine was paired
with the flavor of saccharin during gustatory conditioning. This
compensatory response would summate with the actual drug effect
and diminish its magnitude. All of this should lead to attenuation
82of flavor avoidance, which is of course the result of pretreatment.
However, if the drug administration procedure were specifically non-
reinforced we would expect a reduction in its ability to evoke
the compensatory response. There would be no subtraction from the
actual drug effect when it occurred during gustatory conditioning,
and avoidance of the flavor should be relatively strong. Of course,
this was the effect of our nonreinforcement procedure.
All of this is very plausible in theory. But we cannot avoid the
question of whether there is any empirical basis for these arguments.
Unfortunately, we can only be highly speculative on this point,
but we can specify some of the requirements that any hypothesis of
compensatory response activity would need to meet to be applicable
to our situation. The most obvious is that it would have to apply
in the case of amphetamine, at least to account for our data. We
know of no evidence to suggest that the conditioned form of the
response to amphetamine administration includes a component that is
compensatory. A second requirement is that this hypothetical com-
pensatory response would need to be engaged by a variety of uncondi-
tioned stimuli in addition to amphetamine. The reason for this is
that pretreatment effects have been obtained even when pharmacolo-
gically dissimilar agents have been used during pretreatment and
conditioning. As we mentioned earlier (Cappell et al. 1973)) pre-
treatment with amphetamine attenuated conditioned aversion by mor-
phine; in an extreme case of dissimilarity of unconditioned stimuli,
Braveman (1975) found that pretreatment with a number of different
pharmacological agents attenuated the gustatory avoidance that could
be conditioned by rotation on a turntable. If associatively medi-
ated compensatory conditioning is involved in these examples of
“tolerance,” clearly the mechanism must be general rather than UCS-
specific. We can identify procedural operations of conditioning
common to the administration of drugs and rotation that can account
in associative terms for successful pretreatment effects using such
discrepant manipulations, but specification of a compensatory mecha-
nism remains quite another matter. Where morphine analgesia is
concerned, a behavioral compensation is a relatively simple matter
to suggest (i.e., analgesia-hyperalgesia) and measure.
One suggestion of a physiological response mechanism that might-be
common to the wide variety of manipulations used in studies of
pretreatment was made recently by Riley et a1.(1976). They reasoned
that the rat’s response to the various pharmacological and other
manipulations used in gustatory conditioning procedures may be com-
monly mediated at the level of the hypothalamo-pituitary adrenal
axis. In support of this hypothesis they cited a large body of
evidence to show that ACTH may be involved in gustatory avoidance
conditioning by a variety of agents. Moreover, they cited some
evidence purporting to show tolerance in the ACTH response to some
drugs. Obviously, a compensatory theory would require that responses
compensatory to the effects of ACTH occur and are conditionable for
this mechanism to be involved in the mediation of the associative
effects that we have found.
83Clearly there is no unequivocal evidential basis for making a com-
mitment to ACTH, or for that matter, any particular physiological
mechanism, as the final common path underlying pretreatment effects
that operate within and between drug classes. We mention this mecha-
nism only because it has been specifically proposed, and because
there is at least some evidence in its favor. One might just as
easily focus on a neuro-transmitter mechanism, since as we saw
earlier, tolerance can be affected by the manipulation of transmit-
ters. The mere suggestion of such a mechanism may, however, bring
us full circle to the idea we raised earlier, namely that we can
profitably think of tolerance as a special case of adaptation. Phy-
siological mechanisms are certainly important considerations here.
What a behavioral perspective has to offer is the idea that the
rate and perhaps even the occurrence of such processes is subject
to modification by environmental manipulations, including Pavlovian
conditioning.
The definitional problems created by the use of the word ”tolerance”
emerge clearly where the study of tolerance in the context of gus
tatory conditioning is concerned. At one level, the reduction in
effectiveness of conditioning by pretreatment seems to have all the
earmarks of tolerance; there certainly appears to be some form of
adaptation involved, and, in fact, habituation has been offered as
an alternative to tolerance in accounting for pretreatment effects
(Vogel 6 Nathan 1976). Yet there are obvious anomalies. What is
intriguing about this is that the puzzling outcomes are anomalous
mainly in the context of a strictly pharmacological conception of
tolerance. It seems that we are faced with two choices: we can
say that it must not be tolerance that we are studying, or we can
change our conception of tolerance. It is tempting to prefer the
latter choice.
CONCLUSIONS AND IMPLICATIONS
In addition to its obvious forensic relevance (e.g., in relationship
to traffic safety), the study of drug tolerance is of special prac-
tical importance to the extent that it can help to provide an
account of drug consumption. There is ample evidence that increases
in alcohol consumption in populations (Schmidt & Popham 1975) are
associated with increases in adverse consequences to health. Unfor-
tunately, we cannot yet estimate the precise contribution of toler-
ance per se to drug consumption. We know much more about tolerance
as a consequence of drug consumption than we do about its contri-
bution to etiology. Therefore, whatever importance we assign to
the contribution of behavioral variables to tolerance cannot be
divorced from the importance we assign to tolerance no matter what
our theoretical bias is. Whether we study motor impairment, operant
behavior, analgesia, or taste aversion, one crucial assumption is
that knowledge of adaptation to these consequences of drugs provides
a basis for making inferences about drug-taking behavior itself.
The case is clear that behavioral factors do contribute substantially
to the adaptive response to drugs. The rate of tolerance can be
84augmented by behavioral manipulations. Moreover, there are circum-
stances under which tolerance appears to be substantially controlled
by associative conditioning mechanisms. Still, the question of
whether such manipulations ultimately have consequences for drug
consumption remains one for speculation. As important as it is for
us to continue to develop an understanding of the modulation of
tolerance to drug effects by behavioral factors, it seems necessary
to develop a firmer basis for relating this information to the
phenomenon of drug-taking. Our research on gustatory aversion repre-
sents an attempt to move in this direction by studying adaptation
to the ability of drugs to control behavior. Obviously, this model
also requires a considerable inferential leap in order to draw
conclusions about drug-taking. Research relating tolerance more
directly to drug-taking behavior must, therefore, be considered as a
high priority.
Another issue that bears consideration is the relationship of toler-
ance to physical dependence or withdrawal. Physical dependence is
of concern because it can represent a health problem in itself, and
also because it may play a role in the maintenance of drug-taking
(i.e., by self-medication of withdrawal effects). Earlier we noted
that a behavioral manipulation that augmented tolerance had the
effect of augmenting physical dependence as well. Thus it seems
likely that any increase in our understanding of the behavioral and
other factors that affect tolerance may have implications for an
understanding of physical dependence. One of the more interesting
developments in this area is the evidence that Pavlovian conditioning
mechanisms are involved in the adaptive response to drugs. It is
tempting to relate the concept of conditioned compensatory response
not only to tolerance but to physical dependence as well. Such
conditioning has clear implications for relapse to drug use (c.f.,
Wikler 1973). Conditioning may underly the “savings” observed in
repeated cycles of tolerance acquisition (Kalant et al ,1971b), and
it may also provide a mechanism whereby the potential for the elici-
tation of withdrawal is preserved long after apparent recovery has
taken place. This suggests that “normalization” of the tolerant-
dependent organism may require a process of active behavioral inter-
vention beyond abstinence per se. Further research on the phenomenon
in animals should be addressed to its generality, since our knowledge
is largely confined to a single drug (morphine), a single response
criterion (analgesia), and relatively low doses. Our work with con-
ditioned gustatory avoidance by amphetamine may be a step toward
generality, but its relevance is not yet established.
To summarize, there is no question that there is a loss in sensiti-
vity to many of the effects of drugs with repeated exposure. Equally
beyond question is that this adaptive process can be manipulated
behaviorally. However, the relative importance of behavioral and
pharmacological or physiological variables in the acquisition of
tolerance is not established. Certainly there is no empirical jus-
tification for entirely discarding one type of account in favor of
the other. And finally, whatever view of tolerance we choose to
emphasize, it must always be kept in mind that its etiological signi-
ficance for drug consumption is still based largely on indirect infe-
85rence from effects of drugs (e.g., motor impairment) whose predic-
tive relationship to drug consumption is still presumptive.
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89IV. MARIHUANA
Environmental Influences on
Marihuana Tolerance
Brooks Carder, Ph.D.
INTRODUCTION
The concept of behavioral tolerance appears to have evolved
from the observation that tolerance to a drug can develop to
certain behavioral effects of a drug but not to others. Thus
Thompson and Schuster (1968) reported that when rats showed
tolerance to the effects of amphetamine on responding to one schedule
of reinforcement, they did not show tolerance on a second schedule.
They called this phenomenon “behavioral tolerance,” because the
tolerance appeared to be altered by stimulus, response, and reinforce-
ment conditions.
Along this line, we have shown that tolerance to marihuana develops
more rapidly when drug administration is followed by behavioral
testing than when it is not (Carder and Olson 1973). This is another
example of behavioral tolerance in the sense that we will use the
term in this paper. “Behavioral tolerance” applies to those phenomena
in which tolerance development is influenced by environmental vari-
ables .
It is important to make some qualifications at this point. Previous
workers have used such terms as “learned tolerance,” “behaviorally
augmented tolerance,” or “psychological tolerance.” These terms
frequently lead to assumptions that: 1) Learning is involved in the
development of this tolerance; 2) Behavioral tolerance is fundamen-
tally different from “physiological tolerance”; 3) Behavioral toler-
ance involves an adjustment of behavioral control mechanisms rather
than of the biochemical systems which are responsible for the action
and metabolism of the drug. This paper is directed at a critical
examination of these assumptions. It will examine the phenomenon of
behavioral tolerance to marihuana and its principal active constituent
1-A
9-tetrahydrocannabinol (THC). It will describe reasons which lead
us to question the role of learning in behavioral tolerance and to
question whether behavioral tolerance is fundamentally different from
other forms of tolerance. Finally, it will discuss some of the
implications of this work for the study of marihuana in humans.
90THEORIES OF BEHAVIORAL TOLERANCE
The Instrumental Response Model
In spite of the fact that we will ultimately question this view, we
will start where this line of research began, with the hypothesis
that instrumental learning plays a role in the development of be-
havioral tolerance. In one of the early demonstrations of tolerance
to THC, McMillan, et al. (1970) first trained pigeons to peck a key
for grain on a multiple reinforcement schedule and then gave them
daily increasing intramuscular doses of WC. The first application
of a dose of 1.8 mg THC/kg impaired performance, but by day 25 a dose
of 36 mg/kg left performance unaltered. In this case, the adjustment
was ultimately a behavioral one, an increase in responding under the
drug. One potential mechanism for behavioral adjustments is, of
course, learning. In fact this study could provide an excellent para-
digm for tolerance due to learning. Tolerance, or the increase in
responding under the influence of the drug, would be reinforced by
the increase in frequency of food rewards which accompany the
increase in responding.
While we do not wish to engage in an extended discussion of the
definition of learning, it is essential to differentiate conditioning
from other types of behavioral adjustment. Conditioning requires
reinforcement. There are two types of conditioning: instrumental
and Pavlovian. In the case of instrumental (operant) conditioning,
an organism’s response is followed by an event (reinforcer) which in-
creases the future probability of occurrence of that response. Rein-
forcers are usually events such as the presentation of food to a
hungry organism or the termination of painful electric shock. In the
case of Pavlovian conditioning, a neutral stimulus (conditional
stimulus or CS) is paired with a stimulus which naturally elicits a
response (unconditioned stimulus or US). After one or more pairings,
the CS elicits a response (conditioned response or CR) which it
previously did not. The class of US’s and the class of instrumental
reinforcers overlap considerably.
In 1972, Olson and I (Carder and Olson 1973) decided to investigate
the role of learning in the development of behavioral tolerance to
marihuana. Rats were first trained to lever press for positive
reinforcers. One study employed food and the second, water. In each
study, one group was treated with marihuana extract before each daily
training session. The second group was treated marihuana ex-
tract, in the same dosage, after each training session. Initially,
when the drug was given before session, responding decreased. When
the drug-before group demonstrated tolerance to this disruption of
responding, the drug-after group was tested for tolerance by giving
them the drug before a test session. In both studies the drug-after
group showed little or no tolerance. The drug interfered with respond-
ing as much as it did in the drug-before group on the first day. Thus
the development of tolerance was facilitated when the subjects had
the opportunity to respond for reinforcers during the period of drug
action as the drug-before group did and the drug-after group did not.
91There are a number of other studies which have confirmed the role of
practice and/or reinforcement in the development of behavioral
tolerance to marihuana and THC. For example, Grilly et al. (1973)
described the development of tolerance in chimpanzees on a delayed,
matching-to-sample task. Tolerance development was interval specific.
That is, tolerance which developed at one delay interval did not trans-
fer when the interval was increased. Grilly et al. proposed that
the tolerance involved the learning of compensatory responses which
were specific to each particular set of test conditions. This re-
sponse was reinforced by increases in food which resulted from
improved performance under the drug.
Manning (1974) reported the development of tolerance to the effect
of MC on free-operant avoidance in rats. He noted that tolerance
developed only in those subjects for which the drug-induced depres-
sion of responding led to an increase in shock frequency. Of course
only these subjects would receive reinforcement (in the form of a
decrease in shock frequency) for the development of tolerance.
More recently, Manning (1976) administered THC to rats for 12 days,
each time followed by a return to the home cage. When these rats
were tested under the drug on a Differential Reinforcement of Low
Rate (DRL) schedule, they demonstrated no tolerance. When they were
then tested daily under the influence of THC, they developed toler-
ance at the same rate as rats that had never been exposed to the
drug. This study provides strong confirmation for the finding of
Carder and Olson (1973) that practice under the drug facilitates the
development of tolerance to THC.
In all of these studies, tolerance development may be interpreted as
having had an instrumental value for the subject. In the Carder and
Olson (1973), Grilly et al. (1973) and Manning (1976) studies, sub-
jects obtained more food reinforcers as they developed tolerance.
In Manning’s (1974) study of free-operant avoidance, tolerance
development was reinforced by a decrease in shock frequency. Thus
it is possible to view these demonstrations of behavioral tolerance
as instances in which tolerance developed as a learned instrumental
response.
It should be noted that there are numerous reports that demonstrate
development of tolerance to THC in situations in which no apparent
reinforcement was involved. For example, Ten Ham (1977) reported
that rats given THC developed tolerance to the effect of the drug
on shuttle avoidance and body temperature whether the drug was given
before or after testing. The point remains, however, that in many
cases, environmental conditions during the period of drug action do
exert powerful effects on tolerance development.
The Pavlovian Model
Most investigators seem to have favored an instrumental response model
for behavioral tolerance to THC. However, there are at least two
other models which can account for most, or perhaps all, of the data
which demonstrate behavioral tolerance. The second model we would
like to discuss is a Pavlovian model.
92Siegel (1975) working with morphine, seems to have been the first
to develop a Pavlovian model of learned tolerance, although his work
derives from earlier work by Adams et al. (1969), Gebhart and Mitchell
(1972), and others. Siegel argued that the administration of morphine
produces an unconditioned response, and that over the course of
several drug administrations a conditioned response of tolerance
develops to the conditioned stimuli associated with intoxication
(Particularly the test chamber). According to this hypothesis, instru-
mental reinforcement is incidental to tolerance development. What
is important is that during the period of tolerance development the
unconditioned response (UR) which follows drug administration must be
paired with the CS of the test chamber. In the test, the CS of the
test chamber elicits the conditioned response of tolerance. Siegel
showed that rats which received morphine in the home cage failed to
demonstrate tolerance to the drug in a hot-plate analgesia test,
presumably because the UR produced by the drug was never paired with
the CS of the test chamber. Subjects that received daily doses of
the drug, followed by exposure to the hot plate, did develop toler-
ance, whether the plate was hot or cold. Apparently, instrumental
reinforcement was not involved, since it is difficult to see how
Siegel’s subjects could have been instrumentally reinforced for
developing tolerance.
Siegel’s hypothesis could lead to some very interesting predictions.
We know for example that Pavlovian CR’s can be brought under dis-
criminative stimulus control. Thus a dog that is reliably fed follow-
ing a tone (CS+), but not following a light (CS-), will develop a
conditioned salivary response to the tone and will not respond to
the light. To bring tolerance under stimulus control, rats could be
dosed with morphine and then placed in a black chamber (CS+). Placebo
injections could be followed by placement in a white chamber (CS-).
The CR of tolerance should appear when subjects are tested in the
black box, but not in the white. Gebhart and Mitchell (1972) have,
in fact, done something like this. They developed tolerance in the
hot plate environment and then demonstrated that removing various
components of the apparatus, thereby changing the CS, attenuated the
tolerance.
The Stress or Arousal Model
Our third hypothesis, which no one seems to have considered yet, is
the notion that stress, or arousal, plays a role in tolerance develop-
ment. When a subject is dosed with a drug and then placed in an
experimental test environment, it is presented with the opportunity
to associate a CS with the US of the drug and in some cases with the
opportunity to obtain instrumental reinforcement for tolerance
development. It is also placed in a situation which produces rela-
tively more arousal than does the home cage. Perhaps it is this
increase in stress or arousal during the period of intoxication, and
not the opportunity to obtain instrumental reinforcement or the
exposure to potential Pavlovian conditioning situations, which
facilitates the development of tolerance.
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This third hypothesis gives rise to an easily testable prediction.
Subjects given a drug and then placed in an arousal-producing
situation, even without opportunities for instrumental reinforce-
ment, should develop tolerance to the drug and demonstrate it in a
test situation which is quite dissimilar to the situation in which
tolerance was developed.
Some pilot studies in our laboratory have addressed this question.
In the fundamental experiments, 6 groups of 4 rats were treated as
follows: Group THC-cage was treated with 5 daily, intraperitoneal
doses of THC an rep aced in the home cage. Group saline-cage was
treated with 5 daily doses of saline and also replaced in the home
cage. Groups THC-box and saline-box were given the same drug treat-
ment as the first “cage” groups, but 30 minutes following drug
administration each rat was placed for 20 minutes in a small experi-
mental chamber. Groups THC-shock and saline-shock also received the
same drug treatments and exposure to the experimental chamber, but
painful electric shocks were presented during the exposure to the
chamber.
On the day following the final day of pretreatment, each rat was dosed
with 5 mg THC/kg and tested for swimming escape. The rat was placed
in the center of a circular tub of water about 90 an in diameter with
a small platform at one edge. The rat could escape by swimming to the
platform and mounting it. Rats that did not mount the platform within
60 seconds were removed and given a score of 60. Rats that were un-
able to swim and sank were immediately removed and given a score of
60. There was one test trial with no pretraining.
The results of the test are presented in Table 1. An analysis of
variance revealed a significant effect of pretreatment with THC
compared to saline (F=6.19, df=l/18, p<.02) and a significant effect
of the pretreatment environment (home cage, box, shock) (F=7.13,
df=2/18, p<.01). There was not a significant interaction (F=0.84).
Thus, either the application of THC, the application of stress in the
form of handling, exposure to a novel environment, or electric shock
is sufficient to decrease the sensitivity of rats to THC in the
swimming escape task.
TABLE 1. Mean escape time as a function
of pretreatment.
stress pretreatment
drug-pre-
treatment
The combination of THC and exposure to either the box or to the box
with shock seemed to produce maximal tolerance. Rats tested under
94saline in the swimming escape task escaped in a mean of 13 seconds.
In rats pretreated with saline, exposure to shock seemed to produce
more tolerance than exposure to the box without shock, although this
was not statistically reliable (t=1.25, df=6, p<.26).
It should be noted that the stress pretreatment does not produce the
appearance of increased tolerance merely by increasing the strength
of the escape response. Rats pretreated with saline and 5 daily
shock sessions, then tested under placebo, escaped in a mean of
21.25 seconds, indicating that, if anything, shock pretreatment im-
pairs swimming escape.
These data provide strong support for the hypothesis that behavioral
tolerance in this situation is not a learned instrumental response,
since there was no opportunity for the subjects to be reinforced for
tolerance development. Nor does Pavlovian conditioning seem to be
involved, since the tolerance was developed in one environment and
demonstrated in another. Rather, this appears to be an example of
the effect of stress on rats’ sensitivity to THC. The presence of
stress during the period of intoxication accelerates the development
of tolerance to THC.
Perhaps the most interesting aspect of our findings is the fact that
stress alone reduced rats’ sensitivity to THC in a subsequent test.
Pats in the saline-shock group, exposed to the experimental chamber
and shocked for 5 daily sessions, escaped faster under THC than did
the saline-cage group (t=3.37, df=6, p<.02). We have termed this
phenomenon, in which exposure to environmental situations without the
application of drugs reduces sensitivity to a drug in a subsequent
test, “behaviorally induced tolerance.”
We have followed up this initial finding of behaviorally induced
tolerance with several studies designed to explore the dimensions of
the phenomenon. The following study demonstrates two very important
characteristics of the phenomenon: 1) It has a duration of effect
of at least several days, and 2) it extends to physiological as well
as behavioral measures of the THC effect.
The temporal characteristics of tolerance to cannabis following chronic
administration have been widely detailed. While tolerance reversal
has not been consistently noted (Davis et al., 1972), Silva and
Carlini (1968) as well as Webster et al. (1973) observed that tolerance
to chronic administration of THC was virtually absent 8-11 days after
cessation of treatment. In the study below we compared the duration
of shock-induced tolerance with the duration of tolerance produced by
repeated THC administration. In this experiment, tolerance was
assessed by monitoring the hypothermic effect of THC rather than
swimming escape.
Sixty rats were randomly assigned to groups I, II, or III for tolerance
testing at different intervals following tolerance development. Each
group was then subdivided as follows: THC-MC (T-T); shock-THC (S-T);
shock-propylene glycol (S-P-G.) ; and propylene glycol-THC (P.G. -T) .
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injections of 5 mg THC/kg and replaced in the home cage. Subjects
in S-T and S-P.G. were given 7 daily injections of propylene glycol
followed by 20-minute exposures to shock in the experimental chamber,
as in the previous study. Subjects in the P.G.-T group were given
7 daily injections of propylene glycol followed by placement in the
home cage. Following pretreatment, all subjects were tested for the
hypothermic effect of THC. Colonic temperature was measured by a
telethermometer via a rectal probe. Pats in group I were tested on
the first day following pretreatment? while rats in groups II and III
were tested at 3 and 10 days respectively. Rats in groups T-T, S-T,
and P.G.-T were given 5 mg THC/kg before the measurement of body
temperature, while the rats in group S-P.G. were given propylene
glycol before the measurement of body temperature.
FIGURE 1
Mean core temperature as a function of
pretreatment and test condition at three
intervals following pretreatment.
Figure 1 presents the mean core temperature for all groups and condi-
tions throughout the experiment. Neither the S-T, T-T, nor S.P.G.
subjects exhibited noticeable hypothermia on the first day following
cessation of pretreatment. In contrast, subjects in P.G.-T demon-
strated significant reductions in temperature following THC administra-
tion (pc.05). S-T subjects tested 1 or 3 days following cessation of
pretreatment exhibited no hypothermia. By day 10, however, all Pre-
treatment groups had lost their tolerance and showed a hypothermic
reaction to THC.
Thus, several brief periods of electric shock can induce a tolerance
to the hypothermic effect of THC that persists for at least 3 days.
It is important to note that while our previous demonstration of be-
haviorally induced tolerance employed a behavioral measure of toler-
ance, this study demonstrates that past environmental conditions can
alter a physiological effect of THC.
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There have been previous studies that show that past experience can
alter the effect of a drug. The studies that we are aware of, how-
ever, including two from our laboratory (Carder and Olson 1972; Olson
and Carder 1974) and the work of File (1973) involve experience with
the situation in which the effects of the drug are ultimately tested.
This experience would be expected to alter the subject’s reaction
to the test situation and, therefore, it is not at all surprising
that this could alter the effect of a drug in the test situation.
The studies described above demonstrate that experiences which in-
volve neither the drug nor the test situation can alter the effect
of THC. It is very difficult to explain these findings on the basis
of transfer of training.
A possible explanation for the influence of stress on THC tolerance
is that the biochemical changes induced by stress and by THC have
certain common elements and that it is these common elements that are
responsible for the transfer, just as tolerance will transfer between
two drugs that have biochemical actions in common. There is consider-
able evidence, for example, that stress increases catecholamine turn-
over (Stolk and Barchas 1973). Several biochemical studies (Johnson
et al. 1976; Howes and Osgood 1974; Ho et al. 1972; Ho and Johnson
1976; Maitre et al. 1970; Maitre et al. 1973; Poddar and Gosh 1976;
Schildkraut and Efron 1971; Singh and Das 1976) indicate that THC
increases catecholamine turnover. Recently, behavioral studies
(Carder and Delkel 1976; Singh and Das 1976) have indicated that the
alteration of catecholamine turnover may underlie some of the behavior-
al effects of THC. Moreover, the studies provide evidence for cross
tolerance between THC and reserpine and tetrabenazine compounds known
to increase catecholamine turnover. Thus lt is possible that increased
catecholamine turnover may provide the common element between stress
and THC that is responsible for behaviorally induced tolerance to THC.
Along this line, Seiden et al. (1975) have proposed that catecholamine
alterations underlie the observed rate-dependent effect of amphetamine.
A dose which can increase low rates of operant responding will decrease
high rates (Dews 1958). Seiden’s notion, like the one presented above,
is that amphetamine produces different effects on different baseline
rates of responding because both the drug and the behavior influence
catecholamine metabolism. Therefore the net effect of the drug must
depend both on the biochemical effect of the drug and the biochemical
effect of the behavior.
It is important to describe how the stress hypothesis can account for
tolerance which has been ascribed to Pavlovian or instrumental learning.
For example, Siegel (1975) found that the application of morphine,
followed by exposure to the test chamber, led to the development of
tolerance to morphine. According to Siegel, this was because the CS
of the test chamber was paired with the UR produced by the drug,
leading to the development of the CR of tolerance. An alternative
explanation is that the test chamber is a more stressful environment
than is the home cage, and that placement in the chamber during intoxi-
cation would accelerate tolerance development. A simple test would
involve the placement of subjects in a novel environment other than the
test chamber during the period of tolerance development. If the
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development. If the stress hypothesis is correct, this should indeed
facilitate tolerance development. In our studies described above,
tolerance developed in an operant test chamber was transferred
to a swimming escape test, a very different situation. This finding
is quite inconsistent with a Pavlovian interpretation.
Those studies such as the Carder and Olson (1973) study, in which
tolerance is developed in an instrumental training situation, are
also subject to explanation by the stress hypothesis. According to
the instrumental learning hypothesis, tolerance develops as a result
of the increased reinforcement which accrues to improved performance
under the drug. According to the stress hypothesis it is the decrease
in reinforcement frequency which accelerates tolerance development.
A test which could discriminate between the two explanations is again
quite simple. Rats would be trained to press a lever to obtain food.
Following THC administration and the consequent reduction in the rate
of responding and reinforcement, the rate of reinforcement could be
kept low no matter what happened to the response rate. This would
prevent the reinforcement of tolerance development and if the instru-
mental learning hypothesis is correct, tolerance development should
be retarded. If the stress hypothesis is correct, the stress created
by the continued decrease in the frequency of reinforcement should
accelerate the development of tolerance.
CONCLUSIONS
The preceding analysis of environmental influences on marihuana toler-
ance has implications for both theory and research. We have attempted
to expand the concept of behavioral tolerance. Our data indicate that
in some cases behavioral tolerance is not a simple learned adjustment
which results in a decreased response to a drug. In studying the in-
teraction between environmental factors and tolerance development, we
have found that shocking a rat or exposing it to a novel environment,
with or without THC, can decrease the rat’s response to the drug.
While it is possible that some type of learned adjustment may be in-
volved, it is very difficult to see how there could be a transfer of
training from inescapable shock to swimming escape. The data indicate
that, if anything, the transfer of training is negative.
Another argument against the notion that behavioral tolerance always
involves a learned adjustment is our finding of behaviorally induced
tolerance to the hypothermic effect of THC. It is difficult to see
how learning could lead to an adjustment of mechanisms which control
this hypothermic reaction.
In addition, the duration of effect of behaviorally induced tolerance
seems to approximate the duration of tolerance to THC produced by
repeated THC application: 8-12 days. Learned responses typically
persist much longer than this.
I would suggest the view that in their effects in the central nervous
system there is no essential difference between pharmacologic and
environmental events. The function of the CNS can be altered, either
temporarily or permanently, by either. Of course, tolerance to both
modes of alteration of CNS function has been described. When a rat
98is placed in a chamber and presented with a particular auditory stimu-
lus, it will react in a number of ways, both physiologically and
behaviorally. Repeated presentations of the stimulus will lead to an
attenuation of this reaction. We call this tolerance which develops
to environmental stimulation ‘habituation.” The attenuation of be-
havioral and physiological reactions to a drug on repeated application
is called “tolerance.” There is no a priori reason to expect that
the mechanisms of habituation and tolerance should be different. More-
over, the finding that repeated application of shock leads to tolerance
to THC suggests some overlap between the mechanisms.
If this is the case, it would appear that it is impossible to study
tolerance independently of environmental circumstances. Factors such
as handling, adaptation to the apparatus, housing conditions of the
subjects , deprivation schedules , and a host of other experimental
procedures could play a powerful role in tolerance development. It
is essential to begin to assess the contribution of these factors in
order to gain an understanding of tolerance to any drug. Behavioral
tolerance is not a special case. The term simply refers to the con-
tribution of environmental variables. These appear to be no more or
less important than other variables such as route of administration
of the drug, frequency of administration, dosage, etc.
The phenomenon of behaviorally induced tolerance is particularly
exciting because it may provide us with a model with which to conduct
extensive studies of how an organism’s past history can alter its
reactions to an initial application of a drug. One of the fundamental
questions in the field of drug addiction is why some individuals use
drugs and become addicted while others use the same drugs but do not
develop an addictive pattern. It would be attractive to trace the
differing responses to differences in the histories of the individuals.
The existence of animal models could help us to define the important
variables for such work.
An example of how the animal model might be generalized to research
with humans can be developed with the so-called “panic reaction” to
marihuana. This reaction is usually seen in naive users, persons who
have had no opportunity to develop tolerance through repeated use of
the drug. However, the reaction does not occur in all such persons.
It also appears that the use of the drug under stressful circumstances
IS more likely to lead to a panic reaction, although there is no
statistical data on this. Our pilot studies suggest a third variable
that may be important: tolerance to stress. A person who had had a
great deal of stressful experience and had developed a tolerance to
this should be much more resistant to developing a panic reaction than
a person without this tolerance. This hypothesis could be examined
experimentally or evaluated on the basis of existing clinical data.
Of course, marihuana addiction--if such a phenomenon exists--does not
appear to present a significant social problem in this country. Thus
the most important function of our work may be to provide a model for
the study of other drugs. The study of environmental influences on
tolerance to narcotics, alcohol, barbiturates, minor tranquilizers,
and amphetamines is of the greatest potential interest. Such studies
may be fundamental to the development of a scientific understanding
of the etiology of drug addiction.
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102IV. MARIHUANA
Behavioral Tolerance to Marihuana
Douglas P. Ferraro, Ph.D.
In the lexicon of behavioral pharmacology, the term behavioral
tolerance is used in an unfortunately wide variety of ways. In
some instances the term is used to refer to a specific empirical
event which is observed to occur only in a limited context. In
other instances the term is used to refer to a general theoretical
mechanism which is assumed to account for a myriad of drug-induced
phenomena. Given these extremes of usage, it is little wonder that
confusion arises and controversy surrounds the concept of behavioral
tolerance.
It should be noted at the outset that either an empirical or a
theoretical use of the term behavioral tolerance is acceptable in
its own right; neither usage is necessarily more correct or appro-
priate than the other. But it is necessary that a distinction be
drawn between the two and that in any particular instance the
intended meaning of behavioral tolerance is made certain. Otherwise,
it is difficult to appreciate the arguments of those who embrace
and those who eschew the concept of behavioral tolerance.
It is my intention to draw the distinction between empirical and
theoretical behavioral tolerance, and to do so with specific
reference to the preclinical behavioral pharmacology literature on
marihuana effects in animals. The choice of drug is no more than
a convenient one; the distinction between empirical and theoretical
behavioral tolerance is as readily elaborated and illustrated with
many other pharmacological compounds. Indeed, the distinction is
a conceptual one which emerges regardless of pharmacological class
or behavioral task.
EMPIRICAL BEHAVIORAL TOLERANCE
Empirical Definition of Behavioral Tolerance
A well-framed empirical definition of the concept of behavioral
tolerance has the characteristics of being both operational and
functional. It is operational in that it states the procedures and
103conditions which are necessary to observe the concept. It is func-
tional in that it states what sorts of observable behavioral changes
constitute the concept. Take as one instance the following empirical
definition of behavioral tolerance to marihuana: Following prior
exposure to a fixed dose of marihuana (operational), a specified
behavioral effect of marihuana diminishes (functional). A second
acceptable example of an empirical definition of behavioral tolerance
to marihuana is: Following repeated administrations of marihuana
(operational), the dose-effect relationship on some specified
behavior shifts to the right (functional).
By way of summary, what it is that makes both of these definitions
acceptable, and what would make still others so, is that they specify
what is necessary in order to observe behavioral tolerance to
marihuana (operationally, to administer marihuana repeatedly), and
what observed behavioral change constitutes behavioral tolerance
(functionally, a diminution in the behavioral effect induced by
marihuana) . Conversely, the empirical definitions imply what
behavioral tolerance is not. For example, repeated administrations
of marihuana do not constitute behavioral tolerance if they
occasion an increase in the drug’s effect on behavior. Likewise,
a diminution of the behavioral effect does not constitute behavioral
tolerance if it is produced by some nonpharmacological factor. This
is not to deny the possibility of the latter two empirical outcomes.
Indeed, they may well be considered as positive instances of some
other empirically defined concepts (say, perhaps, reverse tolerance
and environmental tolerance). But they are not instances of
behavioral tolerance as defined empirically.
Of course, empirically defining behavioral tolerance to marihuana
does not assure that instances of the concept actually exist. As
it turns out, however, behavioral tolerance to marihuana is readily
identified for several unlearned and learned behaviors in a range
of animal species and under a variety of marihuana conditions.
Indeed, in many instances behavioral tolerance to marihuana is
characterized by its rapid development and large magnitude. Among
these instances, recently reported, are : spontaneous activity in mice
(Anderson et al. 1975) ; dominance status in monkeys (Sassenrath and
Chapman 1975); conditioned avoidance learning in rats (Waser et al,
1976); analgesia in dogs (Kaymakcalan et al. 1974) ; and reinforcement
schedule performance in pigeons (Bruce and Ferraro 1975).
Empirically defining behavioral tolerance to marihuana also does
not serve to explain the concept. Empirical definitions in no
way presume or imply anything about the mechanism(s) which underlie
the concept defined. That is, the answer to the question of "why
does behavioral tolerance to marihuana occur?” is in no way even
minimally broached by the empirical definition. This is as it should
be, since the specification of underlying explanatory mechanisms is
a theoretical matter, not an empirical one. Explanation, in the
sense of answering the question Why?“, is a reductive process.
Identification and description, in the sense of answering the questions
“When, where, and under what conditions?“, are inductive processes.
The inductive-reductive distinction will be discussed further.
are might anticipate, however, that empirical and theoretical
approaches to the concept of behavioral tolerance differ radically.
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lacking in still another regard. They do not include any specifics
about the parameters of the operations that enter into defining
the concept. This creates some difficulty for those who are inclined
to describe behavioral tolerance empirically. For example, consider
the operation of repeatedly administering marihuana. It is not
clear from the empirical definition what parameters of this operation
are pertinent to describing behavioral tolerance. Several degrees
of freedom are available: drug dose and route of administration
(Abel et al. 1974; Fried 1976); number of drug administrations and
time interval separating successive drug administrations (e.g.,
Davis and Borgen 1975); drug vehicle and form of the drug (Kosersky
et al. 1974); and so on. Further, one may wonder how many times
marihuana must be administered before invoking the concept of behav-
ioral tolerance to marihuana is justified. If a completely
diminished drug effect on behavior is observed following one
marihuana administration (Domino 1971; McMillan et al. 1971))
should this observation qualify operationally as an instance of
behavioral tolerance to marihuana?
The lack of parameter specificity inherent in empirical definitions
of behavioral tolerance is not peculiar to the operational aspects
of the concept. It applies as well to the functional behavioral
aspects of the concept. For example, it is not clearly specified
by the empirical definition whether the observed diminution in a
marihuana-induced behavioral effect should be gradual or abrupt,
immediate or delayed, partial or complete. There are two points
to be made in this context. The first is the obvious one that it
is not always easy to identify an instance of behavioral tolerance
to marihuana, even when it is empirically defined because of a lack
of parameter specificity inherent in the generic concept. The
second point is that empirical definition, while necessary, is not
sufficient to provide an empirical description of behavioral tolerance
to marihuana.
Empirical Description of Behavioral Tolerance
The empirical description of behavioral tolerance to marihuana is a
cumulative affair. It is only through repeated observations that
the parameter values of the operations and conditions of behavioral
tolerance are progressively elucidated. For example, we now know that
behavioral tolerance to the depressant effects of marihuana on
reinforcement schedule performance is directly related to the number
of marihuana administrations and indirectly related to the treatment
interval (Davis and Borgen 1975). With respect to conditions,
we now have empirical knowledge that the age of the subject at the
time of first exposure to marihuana interacts with later behavioral
tolerance development (Parnes and Fried 1974) and that stress may
augment behavioral tolerance development (Deikel and Carder 1976).
Furthermore, there now exists an extensive listing of those
behavioral effects which do and those which do not diminish with
repeated administrations of marihuana. To the abbreviated list of
confirmed instances of behavioral tolerance to marihuana given above,
we may add other instances where a lack of behavioral tolerance
development to marihuana has been observed. Briefly, a lack of
behavioral tolerance has been found for rodents and monkeys in a
wide variety of situations such as: open field behavior (Sjoden
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1973); food and water consumption (Gluck and Ferraro 1974);
conditioned shock avoidance (Manning 1976); discrimination learning
(Adams and Barratt 1976); and performance under a schedule of
reinforcement (Snyder et al. 1975).
However, the endpoint of an empirical description of behavioral
tolerance to marihuana is not the simple collation of a vast
array of specific empirical relationships. Instead, the ultimate
goal in this context is the creation of an empirical descriptive
system. Such a descriptive system constitutes interrelated sets
of empirical relationships which, collectively, generate more
implications than each in isolation. Whereas simple empirical
description answers the immediate questions of when, where, and
under what conditions behavioral tolerance to marihuana occurs,
an empirical descriptive system goes beyond the level of present
observation to generalize extant empirical relationships and to
predict unique relationships regarding behavioral tolerance to
marihuana.
An empirical descriptive system is arrived at by a process of
induction from the existing data base. Since there are no formal
rules for induction (going from the specific to the general) not
all behavioral pharmacologists arrive at the same generalizations,
even though they are all eventually tied to the same empirical
observations. One potential difference among the generalizations
is the level of abstractness at which the descriptive system is
cast. Nevertheless, the overall objectives remain to generalize
from known empirical relationships and to predict unique ones.
For example, one may observe that, "The greater the decrement in
performance initially produced by marihuana, the greater the behav-
ioral tolerance." Taken alone this statement implies only that a
correlation exists between some measure of performance decrement and
some measure of behavioral tolerance. Add to it, however, the
statement, "Reinforcement frequency is a direct function of per-
formance level," and it is possible to predict generally that
behavioral tolerance will occur only when marihuana acts initially
to reduce reinforcement frequency. Indeed, just such an induction
was arrived at by Schuster, Dockens, and Woods (1966) in their
study of the determinants of behavioral tolerance to amphetamine.
One does not always have to be as bold as Schuster et al. (1966)
in making predictions from empirical generalizations. Given the
present marihuana example, it is acceptable to make the more
cautious prediction that behavioral tolerance to marihuana is more
likely to occur (or will occur more quickly) when marihuana acts
initially to reduce reinforcement frequency. At the least, the
latter prediction is more certain to achieve empirical verification
than is one couched in absolute terms. Any specific
prediction arrived at inductively may be incorrect. However, the
empirical generalizations from which the prediction is derived
serve abstractly to summarize a number of concrete empirical
relationships and to direct further experimentation.
The one task which descriptive systems do not accomplish is that of
providing explanations in the earlier-described sense of specifying
106the mechanisms underlying behavioral tolerance; they simply do not
account for why behavioral tolerance occurs as it does, This may
be exemplified by quoting the specific empirical generalization
regarding behavioral tolerance to amphetamine which was referred
to above:
Behavior tolerance will develop in those aspects
of the organism’s behavioral repertoire where the
action of the drug is such that it disrupts the
organism’s behavior in meeting the environmental
requirements for reinforcement. (Schuster et al.
1966, p. 181).
No explanatory mechanism is implied here. We are left to ask the
question, “Why should behavioral tolerance develop in such a fashion?”
But if behavioral tolerance does develop in this way, it may not be
necessary to answer the question of why it does so. That is, if we
can specify lawful empirical generalizations for the development of
behavioral tolerance, we may be better advised to proceed to deal
with the implications of these generalizations than to attempt to
produce a theoretical explanation for them. After all, explaining
the generalizations in no way changes the existence of the
generalizations. And once generalizations have been verified
empirically, there are no remaining grounds for confusion or
controversy about them.
Empirical Generalizations About Behavioral Tolerance
As developed in the preceding section? empirical generalizations
regarding behavioral tolerance to marihuana are abstract statements
arrived at inductively from specific empirical relationships. As
such, empirical generalizations have predictive power but no
explanatory power.
In the present section of this chapter, ten empirical generalizations
about behavioral tolerance to marihuana will be offered in which the
referent behavior change involves an operant/instrumental response.
Many of these generalizations have been previously described
elsewhere (Ferraro 1976), Consequently, the generalizations will
be presented succinctly, and only one of two representative references
will be cited for the specific empirical relationships from which
each generalization was induced. It will be obvious that several of
the empirical generalizations are interrelated and interdependent.
This can be simply explained by the fact that all of the generaliza-
tions are ultimately tied directly back to a common set of observa-
tions.
Generalization 1. Behavioral tolerance to marihuana
is more likely to develop (or will be quicker to
develop) if the drug initially produces adverse
effects on behavior-environment relationships,
such as reductions in reinforcing stimuli or
increases in aversive stimuli (Domino 1971;
McMillan et al. 1970).
Generalization 2. Behavioral tolerance to marihuana
is more likely to continue to develop if drug-induced
adverse effects on behavior-environment relationships
are maintained (Ferraro 1972).
107Generalization 3. Behavioral tolerance to mari-
huana is less likely to develop (or will be slower
to develop) if the drug produces behavioral
changes which are not accompanied by adverse
effects on behavior-environment relationships
(Barry and Kubena 1971; Ferraro 1972).
Generalization 4. Behavioral tolerance to marihuana
is less likely to develop if the development of
tolerance itself produces adverse effects on
behavior-environment relationships (Adams and
Barratt 1976; Hirschhom and Rosencrans 1974).
Generalization 5. Behavioral tolerance to mari-
huana is more likely to develop for some operant/
instrumental responses than for others, or for
some dependent measures of responses than for
others, within the same organism. (Ferraro
and Grisham 1972; Harris et al. 1972).
Generalization 6. Behavioral tolerance to marihuana
is more likely to develop for simple than for
complex operant/instrumental responses (Ferraro
and Grilly 1973; Snyder et al. 1975).
Generalization 7. Behavioral tolerance to marihuana
is more likely to develop the better the referent
operant/instrumental responses are learned (Ferraro
and Grilly 1974; Olson and Carder 1974).
Generalization 8. Behavioral tolerance to marihuana
is more likely to develop the greater the oppor-
tunity to perform the referent operant/instrumental
responses under exposure to marihuana (Bruce and
Ferraro 1975; Carder and Olson 1973).
Generalization 9. Behavioral tolerance to marihuana
which develops under one set of environmental
conditions will not transfer completely to another
set of environmental conditions; the degree of transfer
will be directly related to the similarity of the
conditions (Ferraro et al. 1974; Grilly et al.
1973).
Generalization 10. Behavioral tolerance to
marihuana which develops under one set of
environmental conditions will be relatively per-
manent under those conditions, even if an extended
period of nonexposure to marihuana intervenes
(Ferraro et al. 1974).
Of the ten empirical generalizations presented above, the first
four pertain specifically to the environmental consequences of
behavior, the next four pertain to characteristics of the referent
responses, and the last two pertain to environmental antecedents
of behavior. In other words, in the instance of behavioral
tolerance to marihuana, a dynamic interaction apparently exists
108between behavior and the environment. Still other empirical gen-
eralizations could be presented which pertain specifically to
characteristics of the marihuana treatment (e.g., dose, route of
administration, etc.). Thus, behavioral tolerance to marihuana
may be reasonably well conceptualized as involving drug-behavior-
environment interactions.
Any abstract generalization may be confirmed or discredited
empirically. In this regard, it is important that the empirical
test of a generalization be carried out within the boundary condi-
tions of the generalization, and that conclusions regarding the
suitability of the empirical generalization be correctly formed.
For example, a simple demonstration that behavioral tolerance
develops to marihuana-induced disruptions in avoidance behavior is not
as supportive of Generalization 1 as is an experiment which shows
that when marihuana produces an increase in shocks under an avoidance
schedule behavioral tolerance occurs, but that when a decrease in
shocks is produced no behavioral tolerance occurs (e.g., Manning
1976). Similarly, evidence that behavioral tolerance to marihuana
occurs in the absence of adverse behavior-environment relation-
ships, or that behavioral tolerance fails to occur in their presence,
does not definitively discredit Generalizations 1-4. All of the
generalizations presented above are relative statements about the
likelihood and extent of tolerance development to marihuana, and
none of them determines the possibility of behavioral tolerance
to marihuana in an absolute sense.
This is an important point which can bear elaboration. Take Gen-
eralization 8 as a further example. This generalization states that
behavioral tolerance to marihuana is more likely to occur the greater
the opportunity to respond under the influence of marihuana. This
again is a relative generalization. It does not imply that behavioral
tolerance cannot occur when marihuana is administered outside of
the behavioral situation (Black et al. 1970) or that behavioral
tolerance requires repeated exposures to marihuana (McMillan, et al.
1971). Rather, the generalization predicts that behavioral
tolerance will develop less quickly if marihuana is administered in-
frequently and outside of the behavioral situation.
Finally, where a generalization is shown to be inadequate by an
empirical test of the predictions made from it, the generalization
can be readily dropped and replaced by a new generalization induced
from the now enlarged pool of empirical information. However,
nothing about this latter process provides an explanation of the
generalization.
THEORETICAL BEHAVIORAL TOLERANCE
Theoretical Explanation of Behavioral Tolerance
Providing an explanation of behavioral tolerance to marihuana in
terms of the mechanisms which underlie it invades the domain of
theory. Theoretical approaches to behavioral tolerance are reductive.
That is, explaining empirical relationships regarding behavioral
tolerance is done by making reference to a different level of dis-
course than that at which the empirical relationships exist. This
altered level of discourse is reductive in the sense that explanations
109are made in terms of molecular processes which occur somewhere
inside the organism. These processes may be hypothetical or they
may be empirically based, but they are always reductive; they
represent the processes that underlie the empirical generalizations
which are to be explained.
In the instance of behavioral tolerance to marihuana, one theoretical
(reductive) approach is to explain the observed empirical phenomena
in terms of pharmacodynamic mechanisms (e.g., McMillan et al. 1971;
McMillan and Dewey 1972). In this context any presumed cellular,
metabolic, or drug distributional mechanism is worthy of consideration
(Davis and Borgen 1975; Dewey et al. 1973; McMillan et al. 1973;
Martin et al. 1976).
A second theoretical approach is to account for the empirical gen-
eralizations about behavioral tolerance to marihuana in terms of
hypothetical or inferred learning processes (Elsmore, 1972;
Ferraro and Grisham, 1972; Harris et al., 1972). This latter
approach is reductive in that explanatory power is invested in
hypothetical learning mechanisms which are presumably located
within the organism, but which are not observable.
Both pharmacological and learning theories of behavioral tolerance
reside at a distinctly different level of discourse from empirical
generalizations of behavioral tolerance. The latter abstractly
summarize observed empirical relationships, while the former
reductively attempt to explain the latter. Accordingly, the touch-
stone of a theory of behavioral tolerance is how well it accounts for
the relevant empirical generalizations. Actually, there is no more
appropriate way to judge the relevance, goodness, truth, or righteous-
ness of a theory of behavioral tolerance than to ascertain how
effectively and efficiently it explains the referent empirical
phenomena.
It is important here to recognize that no one type of theoretical
account is more basic or fundamental than any other. For example,
pharmacological theories are not necessarily to be preferred over
learning theories because by some metric they may be asserted to be
more molecular. Likewise, it is not useful to pursue the truth of
one theoretical approach vis-a-vis another. To be sure, if one
theory is unable correctly to explain an empirical generalization,
then that theory is wrong. But this does not mean that the theory
cannot be suitably revised or that an alternative theory must be
preferred.
When controversy arises over whether behavioral tolerance to
marihuana is learned or pharmacological, the controversy is not an
empirical  one, nor actually, can it be resolved empirically. The
controversy is about what type of theoretical mechanism can best be
offered to account for some existing empirical phenomenon. Such
controversy is silly, perhaps even nugatory. Either a pharmacolog-
ical or a learning theory can equally well serve the functions of
explaining lawful empirical relationships and of generating
future research, and neither type can ever be proved to be true.
The behavioral pharmacologist must choose between these approaches
or some combination of these approaches (e.g., Kalant et al. 1971;
McMillan 1976), actually on the basis of personal preference.
110Behavioral tolerance is empirical: whether its basis is learned or
pharmacological remains a theoretical issue.
Learning Theory of Behavioral Tolerance
Having drawn a distinction between empirical and theoretical
behavioral tolerance, and between learned and pharmacological theories
of behavioral tolerance, I should like now to present one version of
a learning theory of behavioral tolerance to marihuana. This theory,
which was first presented in 1972 (Ferraro 1972) and which has been
since elaborated (Ferraro, et al. 1974; Ferraro 1976), is indebted
conceptually to Dews (1962) and Schuster (Schuster and Zimmerman
1961; Schuster et al. 1966) for their recognition that learning
may explain behavioral tolerance to psychotropic drugs, and to
Loewe for his early observation (1944) that behavioral tolerance
to marihuana is related to the development of compensatory responses.
The present learning theory is intended specifically to explain the
sorts of empirical generalizations presented in a previous section
of this chapter and, in fact, it has rather narrow boundary conditions.
Specifically, the theory is restricted to operant/instrumental
behavior which is maintained by positive or negative reinforcement
conditions.
The following summary account of the theory very closely follows that
recently presented elsewhere (Ferraro 1976).
It is first assumed that an operant/instrumental response is under the
control of antecedent discriminative stimuli, which set the occasion
for the response, and of consequent reinforcing stimuli, which deter-
mine the probability of response occurrence. A second assumption is
that the administration of a behaviorally-effective dose of marihuana
can alter responding so as to produce an adverse change in the
relationship between responses and discriminative and reinforcing
stimuli.
Adverse changes in the behavior-environment relationship produced by
marihuana activate compensatory responses to the extent that they
are available in the situation. Compensatory responses have the
status of a hypothetical construct; they are presumed to exist within
the organism but they are not necessarily observable (they are reduc-
tive) . Once activated by marihuana-produced adverse changes in the
environment, these hypothetical compensatory responses counteract or
offset the adverse changes; that is, they function to reestablish the
original, more favorable, behavior-environment relationships.
As compensatory responses are repeatedly activated under marihuana,
they are gradually learned or associated to the existing stimulus
situation. Thus, under repeated administrations of marihuana there
is a progressive increase in the strength of learned compensatory
responses and a consequent progressive diminution in the drug-induced
behavioral alterations. Compensatory responses are learned because
they are reinforced by the reductions in the adverse environmental
consequences which the compensatory responses themselves produce.
By way of overview, the rate and extent of behavioral tolerance to
marihuana is hypothesized to be a direct function of the rate and
extent to which compensatory responses are activated and learned in
111the situation.
Status of The Learning Theory
As with any other theory of behavioral tolerance to marihuana, the
usefulness of the present theory is gauged by its ability to explain
the empirical generalizations relevant to it. Clearly, the truth-
fulness of the theory cannot be determined empirically since the
central reductive construct of the theory, the compensatory response,
is asserted to be hypothetical. There is no problem here. The
focus of the behavioral pharmacologist’s research attention is more
appropriately directed to engendering empirical relationships than
to certifying hypothetical theoretical constructs. Where empirical
phenomena arise that are not readily explained by the theory, the
theory is revised accordingly, if possible. If this is not possible,
then the usefulness of the theory is compromised to that extent.
As may already have been anticipated, the present learning theory
of behavioral tolerance to marihuana can explain each of the ten
empirical generalizations presented earlier. After all, the theory
was largely created with these generalizations in mind. Nevertheless,
it might be instructive about the theory to discuss briefly how the
theory accounts for a few of these generalizations.
The first four empirical generalizations, which in one way or another
relate behavioral tolerance to adverse behavior-environment relation-
ships produced by marihuana, follow directly from the theoretical
assumption that marihuana-induced adverse environmental consequences
activate compensatory responses so that compensatory responses are
less likely to occur (but still may) in the absence of drug-produced
adversity.
The empirical generalization (Generalization 6) that behavioral
tolerance to marihuana is more likely to develop for simple than for
complex responses is explained theoretically in terms of the relative
availability or effectiveness of compensatory responses. It is
assumed within the theory that compensatory responses are less
available and/or less effective the more complex the referent response
which is affected by marihuana.
Similarly, according to the theory, the opportunity to respond under
the influence of marihuana enhances the development of behavioral
tolerance (Generalization 8) since the opportunity to learn compen-
satory responses is greater when the drug is administered inside
as opposed to outside of the situation.
Finally, the last two empirical generalizations, which relate
behavioral tolerance to antecedent environmental conditions, follow
naturally enough from the theoretical supposition that compensatory
responses are learned to the environmental stimuli present in the
situation. That is, the occurrence of learned compensatory responses
will exhibit specificity to the stimulus situation in which they are
acquired, although some stimulus generalization could certainly be
anticipated (Generalization 9). Furthermore, considered as learned
behavior, compensatory responses will be relatively permanently
associated to the stimulus situation in which they are initially
acquired, unless, of course, explicit procedures are executed to
112counteract the learned associations (Generalization 10).
SUMMARY AND CONCLUSIONS
Confusion and controversy sometimes arise regarding the concept of
behavioral tolerance. This occurs, in part, because a distinction
is not always adequately made between empirical and theoretical
behavioral tolerance. Empirical definitions of behavioral tolerance
are both operational and functional. As such, empirical definitions
permit instances of behavioral tolerance to be identified within
limits. However, they do not provide for the description of parmet-
ric relationships regarding behavioral tolerance nor do they explain
behavioral tolerance. These latter two functions are accomplished,
respectively, by descriptive systems and theoretical systems of
behavioral tolerance.
A descriptive system of behavioral tolerance collates individual
empirical relationships regarding the parameters of behavioral
tolerance and from them inductively arrives at an abstract empirical
generalization which generates more implications than each relation-
ship in isolation. In this abstract form, empirical generalizations
represent a first-order basis for making predictions regarding the
extent and rate of occurence of behavioral tolerance.
Most empirical generalizations regarding behavioral tolerance
relate in some manner to antecedent stimuli, response conditions, and
consequent stimuli. The implication here is that behavioral tolerance
is empirically constituted of various drug-environment-behavior
interactions. But since empirical generalizations are arrived at
inductively, there is no assurance regarding their correctness.
Empirical confirmation of the predictions made from empirical
generalizations of behavioral tolerance must be sought within the
boundary conditions which apply to the generalizations.
Theories of behavioral tolerance go beyond empirical descriptive
systems of behavioral tolerance in attempting to explain the concept
in terms of the mechanisms which underlie it. Accordingly, theories
of behavioral tolerance are reductive; they resort to presumed
processes within the organism to explain observed empirical phe-
nomena. Typically, these are processes described either in terms
of pharmacological or learning constructs. Neither type of theory
of behavioral tolerance is more fundamental, relevant, appropriate,
or correct than the other. Either is acceptable to the extent
that the reductive mechanisms it proposes are Capable of ex-
plaining the existing empirical generalizations regarding
behavioral tolerance. Behavioral tolerance is empirical. Thus.
it is inappropriate to debate whether behavioral tolerance is
ultimately a learned or a pharmacological process; this remains
a theoretical question.
Theories of behavioral tolerance are not necessary. They do, however,
represent an efficient, second-order basis for making predictions
regarding behavioral tolerance. Accordingly, theories of behavioral
tolerance can be quite useful (even if not always correct). In this
regard, it is possible to account for several empirical generaliza-
tions regarding behavioral tolerance to marihuana with a learning
theory which asserts that behavioral tolerance is directly related
113to the extent to which compensatory responses are activated and
learned under the drug. The important aspect of this learning
theory is not its correctness or incorrectness (it is most likely
incorrect) but its probability of generating future research and
of providing direction regarding the application of behavioral
tolerance phenomena to clinical and therapeutic situations. These
latter probabilities remain to be determined.
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117IV. MARIHUANA
Behavioral Tolerance: Lessons
Learned from Cannabis Research
Reese T. Jones, M.D.
INTRODUCTION
From the beginning of our cannabis research we were impressed that
so-called nonpharmacologic factors were very important in determining
many of the drug’s effects. I suppose, right from the start, we were
studying the phenomenon this conference is about. However, “behav-
ioral tolerance” and “learned tolerance” are terms I have never felt
a great need to use. I’m not sure why. Perhaps it is due to fuzzy
thinking, but I would rather think it is due to a belief that the
mechanisms of behavioral, learned, physiologic, and other kinds of
tolerance are more similar than different. The definition of
tolerance:
(a) Diminished effect with repeated exposure to a given dose
and
(b) Return of original effect or an increased effect following
an increased dose,
assumes nothing about mechanisms. To adopt a terminology like
“behavioral” or “learned” tolerance that assumes mechanisms and that
may mislead the nonspecialist doesn’t seem to be progress to me.
At one point I kept a list of various terms used to describe (and by
some to explain) different types of tolerance. These include
behavioral, psychological, learned, behaviorally augmented, bio-
chemical, metabolic, cellular, tissue, organic, dispositional,
pharmacological, physiologic, central, peripheral, functional,
central nervous system, cross, acquired, innate, reverse, negative,
and real. Except for the relatively rare instances of “metabolic”
tolerance, most of these terms may well be referring to similar
processes and common mechanisms. The evidence for this was covered
in a review some years ago (Kalant, LeBlanc, and Gibbons 1971) and by
other reports in this monograph (LeBlanc, Poulos, and Gappell 1977;
Carder 1977).
In my own research strategy I have avoided trying to make clean dis-
tinctions between behavioral, physiologic, and mental phenomena. This
113is mostly due to a faith that all mental and psychological and behav-
ioral events do, at some level, have physiologic, neurochemical, neuro-
pharmacologic mechanisms in common.
The psychopharmacology of cannabis is such that the behavioral history
of the person using the drug and things like set and setting are per-
haps more important than with many other CNS-active drugs. Cannabis
is a drug that tends to be consumed at fairly low doses by most people,
leading to a low level of intoxication. The material available to
most users tends to be of low potency or often of hardly any potency
at all. The smoked route of administration commonly employed allows
easy titration of dose and level of intoxication. Tremendous “adver -
tising’” and social and cultural forces tend to shape experienced
effects, or at least influence the effects reported by users. It is
difficult to think of a drug about whose effects more mythology, fact,
and fantasy have been spread. Cannabis’ pharmacology, particularly
its spectrum of effects, allowing a relatively clear consciousness
during intoxication (relative to autonomic and other physiologic
effects), perhaps makes psychological factors more important than is
the case with CNS depressants like alcohol and barbiturates. The
drug’s relatively short duration of action and relatively infrequent
use (in our culture) tend to make psychological factors more important
and such pharmacologic factors as the “bathing of the neuronal pool”
less important. All this comes together so as to make expectation,
setting, past psychoactive drug experience, personality, associates,
time of day, etc., more important determinants of ultimate drug
effects than if, for example, we were considering the effects of 150 mg
percent blood levels of alcohol or 1 gram doses of LSD (Jones 1971).
That regular smokers of cannabis become more intoxicated when smoking
in a group, or more intoxicated when they can smell and taste the smoke,
or be more subject to feelings of intoxication after smoking placebos
might strike some as having only tangential relevance to behavioral
tolerance. So I will describe some data from recent experiments that
may have more direct relevance to our topic. The first experiment
concerns the effects of practice on marihuana-induced changes in
reaction time. The second has to do with behavioral tolerance evident
in subjects chronically treated with oral doses of tetrahydrocannabinol
(‘MC) in a situation where behavior, behavioral tolerance, cardiovas-
cular physiology, cardiovascular tolerance, and other things get con-
ceptually muddled in my mind.
EFFECTS OF PRACTICE AND LEARNING ON MARIHUANA EFFECTS
The reaction time study grew out of a problem that arose when we began
studies of ‘IX effects over a 4-to 6-week period in hospitalized
volunteers who were tested repeatedly (Jones, Benowitz, and Bachman
1976).
In our earlier outpatient studies, largely involving single or a few
doses of THC or cannabis given to subjects who visited the lab on only
a few occasions, we found what many investigators have--decrements in
reaction time and impaired performance on a variety of perceptual,
motor, cognitive, and other tasks. Dose-related, to be sure, but
fairly predictable.
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daily schedule or even with multiple tests during the day, and most
of their waking hours were spent in the lab. The paradigm used with
the hospitalized volunteers involved a week or so of practice on a
task before administration of the THC or cannabis. Thus, they were
well adapted to a test situation, well trained in laboratory rituals,
and, specifically, well practiced on the task before being drugged.
With such a test schedule we found that the previously reliable drug
treatment effects disappeared. Doses of THC that reliably slowed
reaction time or impaired performance on a memory task in the out-
patients had no effect in the hospitalized subjects. It looked like
acquired tolerance developing before any drug was given to them.
We decided to see if this unexpected resistance to drug-induced
alterations in behavior was evident in well-practiced outpatient
volunteers. It was. Since a full description of this study has been
published, I’ll only cover a few points here (Peeke, Jones, and Stone
1976). A group of outpatient volunteers practiced on a complex visual
reaction time task on four successive test days before receiving
marihuana, in order to see whether practice alone in a nondrugged state
would alter the response to cannabis. The 34 volunteers all used
marihuana two to three times a week during the few months prior to
the experiment. They were divided into three experimental groups.
Group M-P smoked marihuana (cigarette containing 20 mg WC) during
successive daily test sessions 1 through 4 and then smoked a placebo
cigarette on session 5. Group P-M smoked placebo cigarettes on
sessions 1 through 4 and a marihuana cigarette on session 5. The
third group performed the tasks on five daily test sessions, not
smoking cigarettes on any. All testing was at the time of peak
effects.
A number of tasks were used, but I’ll just describe the results on
the most difficult one--a categorization task where the subject had
to make a judgment as to whether a two-attribute stimulus, varying
as to both form and color, matched a preceding two-attribute stimulus.
It was a fairly difficult task where four judgments were possible:
that is, the Judgment could be (1) same color, same form; (2) same
color, different form; (3) different color, same form; and (4) dif-
ferent color, different form. If a correct response was made, the
stimulus disappeared to be replaced 368 msec later by the next
stimulus requiring another Judgment. The test stimulus about which
the judgment was made became the “preceding” stimulus for the next
trial and thus had to be retained in memory after the response. Thus
the memory trace for a stimulus served in different capacities on two
successive trials. During an experimental session the task was run
for five blocks, each containing 40 trials. In the data in figure 1
tire mean reaction time for each block of trials was computed, yielding
five data points per session for each Judgment.
As judged by the mean reaction times, the task was a fairly difficult
one. Initial reaction times of over one second were common. The
group M-P, who had received no practice before performing the task
under marihuana, showed considerable impairment during the first test
session. The short duration of the impairment was surprising. The
M-P group showed considerable improvement during session 1 (that is,
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Fig 1 Mean reaction time for drug treatment groups for each
block of trials within each session for the Different Color- Different
Form Judgment of the Contingent Categorization task
during their first exposure to marihuana in the laboratory) and by
the end of session 2 (that is, their second laboratory day smoking
marihuana) , their performance was indistinguishable from the per-
formance of the group that had been smoking placebo only. Remember
that each data point in the figure represents 40 trials on the task
for each subject, so that by block three, when the greatest perform-
ance gain is seen, the subjects had already received considerable
practice on the task. Despite the disappearance of marihuana effects
on performance, the physiological and subjective responses to the
marihuana diminished only slightly over the four daily sessions.
These included salivary flow, pulse rate, and self reports of intoxi-
cation levels. Practice while intoxicated improved performance. The
rate of improvement differed for the M-P and the P-M groups; however,
the final level of performance was comparable for both groups.
The performance of the group who smoked nothing was not different
from the P-M group on the first four sessions nor different from M-P
on the fifth session. Thus, the well-practiced outpatients resembled
our well-practicedinpatients in terms of diminished magnitude of drug
effects. Our hunch is that with practice, particularly on a complex
perceptual task, such things as the importance of attention are
121gradually reduced and behavior becomes far more automatic. Thus,
the demands of the task may well change and resulting drug effects
diminish. The alternate explanation--a fundamental adaptation at
the neuronal level with practice and consequent drug effect differ-
ences--is also plausible and intriguing.
BEHAVIORAL TOLERANCE : IN THE HEART OR IN THE HEAD?
The utility of considering both behavioral and physiologic data when
trying to understand what might seem to be behavioral tolerance I
hope is illustrated in the next example. The data is from our toler-
ance studies with hospitalized volunteers (Jones, Benowitz, and
Bachman 1976). The dose of tetrahydrocannabinol was 20 mg given
orally every three hours. Our goal in this study was to produce
tolerance as rapidly as possible so as to study drug interactions
in the tolerant and nontolerant state. Hence, the dosage schedule
was selected so that we could maintain a fairly constant tissue
level of cannabinoids, or “continually bathe the neuronal pool,” as
Seevers and Deneau (1963) said a bit more poetically some years ago
when discussing optimal conditions for the appearance of tolerance
and dependence to opiates. It would be handy if we could implant a
pellet of THC or use some similar strategy. This, of course, is
difficult to do in human studies, so the every-three-hour dosage
schedule used in our current studies is a compromise.
The behavioral tolerance that I’ll discuss has to do with behavior
that I’ll term “falling down.” Many of our experimental subjects
frequently become dizzy and some fall down early during the period
of the THC administration. Even though the MC is continued, the
falling down behavior rapidly decreases and disappears, fulfilling
part of the definition of tolerance. It returns if the THC dose is
rapidly increased. The change in behavior is most dramatic. In most
subjects the falling tends to disappear completely within 24 to
48 hours after the THC is begun, indicating rapid development of
tolerance. One might assume that such behavioral tolerance to
falling down is indicative of some sort of so-called “functional”
or “CNS” or other nonmetabolic mechanisms. Although we are looking
hard, we as yet find no evidence for metabolic tolerance sufficient
to account for the phenomenon. However, by following some fairly
simple cardiovascular changes, we can partially account for the
behavioral tolerance and, I hope, to a small extent illustrate the
utility of not distinguishing too sharply between physiological
and behavioral tolerance.
The falling down behavior tends to occur after a subject has just
stood up following a period of being supine or sitting. Of course,
whenever a person stands up from a prone or supine position, drugged
or not, there is a transitory drop in blood pressure. Tetrahydro-
cannabinol and many other drugs produce fairly dramatic drops in
blood pressure when measured right after standing. When symptoms
appear we call this orthostatic hypotension. These changes are des-
cribed in a recent report from our laboratory (Benowitz and Jones
1975).
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in figure 2. The change in systolic blood pressure from supine to
quiet standing for one minute is plotted over the one-month course
of the study. me pressures were all measured at 7 a.m. when the
subject first got out of bed. The drops in BP can be dramatic- -for
example, on day 11. The 20 mg doses of oral THC had been begun at
8 p.m. on day lo, so the subject had a total of four 20 mg doses
prior to the BP recording. The BP drops diminished over the next
four days. on day 17 the THC was stopped at 11 p.m., so that the
BP recorded at 7 a.m. on day 18 was 8 hours after the last dose of
THC . Note the increase in BP on day 18. The drug was restarted at
bedtime on day 18 (11 p.m.). Note the apparent decrease in degree
of tolerance at the 7 a.m. recording on day 19.
Some might view the blood pressure changes as being more evidence of
physiologic tolerance than of behavioral tolerance. An orthostatic
BP drop is not ordinarily viewed as behavior even though one must
engage in behavior to evoke it, i.e., stand up. At least standing
BP requires more behavior on the part of the subject than does
supine BP.
The subject in figure 2 showed fairly typical changes in body weight
during the experiment. During the first 5 days on THC he gained 12
pounds. Although one might consider this to be due to the ‘munchies”
or other THC-induced changes in appetite and diet, our data indicates
it is largely, if not entirely, due to an increase in body water,
mainly increased plasma volume (Benowitz and Jones 1975). When a
person experiences episodes of orthostatic hypotension, various
mechanisms are often triggered so as to increase plasma volume (Weil
and Chidsey 1968). In a sense the organism “learns” and adapts to
the BP drops. During THC administration, tolerances does not develop
or develops slowly to the weight gain or increase in plasma volume.
Thus, the behavioral impairment produced by MC (falling down) dis-
appears after a complicated set of homeostatic cardiovascular changes.
The performance of certain behaviors (for example, getting up and
walking around) is probably of great importance in determining
whether the homeostatic cardiovascular changes take place.
We have not yet done the crucial experiment, but I’m fairly certain
how it would come out, so I will speculate a bit. Suppose the behav-
ior I’m interested in (falling down) did not occur during the period
of THC administration. Would the weight gain and tolerance to the
postural BP drops still develop? What if the person never had occa-
sion to stand up while drugged and thus never became dizzy, faint,
and weak, never experienced precipitous BP drops, and subsequently
fell down? Under such conditions I think the tolerance to the hype-
tension would develop much more slowly, if at all. The rapid toler-
ance to the orthostatic hypotension (and to falling) in our test situ-
ation I think is a good example of behaviorally augmented tolerance.
Others have speculated that: “Stimulus to the development of toler-
ante.. .would not be the presence of the drug itself, but the degree
of impairment of required neuronal functions which the drug produces
(Frankel et al. 1975)." Those investigators were talking about CNS
neuronal functions, but cardiovascular system measures make the same
123FIGURE 2
Figure 2. Body weight and change in systolic blood pressure from
supine to standing for one minute. Measures all taken at 7 A.M.
Maximum THC dose was 20 mg every 3 hours. THC began at 8 P.M. on
Day 10 and stopped 8 P.M. on Day 22.point. If our hospitalized patients were kept in bed in a supine
position for the first few weeks of THC administration, I’m reason-
ably sure there would be marked hypotension when they then first
stood up, i.e., there would not be the rapid tolerance shown by the
patient in figure 2. In fact, just lying prone for a week without
any THC administration would, of course, be associated with a certain
degree of “acquired” hypotension upon standing. This maybe reflects
the loss of some other sort of “tolerance” (nondrug-related) to
postural BP changes. If the subject was never exposed to an episode
of hypotension, the necessary stimulus for the increase in plasma
volume would not occur and the large gain in body weight would not
follow. Tolerance in our test situation clearly has instrumental
value for the subject but, if no BP drop occurs, such homeostatic
changes would have no instrumental value.
We have not yet done such an experiment, but have observed that sub-
jects who stay in bed when the THC is begun have less weight gain and
more problems with persistent hypotension. Subjects who are success-
fully encouraged to get up slowly and keep moving despite the hypo-
tension and other symptoms develop tolerance very rapidly (as in the
case of the subject in figure 2).
I have an impression that our subjects tend to demonstrate more rapid
and profound tolerance to many cannabis effects than is the case in
other chronic administration experiments. It may well be that our
particular dose schedule, i.e., around-the-clock administration, in
a sense forces the subjects into an optimal behaviorally augmented
tolerance paradigm. That is, our subjects can’t smoke a number of
marihuana cigarettes and then go to bed, as happens in other studies.
Even though intoxicated, subjects in our experiment are required
frequently to perform and behave. These subjects very rapidly develop
tolerance.
Does all this mean that BP and plasma volume changes are to be con-
sidered part of behavioral tolerance? Or are they examples of physio-
logic tolerance? I’m inclined to agree with those (Kalant, LeBlanc,
and Gibbons 1971) who emphasize the similarities rather than differ-
ences in varieties of tolerance.
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126V. STIMULANTS
Behavioral Tolerance to Cocaine
William L. Woolverton, Ph.D., and
Charles R. Schuster, Ph.D.
Conflicting reports regarding the development of tolerance to the
effects of cocaine have appeared in the literature. It has been
reported (Jaffe 1975; Kosman and Unna 1969) that human cocaine
addicts can tolerate doses as high as 10 grams per day. However,
whether this tolerance is acquired or simply the result of normal
variability in initial tolerance in the population is unclear.
In the animal laboratory, the consensus is one of increased sen-
sitivity (reverse tolerance) to many of the behavioral effects
of cocaine. As early as 1924, Lewin stated that
as opposed to morphine, animals cannot become
accustomed to cocaine; they even exhibit an
increasing sensibility to the drug (Byck 1974,
p. 245).
Indeed, numerous reports of increased sensitivity to the central
stimulant effects of cocaine in rats (Downs and Eddy 1932; Post
1977; Stripling and Ellinwood 1977),. dogs (Tatum and Seevers
1929) and rhesus monkeys (Tatum and Seevers 1929; Post 1976)
have appeared in the literature. Doses of cocaine which initial-
ly produced a mild stimulation induced convulsions and often
death during repeated administration. However, changes in sen-
sitivity to the effects of cocaine on conditioned behaviors in
laboratory animals have not been studied.
With these considerations in mind, we have been studying the
effects of repeated administrations of cocaine in rats in several
behavioral situations. Both tolerance and increased sensitivity
to cocaine have been observed, depending upon the relationship
of time of injection to the experimental session. Further, cross
tolerance between cocaine and d-amphetamine, as well as increased
sensitivity to d-amphetamine, has also been observed. The find-
ings support the hypothesis of Schuster et al. (1966) that behav-
ioral tolerance develops to the effects of a drug that interfere
with the ability of the organism to meet the contingencies of
reinforcement.
127GENERAL PROCEDURE
Two basic experimental procedures were used to test the effects of
single and repeated administrations of cocaine in rats.
Milk Drinking Procedure. Daily experimental sessions consisted of
15 minutes access to 50 ml of a sweetened condensed milk solution.
At the end of this period, the quantity of milk remaining was
measured to determine milk intake.
Operant Procedure. Rats were trained in a standard operant cham-
ber to press a lever for food delivery on a schedule of reinforce-
ment that required that responses be spaced by at least 20 seconds
(differential reinforcement of low rates 20 seconds: DRL 20”).
The effects of cocaine on lever pressing frequency were measured.
All animals in both procedures experienced 1) initial dose-effect
determinations of cocaine or d-amphetamine, 2) a period of re-
peated administration of cocaine or d-amphetamine, 3) dose-effect
redetenminations of cocaine or d-amphetamine. These procedures
were carried out in the following manner:
1) Initial Dose-Effect Determinations. Initially all animals
were injected (i.p.) 15 minutes before the session with 1 ml/kg
0.9% saline. When behavior had stabilized (less than 10% varia-
tion in mean intake or number of food pellets delivered for at
least 3 consecutive days) a dose of drug was substituted for the
injection of saline before the session. Doses of cocaine (4.0,
8.0, 16 and 32 mg/kg) or d-amphetamine (0.5, 1.0, 2.0, and 4.0
mg/kg) were administered once each in an ascending order in the
milk drinking procedure. Doses of cocaine (4.0, 8.0, 16, and 32
mg/kg) were administered once in an ascending and once in a de-
scending order to rats responding in the operant procedure. d-
Amphetamine was not tested in the operant procedure.
2) Repeated Administration. A dose of cocaine or d-amphetamine
that reduced milk intake to at least 50% of levels observed fol-
lowing saline injections was chosen for daily administration to
rats in the milk drinking procedure. Similarly, a dose of cocaine
that decreased number of reinforcements to less than 50% of that
observed following saline injections was chosen for daily admin-
istration to the rats trained in the operant procedure. Daily
drug administration continued for between 75-110 days. When milk
intake reached a new stable level, dose-effect redeterminations
were begun in the milk intake procedure. In the operant proce-
dure, dose-effect redeterminations were begun on day 61 of re-
peated administration.
3) Dose-Effect Redeterminations. Dose-effect redeterminations
were conducted in the following manner. On selected days, test
doses of saline, cocaine, or d-amphetamine were substituted for
the usual drug or saline injection. Test doses were given in an
ascending order in the milk drinking procedure and in an ascend-
ing and descending order in the operant procedure. There were at
128least 3 sessions between test doses of drug in which the animal
was injected with the usual daily injection. Thus, it Was possi-
ble to measure the effect of each dose of both drugs during the
period of repeated administration of either drug.
RESULTS
Milk Drinking Procedure. In the initial dose-effect determinations,
cocaine and d-amphetamine produced dose-related decreases In milk
intake [Figs, IA, 2A, 3A, & 5). When the two highest doses of
cocaine (16 and 32 mg/kg) or d-amphetamine (2.0 and 4.0 mg/kg)
were given, stereotyped behaviors including sniffing and head
bobbing were observed.
FIGURE 1
Dose Cocaine (mg/kg) Sessions
Left Panel (A). Effects of injections of cocaine on mean milk
intake of rate in Part 1, before (0-r) and during (0-0) a
period of repeated daily injections of cocaine (16 mg/kg). Drug
effects are expressed as percent of non-drug control levels.
Vertical lines represent the standard error of the mean. The
points above S represent the effects of saline injection on intake.
Right Panel (B). Effects of repeated administration of cocaine
(16 mg/kg) or saline on mean milk intake. Drug effects on milk
intake are expressed as percent of non-drug control Levels. Each
data point is the mean of 5 consecutive sessions.
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Left Panel (A). The effects of d-amphetamine on the mean milk
intake of the rate in Group B of Experiment II before (0-O) and
during (O-O) a period of repeated administration of d-ampheta-
mine (2.0) mg/kg) . Drug effects are expressed as percent of non-
drug control levels. The points above S represent the effects
of saline injections on intake. vertical lines represent the
standard error of the mean.
Right Panel (B). Effects of repeated administration of d-ampheta-
mine (2.0 mg/kg) on the mean milk intake of the rats in Group
B from day 1 to day 30. Each point is the mean of 5 consecutive
seesions.
The dose of 16 mg/kg cocaine initially reduced milk intake to
about 30% of control levels and was chosen for daily administra-
tion. During the first 45 days of repeated cocaine administra-
tion milk intake increased from 30% of control levels to about
70% of control levels. Milk intake of rats receiving saline daily
remained at about 100% of control levels throughout this period
(Fig. 1B). In a group of animals receiving cocaine after the
session during this period, milk intake decreased to about 80% of
original control levels (Fig. 3B).
The dose of 2.0 mg/kg d-amphetamine reduced intake initially to
about 30% of control levels. Intake increased during the first
30 days of repeated administration to about 85% of original con-
trol levels (Fig. 2B).
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Left Panel (A) ; Effects of cocaine on mean milk intake before
(0-0) and during (0-0) a period of daily injections of cocaine
(16 mg/kg) given after the session. Milk intake is expressed as
percent of control levels. The points above S represent the
effects of saline injections on intake. Vertical lines represent
the standard error of the mean.
Right Panel (B). The effects of repeated administration of co-
caine (16 mg/kg) on milk intake of the rats in Part 2. Injec-
tions of cocaine were given immediately after the 15 minute access
period. Intake is expressed as percent of control levels.
After tolerance had developed to the disruptive effects of 16 mg/
kg cocaine, the dose-effect function of cocaine was shifted to
the right in animals receiving cocaine daily before the session
(Fig. l.A) (F=16.6, d.f. 3,48, p<.00l) . Furthermore, when the
dose-effect function of cocaine on milk intake was redetermined
in rats receiving d-amphetamine before the session, it was simil-
arly shifted to the right (Fig. 4B) (F=13.2, d.f.=1, 40, p<.00l).
In contrast, when cocaine dose-effect function was redetermined
in rats receiving cocaine daily after the session, a shift to the
left in the function was observed (Fig. 3A) (F=4,97, d.f.=1,40
P<.05).
131FIGURE 4
Dose d-Amphetamine (mg/kg) Dose Cocaine (mg/kg)
Left Panel (A). Effects of d-amphetamine (0.5 - 4.0 mg/kg) on
milk intake in Group-A before (0-0) and during (0-O)
a period of daily injections of cocaine (16 mg/kg). Drug effects
on intake are expressed as percent of non-Drug control levels.
The points above S represent the effects of saline injections on
intake. Vertical lines represent the standard error of the mean.
Right Panel (B). Effects of cocaine on milk intake of the rate
in Group B before (0-0) and during (0--0) a period of daily
injections of d-amphetamine (2.0 mg/kg). Drug effects are ex-
pressed as in the left panel (above).
Following the redetermination of the cocaine dose-effect function
in animals receiving pre-session cocaine, all injections were
stopped. On selected days (4 and 10) after termination of injec-
tions, the effect of 16 mg/kg on intake was again determined. On
day 4, the animals were still tolerant to the effects of this
dose on intake. However, on day 10 the effect of 16 mg/kg on in-
take was the same as that observed in the initial dose-effect
function, indicating that the animals were no longer tolerant
(Table 1).
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THE EFFECTS OF 16 MG/KG COCAINE ON MILK INTAKE BEFORE,
DURING, AND AFTER THE DAILY COCAINE REGIMEN
Condition Intake (ml)
Initial dose-effect determination 13.6 ± 4.61 (S.E.M.)
Dose-effect redetermination 25.6 ± 1.96 (S.E.M.)
4 days after daily
cocaine administration 27.3 ± 3.13 (S.E.M.)
10 days after daily
cocaine 14.3 ± 5.4 (S.E.M.)
After tolerance had developed to the effects of 2.0 mg/kg d-am-
phetamine on milk intake, the dose-effect function of d-ampheta-
mine was shifted to the right in animals receiving daily d-amphet-
amine before the session (Fig. 2A) (F=18.7, d.f.=1, 40, p<00l).
When the dose-effect function of d-amphetamine on intake was re-
determined in animals receiving cocaine daily before the session,
a similar shift in the d-amphetamine dose-effect function was ob-
served (Fig. 4A) (F=35,-d.f.=3,48, p<.001). On the other hand,
when the d-amphetamine dose-effect function was redetermined in
animals receiving cocaine after their daily session, a shift to
the left in the function was observed (Fig. 5) (F=30.9, d.f.=1,40,
p<.00l). Thus, whether tolerance or supersensitivity developed
to the effects of cocaine on milk drinking was dependent on the
relationship of the drug administration to the period of access
to milk.
Operant Procedure. In the initial dose-effect determinations
single injections of cocaine resulted in a dose-related increase
in responses per session (Fig. 6A) and a decrease in the number
of reinforcements received (Fig. 7A). The IRT distribution (Fig.
8A) was shifted to the left with increasing dose of cocaine. A
dose of 16 mg/kg was chosen for repeated administration since it
decreased reinforcements by at least 50% in all cases.
133FIGURE 5
Initial dose-effect determination
Dose-effect redetermination
Dose d-Amphetamine (mg/kg)
Effects of d-amphetamine on mean milk intake before (0-0) and
during (0-O) the period of repeated daily injection of cocaine
(16 mg/kg). Injections of cocaine were given immediately after
the session. Milk intake is expressed as percent of control
levels of intake.
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Dose Cocaine (mg/kg) Sessions
Left Panel (A). Effects of single injections of cocaine on the
mean numver of responses/session for the rats (N=4) responding
on a DRL 20" schedule for food before (0-O) and during (0-O)
a period of daily injection of cocaine (16 mg/kg). The points
above S represent the effects of saline injection on responding.
Vertical lines represent the standard error of the mean.
Right Panel (B). Effects of repeated administration of cocaine
(16 mg/kg) on responses/session for the rats (N==4) responding
on a DRL 20" schedule for food during the period of repeated
administration. Each point is the mean of 5 consecutive sessions.
During the first 60 days of repeated administration, responses
per session decreased from 278.1 (+ 25.2 s.e.m.) for days l-5 to
195 (+ 12.6 s.e.m.) for days 55-60-(Fig. 6B). Furthermore, in the
initial dose-effect determinations, responses per session follow-
ing 16 mg/kg averaged 336 (+ 34 s.e.m.) while an average of 195
(+ 18.9 s.e.m.) responses per session was observed following this
dose on days 59 and 60. The decrease in responding was maximal
at about day 40 and relatively stable thereafter. The change in
mean number of reinforcements per session over the first 60 days
135of daily cocaine injections is shown in Fig. 8B. During this per-
iod, reinforcements per session increased from 51.1 (+ 6.0 s.e.m.)
for days 1-5 to 59 (+ 5.4 s.e.m.) for days 55-60. Reinforcements
per session for days l-5 is high since this point is an average.
Most importantly, in the initial dose-effect determinations,
reinforcements per session averaged 32.5 (+ 2.5 s.e.m.) while an
average of 57 (+ 9.4 s.e.m.) food pellets was delivered for
sessions 59 and-60. The increase in number of reinforcements per
session was maximal at about day 40 and relatively stable there-
after,
FlGURE 7
Dose Cocaine hg/kg) Sessions
Left Panel (A). Effects of single injections of cocaine on the
mean number of reinforcements per session for the rats (N=4)
responding on a DRL 20” schedule for food before (0-0) and
during (0-O) a period of daily injection of cocaine (16 mg/kg).
The points above S represent the effects of saline injection on
number of reinforcements. Vertical tines represent the standard
error of the mean.
Right Panel (B). Effects of repeated administration of cocaine
(16 mg/kg) on number of reinforcements per session for rats
(N-4) responding on a DRL 20” schedule for food during the period
of repeated administration. Each point in the mean of 5 coneecu-
tive sessions.
136FIGURE 8
SECONDS
137Figure 8
Left Panel (A). Effects of single injections of cocaine on the
IRT distributions of the rata responding on a DRL 20" schedule
for food before the repeated administration of cocaine (16 mg/kg).
Each IRT histogram is divided into 2 second bins and contains the
percent of the total responses per session that occurred in that
bin. Each histogram is the mean of two determinations of the
effects of each drug dose in all 4 rats. The IRT distribution
following saline injection (S) is the mean of 10 control sessions.
Doses of cocaine (mg/kg) are indicated on the left side of each
bin. Solid bins are 20" and represent reinforced IRT's.
Right Panel (B). Effects of single injections of cocaine on the
IRT distributions of the rats responding on a DRL 20" schedule
for food during the period of repeated administration of cocaine
(26 mg/kg). Histograms are as described above. Each is the mean
of two redeterminations of the effects of each dose in all 4 rats.
Figure 6A shows the effects of single injections of cocaine (4.0 -
32 mg/kg) on number of responses per session during the redeter-
mination of the dose-effect function. There was no effect of dose
of cocaine on number of responses per session in the redetermina-
tion. Relative to the initial dose-effect function, a two-way
analysis of variance revealed a significant interaction between
dose and daily treatment indicating non-parallel dose-effect
curves before and during daily administration. The decrease in
responses per session was significant (p<.0l) at the 16 mg/kg
dose. Changes observed at 4.0, 8.0, and 32 mg/kg were not signifi-
cant due to high variability in the effects of these doses in
different rats during the redetermination.
A one-way analysis of variance revealed no effect of dose of co-
caine on the number of reinforcements per session in the redeter-
mination (Fig. 7A). Relative to the initial dose-effect function,
a two-way analysis of variance revealed a significant effect of
daily treatment and a significant interaction between daily treat-
ment and dose of cocaine (F=4.44, d.f.=1,56, p (.05; F=4.87, d.f.=
3,56, p<.01 respectively) indicating non-parallel shifts in the
dose-effect function during the period of repeated administration.
Further analysis revealed no change in the number of reinforce-
ments per session following injections of saline, 4.0 and 8.0
mg/kg. `However, a significantly greater number of reinforcements
was delivered at 16 and 32 mg/kg during the dose-effect redeter-
minations, (p<.01 in both cases).
The average IRT distributions for the group during the redetermin-
ation of the dose-effect function are shown in Fig. 8. Consistent
with the response and reinforcement data presented above, there is
little noticeable effect of dose of cocaine on the IRT distribu-
tion during the redetermination. Relative to the initial dose-
effect data, the IRT’s following saline injection were shifted
slightly to the left as were IRT’s following 4.0 mg/kg. Following
8.0 mg/kg, there is some shift in the IRT’s toward the 20-22
second bin, but the percent of IRT’s that were reinforced remained
the same as was observed initially. Following 16 and 32 mg/kg,
138there was a distinct shift in the IBT distribution to the right
relative to those observed initially, indicating a decrease in
response bursting and a higher percentage of reinforced IRT’s.
SUMMARY
The experiments reported here demonstrated that single injections
of cocaine caused a dose-related disruption of both milk intake and
scheduled controlled behavior of rats. Cocaine increased the
low response rates of animals responding on a DRL 20” schedule.
In this regard, cocaine is similar to all other psychomotor stimu-
lant drugs (Sanger and Blackman 1976). Furthermore, high doses
of the drug (16 - 32 mg/kg) produced stereotyped behaviors that
were similar to those reported for other psychomotor stimulant
drugs (Ellinwood and Balster 1974; Randrup and Munkvad 1970).
Attenuation of the effects of a single dose of’ a drug and a shift
to the right in the dose-effect function during repeated adminis-
tration are evidence for tolerance to a drug. Pre-session admin-
istration of an intermediate dose of cocaine on a daily basis to
animals allowed to drink milk resulted in the development of
tolerance to the disruptive effects of cocaine on milk intake.
This tolerance was lost, however, by the tenth day following the
cessation of daily administration of cocaine. In contrast, when
the same dose of cocaine was administered post-session to animals
allowed to drink milk, increased sensitivity to the disruptive
effects of cocaine was subsequently observed. This increased
sensitivity was shown as well to d-amphetamine. In addition,
cross-tolerance was clearly observed between cocaine and d-amphet-
amine, suggesting a common mechanism of tolerance to both drugs.
The repeated administration of cocaine to animals trained to lever
press on schedules of reinforcement generating low response rates
resulted in tolerance to the behavioral effects of cocaine that
result in a decreased rate of reinforcement.
Thus, tolerance develops to the effects of cocaine that disrupt
milk intake and DRL 20” performance. These data are consistent
with the hypothesis of Schuster et al. (1966) which states that
behavioral tolerance will develop to the effects of a drug that
interfere with the ability of the organism to meet the contingen-
cies of reinforcement. In this respect, cocaine is similar to
many other drugs for which behavioral tolerance has been demon-
strated. In view of the numerous reports of increased sensitivity
to the behavioral effects of cocaine (Downs and Eddy 1932; Strip-
ling and Ellinwood 1977; Tatum and Seevers 1929) it is signifi-
cant that this effect was only observed when cocaine administra-
tion did not decrease reinforcement density. It is possible that
increased sensitivity to cocaine is the major pharmacological
effect of repeated administration but that environmental influen-
ces (e.g., reinforcement loss) are capable of activating compen-
satory mechanisms resulting in the development of tolerance.
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141VI. DEPRESSANTS
Behavioral and Pharmacological
Components of Phenobarbital
Tolerance
Maisy Tang, Ph.D., and John L. Falk, Ph.D.
While the degree of tolerance development to barbiturates is not as
great as to opioids, it is well documented (Kalant et al. 1971)
and its physiological basis is a combination of both drug metabolic
and central nervous changes (Goldstein, Aronow, and Kalman 1974).
Tolerance can develop to the behavioral effects of a drug: as well
as to its physiological effects. The development of behavioral
tolerance to repeated drug administration could be due to progres-
sive, general, physiological consequences of the drug regimen, or
to a more specific development of behavioral changes that allow
the organism to accommodate to the drugged condition. One method
for distinguishing these possibilities is to compare the develop-
ment of tolerance to repeated daily drug doses when they are given
prior to sampling behavior versus after such sampling (Campbell and
Seiden 1973; Carlton and Wolgin 1971; Chen 1968; LeBlanc et al.
1973, 1976). The present experiment used this method to evaluate
the behavioral tolerance which develops to the repeated administra-
tion of phenobarbital. Both schedule-dependent and schedule-
induced behaviors were examined to determine If these behaviors
would be differentially sensitive either to the degree of behavior-
al tolerance developed, or to the dosing regimen in relation to the
tolerance developed.
METHOD
Animals. Eight male, albino, Holtzman rats with an initial mean
body weight of 369 g (range: 350-389 g) were used. Except during
the dally 3-hr experimental session, all animals were housed
individually in standard Acme stainless steel cages in a tempera-
ture-controlled room with a 12-hr light-dark illumination cycle
(lights on 7 AM-7 PM). Water was continuously available in the
home cage from calibrated Richter-type drinking tubes.
Experimental chamber. Individual chambers consisted of Plexiglas
boxes (25.5 x 25.5 x 30.3 cm) with stainless steel rod floors. An
142operant lever and a food-pellet magazine were mounted on one side
of each box. On an adjacent side, a metal drinking spout attached
to a calibrated water reservoir was available. Licks on the drink-
ing spout were recorded with a drinkometer.
Naci). The vehicle solution was made from isotonic saline solution
. Drugs. Sodium phenobarbital was dissolved in isotonic saline (0.9%
titrated with 0.1 N sodium hydroxide to match the pH of the sodium
phenobarbital solution (pH 10.0). All doses were given sub-
cutaneously into the loose sldn on the back.
Procedure. Animals were reduced to 80% of their free-feeding body
weights and held at that level for the duration of the experiment
by limiting food rations. They were trained to lever press on a
fixed-ratio 1 schedule (FR 1) which delivered 45-mg Noyes food
pellets and were then shifted to a fixed-interval one min (FI
1 min) schedule. A lever press delivered a pellet only after at
least one min had elapsed since the last pellet delivery. All
other lever presses were ineffective but were recorded. No pro-
grammed stimulus informed the animal when such one-min periods
had elapsed. Animals were given 3-hr FT 1 min sessions every day
and then returned to their cages and allowed a food ration supple-
ment (Purina Laboratory chow, pelleted) sufficient to maintain them
at 80% of their initial free-feeding weights. Number of lever
presses, licks on the water spout, and pellets obtained were re-
corded both on counters and with cumulative recorders (Ralph
Gerbrands Co.). The volume of water consumed during each session
also was measured. When the values of the above measures became
stable from session to session for individual animals, the effects
of phenobarbital doses (20, 40 and 80 mg/kg, specified as the salt)
given 15 min presession were studied. Each dose was given to each
animal twice, first in an ascending and then in a descending order.
At least 5 noninjection sessions separated drug-injection days.
Two vehicle injections were given, one at the beginning and one at
the end of the drug series. Seven days after the second vehicle
injection, the animals were divided into two equal groups (N = 4).
One group received daily phenobarbital injections of 80 mg/kg
15 min presession (Before Group), while the other group received
the same dose 15 min postsession (After Group). These daily
dosing regimens remained in effect for the duration of the experi-
ment except on dose-effect redetermination days when animals from
both groups received their particular dose 15 min presession.
The dose-effect relation redetermination began on the fourteenth
day of the chronic dosing regimen and subsequent doses in the
redetermination series were at least 8 days apart. On inter-days,
the group dosing regimens continued as previously described. The
Before Group was given dose-effect relation redetermination doses
in the order: 120, 160, 100 and 120 mg/kg; the order for the After
Group was 120, 80, 100 and 120 mg/kg. A vehicle injection was
administered to After Group animals 6 days after the last dose-
effect determination dose. No corresponding vehicle injection was
given to the Before Group as this would have constituted a with-
drawal condition.
143RESULTS
The initial dose-effect relations and their redeterminations are
shown for both the Before and After Groups in Figure 1.
FIGURE 1
Fig. 1. Initial dose-effect relations for 2 groups (N = 4 each)
for phenobarbital. (mean of an ascending and a descending dose
order for all animals) shown as solid line functions, and mean
dose-effect relation redeterminations following 13 days of daily
80 mg/kg doses given either presession (Before Group) or post-
session (After Group).
The solid-line functions on the left side of each quadrant reveal
that prior to exposure to the different repeated-dose regimens
both groups responded in a similar fashion to phenobarbital doses
on all measures. Relative to the mean vehicle-injection levels,
phenobarbital doses had either no effect or a suppressive one on
all measures in the initial dose-effect determination, except for
lever-pressing rate which showed an enhanced rate at 20 mg/kg for
one group and at 40 mg/kg for the other. In contrast to the other
measures, water intake was decreased by the 20 mg/kg dose. Water
144intake levels for both groups under day-to-day and vehicle-injec-
tion conditions were at polydipsic levels characteristic of sche-
dules such as FI 1 min (Falk 1966; 1971).
Both groups developed tolerance to the 80 mg/kg repeated dose regi-
men, but the tolerance was not complete. Fig. 2 shows that only
"number of reinforcements" (pellets earned) attained its previous
level for both groups.
FIGURE 2
Fig. 2. Mean dally session measures for 2 groups (N = 4 each) given
80 mg/kg phenobarbital dally-injections either presession (Before
Group) or postsession (After Group). Baseline = mean of 6 sessions
preceding start of dally phenobarbital Injections.
The other measures remained below the former baseline level for
both groups, except the "licks/min" measure for the Before Group.
(Mean baseline values shown In Fig. 2 are the means of values for
the sessions preceding the beginning of the repeated-dose regimen).
The functions to the right in each quadrant of Fig. 1 (dashed
lines) reveal that the Before Group had developed greater tolerance
to phenobarbital than the After Group, as shown by the greater
shift to the right of the Before Group's dose-effect relation re-
145determination. Tolerance to repeated 80 mg/kg doses, while not
complete for either group (Fig. 2), was equivalent for the two
groups when the presession effect of this 80 mg/kg dose was com-
pared (Fig. 1). However, when larger doses were explored, the
greater tolerance of the Before Group, relative to the After Group,
became evident as a greater shift to the right in the dose-effect
relations. The reliability and lack of any serial-order effect in
the redetermination relations is indicated by the replicability of
the 120 mg/kg points, as this dose was the first and the last dose
given in the series.
DISCUSSION
Both the Before and After repeated-dose regimens produced marked
tolerance to phenobarbital. However, tolerance was incomplete, as
indicated by the incomplete return 'co previous baseline levels of
most of the behavioral indices (cf. Fig. 2). Suppressive effects
of phenobarbital on running in rats revealed a similar failure to
develop complete tolerance under repeated dosing (Schmidt
Both schedule-dependent (lever pressing) and schedule-induced
(polydipsia) behaviors developed tolerance to repeated phenobar-
bital dosing (cf. Fig. 1). Moreover, both kinds of behavior were
affected in a similar way by the differential effect of the two
dose regimens. The enhanced FI lever-pressing rate produced by
low doses of phenobarbital agrees with similar findings in the
pigeon given low doses of barbiturates under FI schedules (Dews
1955, 1964; Rutledge and Kelleher 1965). Low to intermediate
doses of barbiturates increase water intake in the rat (Jones
1943; O'Kelly and Weiss 1955; Schmidt 1958), but decrease it
under schedule-induction conditions (Falk 1964). The present
study confirms this latter result.
LeBlanc and his associates (LeBlanc et al. 1973, 1976) studied
the acquisition of tolerance to ethanol using a Before and an
After Group design as well. They concluded that both groups de-
veloped the same level of tolerance and only differed as to the
rate at which the tolerance developed. In their experimental de-
signs, the repeated-maintenance and testing doses were at the
same level. We too would have come to the same conclusion if our
testing (redetermination) doses had been limited to the mainte-
nance dose (80 mg/kg). In Fig. 1 it is evident that the groups
did not differ at 80 mg/kg in the redetermination phase; both
showed a similar tolerance. But the larger doses revealed the
different tolerance levels of the groups. Other investigators
have used the Before versus After Group design to explore tolerance
to d-amphetamine (Campbell and Seiden 1973; Carlton and Wolgin
1971). It was concluded that the After Groups showed little
evidence of tolerance development. But again a single level of
the test dose was administered rather than a determination and
redetermination of dose-effect relations. Such a procedure might
have unmasked some level of pharmacological tolerance development
in the After Groups.
146In conclusion, while the major portion of tolerance development to
phenobarbital in this study was explicable in terms of pharma-
cological exposure to the drug, nevertheless the greater shift to
the right of the Before Group's dose-effect redetermination func-
tions revealed an additional behavioral tolerance component.
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